Update July 12 - July 18, 2021, Dr. Peter J. Lansberg MD, PhD
Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics
COVID-19 publications - Week 28 2021 1059 Publications
PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]
Reliable on-line resources for Covid 19
WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap)
Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confrmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance
Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial)
Mainstream Media New York Times - Corona update The Delta Variant Is the Symptom of a Bigger Threat: Vaccine Refusal No Longer ‘Hidden Victims,’ Children Are Dying as Virus Surges in Indonesia The Most Influential Spreader of Coronavirus Misinformation Online Israeli Data Suggests Possible Waning in Effectiveness of Pfizer Vaccine Persuasion vs. Coercion: Vaccine Debate in Europe Heats Up The bubble bursts: New Zealand suspends quarantine-free travel from Australia. Should Vaccinated People Start Wearing Masks Again? Why Vaccinated People Are Getting ‘Breakthrough’ Infections
Washington Post - Corona update If you got the J&J vaccine, should you get a booster dose of Pfizer or Moderna? More than 4 million dead: Tracking global cases Europe’s hotels and restaurants are eager to welcome tourists — if they can find enough staff Health experts discuss vaccines Why some experts recommend upgrading to N95 masks to help fight the delta variant
Guardian - Corona update Indonesia loosens Covid restrictions despite record deaths Doctors warn over increasing number of young people with Covid in ICU Under-30s reluctant to take Covid vaccine cite fertility and side-effect concerns ‘Heart-wrenching’: inside a hospital grappling with Delta and vaccine hesitancy PHE upgrade Delta variant’s risk level due to reinfection risk
Key Articles
1. Review of COVID-19 Variants and COVID-19 Vaccine Efficacy: What the Clinician Should Know? J. Clin. Med. Res. 2021; 13:317-325Vasireddy D, Vanaparthy R, Mohan G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267839
2. The devil in the details: Herd immunity and pandemic response. Cell Host Microbe 2021; 29:1048-1051Schaeffer B, Taylor B, Bushman M, Hanage WP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265244
3. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis. Int. J. Immunopathol. Pharmacol. 2021; 35:20587384211031763Golpour M, Mousavi T, Alimohammadi M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250834
4. Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2021; 8:ofab284Yetmar ZA, Chesdachai S, Kashour T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258316
5. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc. Toxicol. 2021:1-9Vitiello A, Ferrara F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255300
6. Venous and arterial thromboembolic disease in COVID-19. J. Thromb. Thrombolysis 2021:1-3Ten Berg J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255267
7. Outcome and death risk of diabetes patients with Covid-19 receiving pre- hospital and in-hospital metformin therapies. Diabetol. Metab. Syndr. 2021; 13:76Tamura RE, Said SM, de Freitas LM, Rubio IGS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256824
8. A living mapping review for COVID-19 funded research projects: nine- month update. Wellcome Open Res 2020; 5:209Norton A, Bucher A, Antonio E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33117894
9. Self-infection with speech aerosol may contribute to COVID-19 severity. J Intern Med 2021; Kushalnagar P, Chow CC, Bax A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268819
10. Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review. BMJ Open 2021; 11:e050519Jenniskens K, Bootsma MCJ, Damen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253676
11. Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab140Hirschbaum JH, Bradley CP, Kingsford P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268475
12. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021; 45:123Hembram P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257504
13. Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies. Acta Cardiol Sin 2021; 37:355-364Chen PW, Tsai ZY, Chao TH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257485
14. COVID-19 and cardiovascular system-a comprehensive review. Rev Cardiovasc Med 2021; 22:343-351AlShahrani I, Hosmani J, Shankar VG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258902
15. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021:1410768211032850Aiyegbusi OL, Hughes SE, Turner G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265229
Basic Science (32 articles)
1. Recent advances in developing small-molecule inhibitors against SARS-CoV- 2. Acta Pharm Sin B 2021; Xiang R, Yu Z, Wang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249607 2. Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression. Appl Soft Comput 2021; 111:107683Dong M, Tang C, Ji J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248448 3. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis. Brief. Bioinform. 2021; Rahman MR, Islam T, Shahjaman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260684 4. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021; 45:123Hembram P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257504 5. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell 2021; Nathan A, Rossin EJ, Kaseke C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265281 6. Metal Organic Frameworks as Biosensing Materials for COVID-19. Cell. Mol. Bioeng. 2021:1-19Udourioh GA, Solomon MM, Epelle EI. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249167 7. Distinctive features of SARS-CoV-2-specifc T cells predict recovery from severe COVID-19. Cell Rep. 2021:109414Neidleman J, Luo X, George AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260965 8. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 2021; 229:108795Jamaly S, Tsokos MG, Bhargava R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252574 9. COVID-19 candidate genes and pathways potentially share the association with lung cancer. Comb. Chem. High Throughput Screen. 2021; Alnajeebi AM, Alharbi HFH, Alelwani W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254909 10. Effcient machine learning model for predicting drug-target interactions with case study for Covid-19. Comput. Biol. Chem. 2021; 93:107536El-Behery H, Attia AF, El-Feshawy N, Torkey H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271420 11. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape. Comput. Biol. Med. 2021; 135:104525Rampogu S, Gajula RG, Lee G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252682 12. The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology. Front Cell Dev Biol 2021; 9:684874Cui H, Su S, Cao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249938 13. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3- Chymotrypsin-Like Protease. Front Chem 2021; 9:692168Ferreira JC, Fadl S, Villanueva AJ, Rabeh WM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249864 14. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? Front. Endocrinol. (Lausanne) 2021; 12:665134Moin ASM, Al-Qaissi A, Sathyapalan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248841 15. Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19. Front. Immunol. 2021; 12:693085Gupta A, Chun HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248990 16. A Computational Approach Identifed Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm. Front. Immunol. 2021; 12:648250Rehan M, Ahmed F, Howladar SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248936 17. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets. Front. Immunol. 2021; 12:694857Riddell S, Goldie S, McAuley AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248993 18. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype. Front. Immunol. 2021; 12:691725Trombetta AC, Farias GB, Gomes AMC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248984 19. Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K. Front Med (Lausanne) 2021; 8:697605Laiton-Donato K, Usme- Ciro JA, Franco-Muñoz C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262921 20. In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms. Front. Microbiol. 2021; 12:698944Lassaunière R, Fonager J, Rasmussen M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248922 21. A protein interactions map of multiple organ systems associated with COVID- 19 disease. Genomics Inform 2021; 19:e14Bharne D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261299 22. Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan. Infect Drug Resist 2021; 14:2579-2581Takano K, Watanabe Y, Hariu M, Seki M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267528 23. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method. J. Basic Clin. Physiol. Pharmacol. 2021; Jalalvand A, Khatouni SB, Najaf ZB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265888 24. SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion. J Infect Dis 2021; Ferreira I, Kemp S, Datir R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260717 25. HIV infection drives interferon signalling within intestinal SARS-CoV-2 target cells. JCI Insight 2021; Fardoos R, Asowata OE, Herbert N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252054 26. Synthetic Attempts Towards Eminent Anti-Viral Candidates of SARS-CoV. Mini Rev. Med. Chem. 2021; Kundu S, Sarkar D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254915 27. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Mol. Pharm. 2021; Chatzikleanthous D, O'Hagan DT, Adamo R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264684 28. Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cells. MRS Commun 2021:1-7Xu X, Nie Y, Wang W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258101 29. A synthetic defective interfering SARS-CoV-2. PeerJ 2021; 9:e11686Yao S, Narayanan A, Majowicz SA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249513 30. Platelet-leukocyte interactions in the pathogenesis of viral infections. Platelets 2021:1-8Hottz ED, Quirino-Teixeira AC, Merij LB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260328 31. Genetic Control of Human Infection with SARS-CoV-2. Russ J Genet 2021; 57:627-641Kucher AN, Babushkina NP, Sleptcov AA, Nazarenko MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248311 32. First detection and molecular analysis of SARS-CoV-2 from a naturally infected cat from Argentina. Vet. Microbiol. 2021; 260:109179Fuentealba NA, Moré G, Bravi ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271305
Biomarkers - Genetics (113 articles)
1. Making a Difference: Adaptation of the Clinical Laboratory in Response to the Rapidly Evolving COVID-19 Pandemic. Acad Pathol 2021; 8:23742895211023948Sahajpal NS, Mondal AK, Ananth S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263025 2. Dye-Loaded Polymersome-Based Lateral Flow Assay: Rational Design of a COVID-19 Testing Platform by Repurposing SARS-CoV-2 Antibody Cocktail and Antigens Obtained from Positive Human Samples. ACS Sens 2021; Ghorbanizamani F, Tok K, Moulahoum H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270230 3. Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfuidic Devices in COVID-19 ELISA Diagnosis. ACS Sens 2021; Gong F, Wei HX, Qi J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263598 4. Reverse Transcription Polymerase Chain Reaction Pattern of SARS-CoV-2 Beta Variant. Acta Med Port 2021; Fonseca ESD, Silva PD, Baldaque I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274029 5. Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression. Adv. Med. Sci. 2021; 66:304- 314Zinellu A, Sotgia S, Fois AG, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256241 6. Enhanced lateral fow testing strategies in care homes are associated with poor adherence and were insuffcient to prevent COVID-19 outbreaks: Results from a mixed methods implementation study. Age Ageing 2021; Tulloch JSP, Micocci M, Buckle P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272866 7. Impaired semen parameters in patients with confrmed SARS-CoV-2 infection: A prospective cohort study. Andrologia 2021:e14157Pazir Y, Eroglu T, Kose A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268784 8. Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study. Ann Intensive Care 2021; 11:111Marais C, Claude C, Semaan N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259942 9. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care 2021; 11:113Yatim N, Boussier J, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273008 10. A chemical-enhanced system for CRISPR-Based nucleic acid detection. Biosens. Bioelectron. 2021; 192:113493Li Z, Zhao W, Ma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271398 11. A rapid, ultrasensitive voltammetric biosensor for determining SARS-CoV-2 spike protein in real samples. Biosens. Bioelectron. 2021; 192:113497Liv L, Çoban G, Nakiboğlu N, Kocagöz T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34274624 12. The TDs/aptamer cTnI biosensors based on HCR and Au/Ti(3)C(2)-MXene amplifcation for screening serious patient in COVID-19 pandemic. Biosens. Bioelectron. 2021; 192:113482Mi X, Li H, Tan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256261 13. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect. Dis. 2021; 21:677LaVergne SM, Stromberg S, Baxter BA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256735 14. Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis. BMC Pulm. Med. 2021; 21:233Shi N, Huang C, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256743 15. COVID-19: a confrmed case of reinfection in a nurse. BMJ Case Rep. 2021; 14Scarpati G, Piazza O, Pagliano P, Rizzo F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257135 16. National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates. BMJ Open 2021; 11:e049703Coltart CEM, Wells D, Sutherland E, Fowler A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257096 17. Vulnerability of patients on immunosuppressive therapy to SARS-CoV-2 reinfection. BMJ Support Palliat Care 2021; Pathania YS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257064 18. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis. Brief. Bioinform. 2021; Rahman MR, Islam T, Shahjaman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260684 19. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021; 45:123Hembram P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257504 20. Distinctive features of SARS-CoV-2-specifc T cells predict recovery from severe COVID-19. Cell Rep. 2021:109414Neidleman J, Luo X, George AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260965 21. Determination of camostat and its metabolites in human plasma - preservation of samples and quantifcation by a validated UHPLC-MS/MS method. Clin. Biochem. 2021; Sørensen LK, Hasselstrøm JB, Gunst JD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252447 22. A theoretical simulation of SARS-CoV-2 pooled testing: Pooled sample collection outperforms pooled RNA extraction. Clin Chim Acta 2021; 521:155- 157He Y, Tong Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274344 23. Calprotectin in viral systemic infections-COVID-19 versus hepatitis C virus. Clin. Exp. Med. 2021:1-7Toma L, Dodot M, Zgura A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254197 24. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 2021; 229:108795Jamaly S, Tsokos MG, Bhargava R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252574 25. The potential clinical utility of measuring SARS-CoV-2-specifc T-cell responses. Clin Microbiol Infect 2021; Goletti D, Petrone L, Manissero D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256141 26. Duration of SARS-CoV-2 viral culture Positivity among different specimen types. Clin Microbiol Infect 2021; Kojima N, Mores C, Farsai N, Klausner JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274524 27. COVID-19 candidate genes and pathways potentially share the association with lung cancer. Comb. Chem. High Throughput Screen. 2021; Alnajeebi AM, Alharbi HFH, Alelwani W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254909 28. Asystole During Nasopharyngeal Swab: Is COVID-19 to Blame? Cureus 2021; 13:e15448Madanat L, Khalife A, Sims M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249579 29. Biomarkers Predictive of Extubation and Survival of COVID-19 Patients. Cureus 2021; 13:e15462Topp G, Bouyea M, Cochran-Caggiano N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258124 30. The Role of Antiphospholipid Antibodies in COVID-19. Curr. Rheumatol. Rep. 2021; 23:72Stelzer M, Henes J, Saur S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259944 31. Higher admission activated partial thromboplastin time, neutrophil- lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K. Diabetes Res Clin Pract 2021; 178:108955Iqbal A, Greig M, Arshad MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273452 32. Extractionless nucleic acid detection: a high capacity solution to COVID-19 testing. Diagn. Microbiol. Infect. Dis. 2021; 101:115458Baksh S, Volodko N, Soucie M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274751 33. The effciency of COVID-19 testing centers in Iran: A data envelopment analysis approach Hamed Seddighi, Hossein Baharmand, Ali Morovati Sharifabadi, Ibrahim Salmani, Saeideh Seddighi. Disaster Med Public Health Prep 2021:1-13Seddighi H, Baharmand H, Morovati Sharifabadi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254576 34. Passive Sampling of SARS-CoV-2 for Wastewater Surveillance. Environ. Sci. Technol. 2021; Schang C, Crosbie ND, Nolan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264643 35. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur. J. Med. Res. 2021; 26:75Keikha R, Hashemi-Shahri SM, Jebali A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256840 36. Association of ABO and Rh blood groups with obstetric outcomes in SARS- CoV-2 infected pregnancies: A prospective study with a multivariate analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 264:41-48Sainz Bueno JA, Cerrillos González L, Abascal-Saiz A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271364 37. Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021. Euro Surveill 2021; 26Alizon S, Haim-Boukobza S, Foulongne V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269174 38. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem infammatory syndrome in children (MIS-C). Exp. Biol. Med. (Maywood) 2021:15353702211028560Kuypers FA, Rostad CA, Anderson EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255566 39. COVID-19 vulnerabilities are intensifed by declining Human Serum Albumin levels. Exp. Physiol. 2021; Johnson AS, Winlow W. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275164 40. B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Cardiovasc Med 2021; 8:690790Zinellu A, Sotgia S, Carru C, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250044 41. The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology. Front Cell Dev Biol 2021; 9:684874Cui H, Su S, Cao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249938 42. PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19. Front Cell Dev Biol 2021; 9:627914Grimaudo S, Amodio E, Pipitone RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249902 43. The Gut Microbiota of Critically Ill Patients With COVID-19. Front Cell Infect Microbiol 2021; 11:670424Gaibani P, D'Amico F, Bartoletti M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268136 44. A Multiplex and Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplifcation Assay for Sensitive and Rapid Detection of Novel SARS-CoV-2. Front Cell Infect Microbiol 2021; 11:653616Juscamayta-López E, Valdivia F, Horna H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268131 45. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? Front. Endocrinol. (Lausanne) 2021; 12:665134Moin ASM, Al-Qaissi A, Sathyapalan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248841 46. Type 2 Diabetes Coagulopathy Proteins May Confict With Biomarkers Refective of COVID-19 Severity. Front. Endocrinol. (Lausanne) 2021; 12:658304Moin ASM, Al-Qaissi A, Sathyapalan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248840 47. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study. Front. Endocrinol. (Lausanne) 2021; 12:611526Yue J, Xu H, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248834 48. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Infammatory Cytokine Production in Macrophages. Front. Immunol. 2021; 12:683800Pantazi I, Al-Qahtani AA, Alhamlan FS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248968 49. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front. Immunol. 2021; 12:700782Patterson BK, Guevara-Coto J, Yogendra R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262570 50. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2. Front. Microbiol. 2021; 12:676314Castonguay N, Zhang W, Langlois MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267735 51. Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Infammatory Response in COVID-19 Patients: A Cross-Sectional Study. Front. Microbiol. 2021; 12:687513Soffritti I, D'Accolti M, Fabbri C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248910 52. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19. Front Public Health 2021; 9:628098Esposito S, Neglia C, Affanni P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249830 53. Rapid Point-Of-Care Serology and Clinical History Assessment Increase Protection Provided by RT-PCR Screening: A Pilot Study Involving Three Nursing Homes in Brescia, a Hotspot of Lombardy. Front Public Health 2021; 9:649524Savio A, Calza S, Guerrini G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249831 54. A machine learning PROGRAM to identify COVID-19 and other diseases from hematology data. Future Sci OA 2021; 7:Fso733Gladding PA, Ayar Z, Smith K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254032 55. Validation of red cell distribution width as a COVID-19 severity screening tool. Future Sci OA 2021; 7:Fso712Pouladzadeh M, Safdarian M, Choghakabodi PM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254030 56. Blood system ABO antigens as risk factor for severity of SARS-CoV-2 infection. Gac Med Mex 2021; 157:174-180Torres-Alarcón CG, García-Ruíz A, Cañete-Ibáñez CR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270530 57. Relevance of vitamin D(3) in COVID-19 infection. Gene Rep 2021; 24:101270Ul Afshan F, Nissar B, Chowdri NA, Ganai BA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250314 58. Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis. Indian J. Med. Microbiol. 2021; Kaur H, Kanaujia R, Rudramurthy SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266698 59. COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Defciencies as Determinants of Risk and Severity of Disease: A Narrative Review. Infect Dis Ther 2021:1-11Salgo MP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251655 60. Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan. Infect Drug Resist 2021; 14:2579-2581Takano K, Watanabe Y, Hariu M, Seki M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267528 61. Genetic and evolutionary analysis of SARS-CoV-2 circulating in the region surrounding Islamabad, Pakistan. Infect Genet Evol 2021:105003Tamim S, Trovao NS, Thielen P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271187 62. Glycemic control among children and adolescents with type 1 diabetes during COVID-19 pandemic in Egypt: a pilot study. Int. J. Diabetes Dev. Ctries. 2021:1- 7Elhenawy YI, Eltonbary KY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257483 63. Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case. Int J Infect Dis 2021; Connor BA, Couto-Rodriguez M, Barrows JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271202 64. nnAge signifcantly infuences the sensitivity of SARS-CoV-2 rapid antibody assays. Int J Infect Dis 2021; Irwin N, Murray L, Ozynski B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271199 65. Analysis of SARS-CoV-2 RT-qPCR Ct values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region. Int J Infect Dis 2021; Markewitz R, Torge A, Wandinger KP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273511 66. AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specifc Nucleocapsid and Receptor Binding Domain IgG. Int J Nanomedicine 2021; 16:4739-4753Sil BK, Jamiruddin MR, Haq MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267520 67. Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single- center evaluation. J. Clin. Lab. Anal. 2021:e23906Mueller T, Kompatscher J, La Guardia M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251047 68. Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study. J. Clin. Lab. Anal. 2021:e23911Zhu Z, Yang Y, Fan L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260764 69. Gut microbiota, infammation, and molecular signatures of host response to infection. J Genet Genomics 2021; Gou W, Fu Y, Yue L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257044 70. COVID-19 diagnosis and testing in pediatric heart transplant recipients. J. Heart Lung Transplant. 2021; Bock MJ, Kuhn MA, Chinnock RE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253455 71. Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients? J Hematol 2021; 10:98-105Kumar G, Nanchal R, Hererra M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267846 72. Blood cell morphology and COVID-19 clinical course, severity, and outcome. J. Hematop. 2021:1-8Pezeshki A, Vaezi A, Nematollahi P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249171 73. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?: Symptoms of COVID-19. J Infect 2021; Mattiuzzi C, Henry BM, Lippi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274361 74. Accuracy of Rapid Point-of-Care Antibody Test in patients with suspected or confrmed COVID-19. J Infect 2021; Vancheeswaran R, Willcox ML, Stuart B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273411 75. SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion. J Infect Dis 2021; Ferreira I, Kemp S, Datir R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260717 76. Cross-sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities. J Infect Dis 2021; Lennon NJ, Bhattacharyya RP, Mina MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255846 77. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report. J Med Case Rep 2021; 15:382Awada H, Nassereldine H, Hajj Ali A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271967 78. Recurrent COVID-19 infection in a health care worker: a case report. J Med Case Rep 2021; 15:363Garg J, Agarwal J, Das A, Sen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253225 79. Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19. J Med Virol 2021; Akdemir Y, Haciseyitoglu D, Celebi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260081 80. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce isolation period for COVID-19 patients. J Med Virol 2021; Aranha C, Patel V, Bhor V, Gogoi D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264527 81. Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients. J Med Virol 2021; Aranha C, Patel V, Bhor V, Gogoi D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264527 82. Effect of Different Storage Conditions on Covid-19 RT-PCR Results. J Med Virol 2021; Gulec EY, Cesur NP, Fazlioğlu GY, Kazezoğlu C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260086 83. Evaluation of Rapid Antibody Test and Chest Computed Tomography Results of COVID-19 Patients: A Retrospective Study. J Med Virol 2021; Ozturk A, Bozok T, Bozok TS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260078 84. Dexamethasone treatment may mitigate adverse effects of vitamin D defciency in hospitalised Covid-19 patients. J Med Virol 2021; Wenban C, Heer RS, Baktash V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273116 85. The evolution of rapid antigen detection systems and their application for COVID-19 and other serious respiratory infectious diseases. J Microbiol Immunol Infect 2021; C SP, M MP. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272205 86. Integrative Modeling of Plasma Metabolic and Lipoprotein Biomarkers of SARS-CoV-2 Infection in Spanish and Australian COVID-19 Patient Cohorts. J. Proteome Res. 2021; Masuda R, Lodge S, Nitschke P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251833 87. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). J. Thromb. Thrombolysis 2021:1-10García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272635 88. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight 2021; Lopez E, Haycroft ER, Adair A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251356 89. Clinical utility of biochemical markers for the prediction of COVID-19-related mortality in kidney transplant recipients. Kidney Int Rep 2021; Caillard S, Chavarot N, Francois H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254049 90. The nasal and pharyngeal swab techniques during the COVID-19-pandemic - The ENT-perspective: SARS-CoV-2, Coronavirus, nasal swab, pharyngeal swab, complications. Laryngo- Rhino- Otologie 2021; 100:517-525Deitmer T, Dietz A, Chaberny IF, Pietsch C. 91. Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? Med. Hypotheses 2021; 153:110641Figueiro-Filho EA, Hobson SR, Farine D, Yudin MH. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256245 92. The considerable impact of the SARS-CoV-2 pandemic and COVID-19 on the UK National Mycology Reference Laboratory activities and workload. Med. Mycol. 2021; Borman AM, Fraser M, Patterson Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259872 93. Absolute quantifcation of SARS-CoV-2 with Clarity Plus™ digital PCR. Methods 2021; Yi Han Tan S, Yi Milton Kwek S, Low H, Ling Joy Pang Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273478 94. Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting. Microbiol Spectr 2021:e0036121Zander J, Scholtes S, Ottinger M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259547 95. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. Microvasc. Res. 2021:104224Andrianto, Al-Farabi MJ, Nugraha RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273359 96. Serum Lateral Flow Assay with Digital Reader for the Diagnosis of Invasive Pulmonary Aspergillosis: A Two Center Mixed Cohort Study. Mycoses 2021; Hoenigl M, Egger M, Boyer J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252244 97. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study. Mycoses 2021; Hoenigl M, Egger M, Boyer J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252244 98. Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts. Open Forum Infect Dis 2021; 8:ofab243Pollock NR, Tran K, Jacobs JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250188 99. First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19. Open Forum Infect Dis 2021; 8:ofab274Tantry US, Bliden KP, Cho A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250193 100. Oxidant and antioxidant balance in patients with COVID-19. Pediatr Pulmonol 2021; Aykac K, Ozsurekci Y, Yayla BCC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265172 101. Platelet-leukocyte interactions in the pathogenesis of viral infections. Platelets 2021:1-8Hottz ED, Quirino-Teixeira AC, Merij LB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260328 102. COVID-19 pneumonia: relationship between initial chest X-rays and laboratory fndings. Radiologia (Roma) 2021; Nava-Muñoz Á, Gómez-Peña S, Fuentes-Ferrer ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253334 103. C-Reactive protein and SOFA scale: A simple score as early predictor of critical care requirement in patients with COVID-19 pneumonia in Spain. Rev. Esp. Anestesiol. Reanim. 2021; Vaquero-Roncero LM, Sánchez-Barrado E, Escobar-Macias D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247837 104. The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence. Rev Med Virol 2021; 31:e2192Cardwell K, Jordan K, Byrne P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260781 105. Genetic Control of Human Infection with SARS-CoV-2. Russ J Genet 2021; 57:627-641Kucher AN, Babushkina NP, Sleptcov AA, Nazarenko MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248311 106. COVID-19 and dysnatremia: A comparison between COVID-19 and non-COVID- 19 respiratory illness. SAGE Open Med 2021; 9:20503121211027778Voets PJ, Frölke SC, Vogtländer NP, Kaasjager KA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262763 107. Monitoring of SARS-CoV-2 RNA in wastewater as an epidemiological surveillance tool in Mendoza, Argentina. Sci Total Environ 2021; 796:148887Giraud-Billoud M, Cuervo P, Altamirano JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274669 108. A direct capture method for purifcation and detection of viral nucleic acid enables epidemiological surveillance of SARS-CoV-2. Sci Total Environ 2021; 795:148834Mondal S, Feirer N, Brockman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252764 109. Sensitive and rapid on-site detection of SARS-CoV-2 using a gold nanoparticle-based high-throughput platform coupled with CRISPR/Cas12- assisted RT-LAMP. Sens. Actuators B Chem. 2021; 345:130411Zhang Y, Chen M, Liu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248284 110. Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients. Technol. Health Care 2021; Zhu X, Zhu X, Wang M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250914 111. Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis. Ther Adv Infect Dis 2021; 8:20499361211027390Windham S, Wilson MP, Fling C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249357 112. Signifcance of SARS-CoV-2 specifc antibody testing during COVID-19 vaccine allocation. Vaccine 2021; Fujimoto AB, Keskinocak P, Yildirim I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274126 113. First detection and molecular analysis of SARS-CoV-2 from a naturally infected cat from Argentina. Vet. Microbiol. 2021; 260:109179Fuentealba NA, Moré G, Bravi ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271305
Children (31 articles)
1. Kids are back in town: the return of high demand for paediatric emergency care. Arch. Dis. Child. 2021; Jenner R, Walker A, Isba R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266875 2. Delayed diagnosis of ingested button battery leading to tracheoesophageal fstula in a child infected with SARS-CoV-2. BMJ Case Rep. 2021; 14Goussard P, Janson J, Nel E, Schubert P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253535 3. Cardiac Implications of Multisystem Infammatory Syndrome Associated with COVID-19 in Children under the age of Five Years. Cardiol. Young 2021:1- 15Rakha S, Sobh A, Hager AH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261560 4. Intraoperative Ultrasonographic Assessment of Vocal Cord motion under sedation, following pediatric thyroidectomy in the Era of COVID-19, a double- blinded preliminary study. Clin. Otolaryngol. 2021; Zavdy O, Schwarz M, Gilony D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255927 5. Intraoperative Ultrasonographic Assessment of Vocal Cord motion under sedation, following paediatric thyroidectomy in the Era of COVID-19: A double- blinded preliminary study. Clin. Otolaryngol. 2021; Zavdy O, Schwarz M, Gilony D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255927 6. Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: Results of an online survey in Switzerland. Compr. Psychiatry 2021; 109:152260Werling AM, Walitza S, Grünblatt E, Drechsler R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265597 7. SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations. Endocrinol Diabetes Metab 2021; 4:e00262Miller R, Ashraf AP, Gourgari E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268455 8. Effect of the COVID-19 quarantine on metabolic control in children and adolescents with type 1 diabetes. Endocrinol Diabetes Nutr 2021; Turan H, Güneş Kaya D, Tarçın G, Evliyaoğlu SO. http://www.ncbi.nlm.nih.gov/pubmed/? term=34274306 9. COVID-19 unmasked: preschool children's negative thoughts and worries during the COVID-19 pandemic in Australia. Eur J Psychotraumatol 2021; 12:1924442Vasileva M, Alisic E, De Young A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249241 10. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem infammatory syndrome in children (MIS-C). Exp. Biol. Med. (Maywood) 2021:15353702211028560Kuypers FA, Rostad CA, Anderson EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255566 11. Case Report: Adult Post-COVID-19 Multisystem Infammatory Syndrome and Thrombotic Microangiopathy. Front. Immunol. 2021; 12:680567Boudhabhay I, Rabant M, Roumenina LT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248962 12. Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View. Front Pediatr 2021; 9:676718Assathiany R, Salinier C, Béchet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249814 13. Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19). Front Pediatr 2021; 9:656720Bigdelian H, Sedighi M, Sabri MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249807 14. Infuenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City. Front Pediatr 2021; 9:676611Laris-González A, Avilés-Robles M, Domínguez-Barrera C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249813 15. Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia. J Allergy Clin Immunol Pract 2021; Margolis RHF, Patel SJ, Sheehan WJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265448 16. COVID-19 diagnosis and testing in pediatric heart transplant recipients. J. Heart Lung Transplant. 2021; Bock MJ, Kuhn MA, Chinnock RE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253455 17. Presentation of a participatory approach to develop preventive measures to reduce COVID-19 transmission in child care. J. Occup. Med. Toxicol. 2021; 16:26Diebig M, Gritzka S, Dragano N, Angerer P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261512 18. YouTube as a source of information about COVID-19 for children: Content quality, reliability, and audience participation analysis. J. Pediatr. Nurs. 2021; Azak M, Şahin K, Korkmaz N, Yıldız S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247879 19. Room for Improvement: The Trephination Procedure for Pediatric Patients with Pilonidal Disease. J. Surg. Res. 2021; 267:605-611Metzger GA, Apfeld JC, Nishimura L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271267 20. Neurological manifestations of paediatric acute COVID infections: A single centre experience. J. Trop. Pediatr. 2021; Dilber B, Aydın ZGG, Yeşilbaş O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254129 21. Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease. Kidney Int Rep 2021; Carr EJ, Kronbichler A, Graham-Brown M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250319 22. Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19. Microbiol Spectr 2021:e0008621Johnson AJ, Zhou S, Hoops SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259552 23. Leukaemia and lockdown: The delayed infection model of childhood acute lymphoblastic leukaemia and the COVID-19 pandemic. Pediatr Blood Cancer 2021:e29194Lillie K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251092 24. SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit. Pediatr Blood Cancer 2021:e29240Nigro O, Sironi G, Bergamaschi L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34264546 25. Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil. Pediatr Pulmonol 2021; Friedrich F, LC EG, Petry LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265188 26. Impact of COVID-19 on pediatric pulmonology healthcare practice. Pediatr Pulmonol 2021; Nayir Buyuksahin H, Emiralioglu N, Ademhan Tural D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265185 27. Unaffected asthma control in children with mild asthma after COVID-19. Pediatr Pulmonol 2021; Tosca MA, Crocco M, Girosi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265183 28. COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring. Prim. Care Diabetes 2021; Salabelle C, Ly Sall K, Eroukhmanoff J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257050 29. Parents' Perceived Impact of the Societal Lockdown of COVID-19 on Family Well-Being and on the Emotional and Behavioral State of Walloon Belgian Children Aged 4 to 13 Years: An Exploratory Study. Psychol. Belg. 2021; 61:186- 199Stassart C, Wagener A, Etienne AM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249370 30. Short-term outcomes in children recovered from multisystem infammatory syndrome associated with SARS-CoV-2 infection. Rheumatol. Int. 2021:1- 6Patnaik S, Jain MK, Ahmed S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259880 31. Comment on: Emerging Evidence on Multisystem Infammatory Syndrome in Children Associated with SARS-CoV-2 Infection. SN Compr Clin Med 2021:1- 2Mantina NM, Madhivanan P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250445
Clinical Features (28 articles) 1. Phlegmasia cerulea dolens during the SARS-COV-2 pandemic: What management ? Ann Med Surg (Lond) 2021; 67:102541Anane O, Rezziki A, Benzirar A, El Mahi O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249354 2. Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID- 19) patients. Ann Palliat Med 2021; Li A, Chen F, Gao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263633 3. Enteroviruses and coronaviruses: Similarities and therapeutic targets. Expert Opin. Ther. Targets 2021; Marjomäki V, Kalander K, Hellman M, Permi P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253126 4. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam. Pract. 2021; van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268556 5. Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning. Front Artif Intell 2021; 4:673527Jamshidi E, Asgary A, Tavakoli N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250465 6. Infuenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City. Front Pediatr 2021; 9:676611Laris-González A, Avilés-Robles M, Domínguez-Barrera C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249813 7. Dissociation between the clinical course and chest imaging in severe COVID- 19 pneumonia: A series of fve cases. Heart Lung 2021; 50:818-824Basille D, Auquier MA, Andréjak C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271253 8. Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge. Indian J Otolaryngol Head Neck Surg 2021:1- 8Kapoor D, Verma N, Gupta N, Goyal A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249668 9. New Onset Vertigo After COVID-19 Infection. A Case Report. Indian J Otolaryngol Head Neck Surg 2021:1-3Motawea KR, Monib FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249665 10. Clinical Features and Outcomes of COVID-19 Infection among Pregnant Women in South Africa. Int J MCH AIDS 2021; 10:1-9Basu JK, Chauke L, Magoro T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262795 11. Discriminatory Value of Self-reported Olfactory Dysfunction in the Prediction of Coronavirus Disease 2019. Intern Med 2021; Akaishi T, Kushimoto S, Katori Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248118 12. Validity of the Use of Wrist and Forehead Temperatures in Screening the General Population for COVID-19: A Prospective Real-World Study. Iran J. Public Health 2020; 49:57-66Chen G, Xie J, Dai G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268206 13. Challenges of Differential Diagnosis, Symptoms of Coronavirus Disease 2019 (COVID-19) or Cannabinoid Hyperemesis Syndrome (CHS)? A Rare Case Report. Iran J. Public Health 2020; 49:109-111Pirnia B, Pirnia K, Malekanmehr P, Zahiroddin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268213 14. "Five-Early" Model: The Magic Weapon against COVID-19. Iran J. Public Health 2020; 49:82-86Yi Q, Fang W, Lang C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268209 15. Characteristics of Patients Presenting with COVID-19 from Balochistan Province and Lessons Learnt. J. Coll. Physicians Surg. Pak. 2021; 31:104- 108Badini AM, Badini A, Mengal NM, Nanji K. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271805 16. Fixed dilated pupils in Covid-19 ARDS patients under rocuronium, reversed after discontinuation. J Crit Care 2021; 65:259-260Zakynthinos GE, Tsolaki V, Bardaka F, Makris D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274833 17. Study of clinical features of patients with COVID-19 hospitalized in an educational hospital in Iran. J Educ Health Promot 2021; 10:202Homauni A, Ghadami L, Abdollahi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250136 18. Blood cell morphology and COVID-19 clinical course, severity, and outcome. J. Hematop. 2021:1-8Pezeshki A, Vaezi A, Nematollahi P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249171 19. Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?: Symptoms of COVID-19. J Infect 2021; Mattiuzzi C, Henry BM, Lippi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274361 20. Taste alteration in COVID-19: Signifcant geographical differences exist in the prevalence of the symptom. J Infect Public Health 2021; 14:1099-1105Cirillo N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274859 21. Future Challenges of Covid-19 and Oral Manifestations in Daily Dental Practice: A Literature Review. J Int Soc Prev Community Dent 2021; 11:242- 247Riofrio G, Castillo S, Salcedo G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268185 22. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021:1410768211032850Aiyegbusi OL, Hughes SE, Turner G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265229 23. Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients. Jpn. Dent. Sci. Rev. 2021; Okada Y, Yoshimura K, Toya S, Tsuchimochi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257762 24. Anthropometric analysis of body habitus and outcomes in critically ill COVID- 19 patients. Obes Med 2021; 25:100358Poros B, Becker-Pennrich AS, Sabel B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250312 25. All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open Forum Infect Dis 2021; 8:ofab246Chen JC, Wong D, Rabi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258312 26. Clinical Features of COVID-19 Patients in Jordan: A Study of 508 Patients. Open Respir. Med. J. 2021; 15:28-34Al-Balas M, Al-Balas HI, Alqassieh R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249180 27. A Narrative Review of Current Understanding and Classifcation of Dry Eye Disease with New Insights on the Impact of Dry Eye during the COVID-19 Pandemic. Ophthalmol Ther 2021:1-13Barabino S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275088 28. Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico. Vector Borne Zoonotic Dis. 2021; García- Alvarado FJ, Muñoz-Hernández MA, Moran Guel E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255563
CNS (32 articles) 1. Neurological Manifestations in COVID-19 Patients: A Meta-Analysis. ACS Chem Neurosci 2021; D V, Sharma A, Kumar A, Flora SJS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260855 2. Neurological Manifestations in COVID-19: An Unrecognized Crisis in Our Elderly? Adv Geriatr Med Res 2021; 3Krupp K, Madhivanan P, Killgore WDS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268500 3. Post-COVID-19 vaccine Guillain-Barré syndrome; frst reported case from Qatar. Ann Med Surg (Lond) 2021; 67:102540Razok A, Shams A, Almeer A, Zahid M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249353 4. Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report. Ann Palliat Med 2021; Fu Q, Li D, He W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263609 5. The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome. Autoimmun Rev 2021; 20:102907Berciano J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274541 6. Fatal Case of COVID-19 Pneumonia Associated with Acute Myelopathy. Case Rep. Neurol. 2021; 13:398-404Hassoun HK, Radeef MR, Aljid Z, Allebban Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248577 7. Hyponatremia and extrapontine myelinolysis in a patient with COVID-19: A case report. Clin Case Rep 2021; 9:e04463Abd Ur Rehman M, Abdulrahman AF, Zainab A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267918 8. Post-COVID worsening of a Parkinson's disease patient. Clin Case Rep 2021; 9:e04409Boika AV, Sialitski MM, Chyzhyk VA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257979 9. Can COVID-19 accelerate neurodegeneration? Clin Case Rep 2021; 9:e04433Salari M, Etemadifar M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267913 10. Effcacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 Pandemic. Ear Nose Throat J 2021:1455613211032534Tsuda T, Hanada Y, Wada K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247535 11. Is SARS-CoV-2 responsible for relapses of Parkinson's disease? Egypt J Neurol Psychiatr Neurosurg 2021; 57:90Scorza FA, Finsterer J, Fiorini AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248349 12. Challenges faced by people with epilepsy on ketogenic diet therapy and their caregivers during the COVID-19 pandemic in Brazil. Epilepsy Behav. 2021; 122:108193Alencastro Veiga Domingues Carneiro R, Dos Santos Lunardi M, Matheus Uberna Giacomini F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256342 13. A follow-up study of patients with COVID-19 presenting with seizures. Epilepsy Behav. 2021; 122:108207Asadi-Pooya AA, Kouhanjani MF, Nemati H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273743 14. Patients with epilepsy during the COVID-19 pandemic: Depressive symptoms and their association with healthcare access. Epilepsy Behav. 2021; 122:108178Dos Santos Lunardi M, Marin de Carvalho R, Alencastro Veiga Domingues Carneiro R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252830 15. Considering temporality in causal relationship between seizure worsening and psychological stress in patients with epilepsy during the COVID-19 pandemic: A systematic review. Epilepsy Behav. 2021; 122:108184Kuroda N, Fujimoto A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252833 16. Importance of access to epilepsy monitoring units during the COVID-19 pandemic: consensus statement of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology. Epileptic Disord. 2021; Beniczky S, Husain A, Ikeda A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34266813 17. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS 2021; 18:32McQuaid C, Brady M, Deane R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261487 18. Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study. Front. Aging Neurosci. 2021; 13:698184Pisaturo M, Calò F, Russo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267649 19. Review article on COVID-19 and Guillain-Barré syndrome. Front Biosci (Schol Ed) 2021; 13:97-104Patnaik UJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256532 20. New Onset Vertigo After COVID-19 Infection. A Case Report. Indian J Otolaryngol Head Neck Surg 2021:1-3Motawea KR, Monib FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249665 21. Deaths of people with intellectual disabilities: Analysis of deaths in England from COVID-19 and other causes. J Appl Res Intellect Disabil 2021; Heslop P, Byrne V, Calkin R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272793 22. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barre syndrome complicating the recovery phase of coronavirus disease 2019 infection: a case report. J Med Case Rep 2021; 15:379Haidary AM, Noor S, Hamed E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271989 23. Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis. J. Neuroimmunol. 2021; 358:577655Ghosh R, Dubey S, Mandal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265625 24. Commentary: The spectrum of neurological manifestations related to COVID- 19 and vaccinations. J. Neuroimmunol. 2021; 358:577660Samudralwar RD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274719 25. Neurological manifestations of paediatric acute COVID infections: A single centre experience. J. Trop. Pediatr. 2021; Dilber B, Aydın ZGG, Yeşilbaş O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254129 26. Acute facial paresis as a possible complication of vaccination against SARS- CoV-2. Laryngo- Rhino- Otologie 2021; 100:526-528Volk GF, Kuttenreich AM, Geitner M, Guntinas-Lichius O. 27. Encephalitis as a neurological manifestation of COVID-19. Med Clin (Engl Ed) 2021; Lozano Gómez H, Pascual Bielsa A, Abansés Moreno P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250243 28. Neurological symptoms and fndings in COVID-19: a prospective clinical study. Neurol. Res. 2021:1-6Köseoğlu Toksoy C, Yavuz T, Orhan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269161 29. New daily persistent headache after SARS-CoV-2 infection: a report of two cases. Neurol Sci 2021; Dono F, Consoli S, Evangelista G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264414 30. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol Sci 2021:1-3Nasuelli NA, De Marchi F, Cecchin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272622 31. Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran. Parkinsonism Relat. Disord. 2021; 89:90-92Salari M, Etemadifar M, Ashraf F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256334 32. The impact of Parkinson's disease on manifestations and outcomes of Covid- 19 patients: A systematic review and meta-analysis. Rev Med Virol 2021:e2278El-Qushayri AE, Ghozy S, Reda A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260773
Coagulation (36 articles)
1. Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies. Acta Cardiol Sin 2021; 37:355-364Chen PW, Tsai ZY, Chao TH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257485 2. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report. Acta Neurol. Scand. 2021; de Mélo Silva ML, Jr., Lopes DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273119 3. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care 2021; 11:113Yatim N, Boussier J, Chocron R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273008 4. Thromboprophylaxis strategies for COVID-19 patients. Arch Med Res 2021; Porres-Aguilar M, Pérez-Nieto OR, Zamarrón-López É I, Ñamendys-Silva SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274156 5. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 2021; 14Malik B, Kalantary A, Rikabi K, Kunadi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261635 6. Clinical patterns of endothelial damage and thrombotic events in two patients with COVID-19: A case report. Clin Case Rep 2021; 9:e04406Moghimi M, Khodadadi K, Sarvandi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257978 7. Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability. Cureus 2021; 13:e16171Burley NB, Dy PS, Kalantri S, Razzaq K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258131 8. A Case Report on Extensive Arterial Thrombosis: A Rare Complication of COVID-19 Infection. Cureus 2021; 13:e15378Mandal S, Gami S, Khadka S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249531 9. The Role of Antiphospholipid Antibodies in COVID-19. Curr. Rheumatol. Rep. 2021; 23:72Stelzer M, Henes J, Saur S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259944 10. Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series. Eur Heart J Case Rep 2021; 5:ytab239Garg A, Hakeem H, Chennu G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263128 11. Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab140Hirschbaum JH, Bradley CP, Kingsford P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268475 12. Primary adrenal insuffciency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Eur J Intern Med 2021; Varona JF, García-Isidro M, Moeinvaziri M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256983 13. COVID-19 vaccination associated severe immune thrombocytopenia. Exp Hematol Oncol 2021; 10:42Shah SRA, Dolkar S, Mathew J, Vishnu P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266487 14. Thromboembolic events in younger women exposed to Pfzer-BioNTech or Moderna COVID-19 vaccines. Expert Opin. Drug Saf. 2021; Sessa M, Kragholm K, Hviid A, Andersen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264151 15. Type 2 Diabetes Coagulopathy Proteins May Confict With Biomarkers Refective of COVID-19 Severity. Front. Endocrinol. (Lausanne) 2021; 12:658304Moin ASM, Al-Qaissi A, Sathyapalan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248840 16. Case Report: Adult Post-COVID-19 Multisystem Infammatory Syndrome and Thrombotic Microangiopathy. Front. Immunol. 2021; 12:680567Boudhabhay I, Rabant M, Roumenina LT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248962 17. Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19). Front Pediatr 2021; 9:656720Bigdelian H, Sedighi M, Sabri MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249807 18. A proposal for the management of COVID-19-induced coagulopathy in adults. Gac Med Mex 2021; 157:201-206Ignacio-Ibarra G, García-Lee MT, González-Ávila AI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270538 19. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. Int. J. Hematol. 2021; Waqar SHB, Khan AA, Memon S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264514 20. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int. Rev. Immunol. 2021:1- 10Novak N, Tordesillas L, Cabanillas B. http://www.ncbi.nlm.nih.gov/pubmed/? term=34251972 21. Left ventricular thrombus with normal systolic function secondary to the novel prothrombotic association of acute on chronic calcifc pancreatitis and COVID-19. J Cardiol Cases 2021; Jariwala PV, Jadhav KP, Aurangabadkar H, Dommata RR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257751 22. Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests. J. Clin. Monit. Comput. 2021; Pavoni V, Gianesello L, Pazzi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264472 23. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine. J Korean Med Sci 2021; 36:e197Huh K, Na Y, Kim YE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254476 24. Cerebral venous thrombosis in a patient with Down syndrome and coronavirus disease 2019: a case report. J Med Case Rep 2021; 15:364Robayo- Amortegui H, Valenzuela-Faccini N, Quecano-Rosas C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253238 25. Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis. J Thromb Haemost 2021; Jevtic SD, Malinowski AK, Othman M, Kadir RAA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260818 26. The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19. J Thromb Haemost 2021; Li A, Kuderer NM, Hsu CY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260813 27. Heparin -Messias or Verschlimmbesserung? J Thromb Haemost 2021; Swan D, Carrier M, Lisman T, Thachil J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272818 28. Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19. J. Thromb. Thrombolysis 2021; Ichikawa J, Okazaki R, Fukuda T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263423 29. Venous and arterial thromboembolic disease in COVID-19. J. Thromb. Thrombolysis 2021:1-3Ten Berg J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255267 30. A Unique Case of Branch Retinal Artery Occlusion Associated with a Relatively Mild Coronavirus Disease 2019. Ocul Immunol Infamm 2021:1-4Uzun A, Keles Sahin A, Bektas O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252339 31. Platelet-leukocyte interactions in the pathogenesis of viral infections. Platelets 2021:1-8Hottz ED, Quirino-Teixeira AC, Merij LB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260328 32. Thrombotic risk in patients with COVID-19. Rev Cardiovasc Med 2021; 22:277- 286Pancaldi E, Pascariello G, Cimino G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34258896 33. Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil. Thromb Res 2021; 205:81-83Machado KLC, Rosa STD, Dobner S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265606 34. Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study. Thromb Res 2021; 205:84-91Metra B, Summer R, Brooks SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274560 35. Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine 2021; Hines AM, Murphy N, Mullin C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247902 36. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-beneft analysis for people < 60 years in Australia. Vaccine 2021; MacIntyre CR, Veness B, Berger D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272095
Complications (40 articles)
1. Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report. Afr J Urol 2021; 27:97Eren MT, Özveri H, Kurtoğlu H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248351 2. Platypnoea-orthodeoxia syndrome in an older patient with COVID-19 pneumonia and orthostatic hypotension-A case of prolonged hospital admission. Age Ageing 2021; Ismail MA, Trevest K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272845 3. Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: another nightmare. Am. J. Infect. Control 2021; Amarsy R, Jacquier H, Munier AL et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273465 4. French Multicentre Observational Study on SARS-CoV-2 infections Intensive care initial management: the FRENCH CORONA Study. Anaesth Crit Care Pain Med 2021:100931Roger C, Collange O, Mezzarobba M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256165 5. Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report. Ann Palliat Med 2021; Fu Q, Li D, He W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263609 6. Incidence and predictors of COVID-19 and fares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France. Arthritis Res. Ther. 2021; 23:188Felten R, Scherlinger M, Guffroy A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256812 7. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021; 20:102899Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274540 8. Corona virus disease 2019-associated Stevens-Johnson syndrome: a case report. BMC Ophthalmol. 2021; 21:274Shahraki T, Hassanpour K, Arabi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253167 9. Coinfection of SARS-CoV-2 and MTB: how not to miss the wood for the trees. BMJ Case Rep. 2021; 14Jacob J, Venkataram R, Hosmane GB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257109 10. COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. Br. J. Haematol. 2021; Passamonti F, Romano A, Salvini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272724 11. Cerebral Vasculitis in a COVID-19 Confrmed Postpartum Patient: A Case Report. Case Rep. Neurol. 2021; 13:324-328Chua AMU, Jamora RDG, Jose ACE, Anlacan VMM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248564 12. Two episodes of acute dyspnea that were induced by COVID-19 in a peritoneal dialysis patient. CEN Case Rep 2021; Toda N, Takeoka J, Tanigaki K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269997 13. COVID-19 in a pregnant patient with beta-thalassemia major: A case report. Clin Case Rep 2021; 9:e04331Hailan YMA, Sayed G, Yassin MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267898 14. Acute epiglottitis after COVID-19 infection. Clin Case Rep 2021; 9:e04419Renner A, Lamminmäki S, Ilmarinen T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267905 15. Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome. Crit Care 2021; 25:248Beloncle F, Studer A, Seegers V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266454 16. Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors. Cureus 2021; 13:e15452Farooque I, Farooque U, Karimi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262803 17. Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru. Ecancermedicalscience 2021; 15:1246Payet E, Perez J, Sarria G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267802 18. Case Report: Systemic Sclerosis After Covid-19 Infection. Front. Immunol. 2021; 12:686699Fineschi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262566 19. COVID-19 and Infuenza Co-infection: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:681469Dadashi M, Khaleghnejad S, Abedi Elkhichi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249971 20. Cancer and COVID-19: analysis of patient outcomes. Future Oncol 2021; Aboueshia M, Hussein MH, Attia AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263660 21. Rhizopus homothallicus: An emerging pathogen in era of COVID-19 associated mucormycosis. Indian J. Med. Microbiol. 2021; Kaur H, Kanaujia R, Rudramurthy SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266698 22. Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient. Indian J Otolaryngol Head Neck Surg 2021:1-5Eswaran S, Balan SK, Saravanam PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258246 23. The Effcacy of Tracheotomy for Covid-19 Pneumonia: Impacts on Survival and Prognostic Factors. Indian J Otolaryngol Head Neck Surg 2021:1-6Tuna B, Birdane L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249667 24. Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital. Infect Dis Ther 2021:1-14Paramythiotou E, Dimopoulos G, Koliakos N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260038 25. Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: results of a prospective observational multicenter study. Infection 2021:1-10De Santis V, Corona A, Vitale D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260055 26. An Increase in Respiratory Protection Device Injuries Associated with the COVID-19 Pandemic. J Am Acad Dermatol 2021; McGwin G, Jr., McGwin M, Griffn RL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274413 27. Coinfection with severe acute respiratory syndrome coronavirus-2 and other respiratory viruses at a tertiary hospital in Korea. J. Clin. Lab. Anal. 2021:e23868Kim Z, Lee JH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273182 28. Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study. J. Epidemiol. Community Health 2021; Serván-Mori E, Seiglie JA, Gómez-Dantés O, Wirtz VJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266980 29. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. J Immunother Cancer 2021; 9Switzer B, Haanen J, Lorigan PC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272309 30. Cytomegalovirus infection in critically ill patients with COVID-19. J Infect 2021; Niitsu T, Shiroyama T, Hirata H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252496 31. Mucormycosis or black fungus infection is a new scare in South Asian countries during COVID-19 pandemic: Associated risk factors and preventive measures. J Med Virol 2021; Rahman FI, Islam MR, Bhuiyan MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260073 32. Increased risk of severe malaria in travellers during the COVID-19 pandemic. J Travel Med 2021; de Laval F, Maugey N, de Bonet d'Oléon A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254146 33. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Mycoses 2021; Avatef Fazeli M, Rezaei L, Javadirad E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252988 34. Mucormycosis and COVID-19: An Epidemic within a Pandemic in India. Mycoses 2021; Selarka L, Sharma S, Saini D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255907 35. Endogenous Endophthalmitis A Complication of COVID-19 Pandemic: A Case Series. Ocul Immunol Infamm 2021:1-4Agarwal M, Sachdeva M, Pal S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255587 36. Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation. Open Respir. Med. J. 2021; 15:23-27Aung H, Avraam E, Ashraf M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249179 37. Henoch-Schönlein purpura: Another COVID-19 complication. Pediatr. Dermatol. 2021; El Hasbani G, Taher AT, Jawad ASM, Uthman I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272762 38. COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges. Praxis 2021; 110:512-516Jakob SM, Michel K, Kindler A. 39. Pre and retroperitoneal necrotizing fasciitis after COVID-19 infection: a case report. Radiol Case Rep 2021; Elashry M, Alagha M, Salama M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254011 40. Secondary spontaneous pneumothorax: a time to re-evaluate management. Respirol Case Rep 2021; 9:e00749Cortes-Telles A, Ortíz-Farias DL, Perez- Hernandez F, Rodriguez-Morejon D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262774
Cured – Recovered (20 articles)
1. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment. Acta Med Indones 2021; 53:141-142Rumende CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251340 2. Dynamic changes of functional ftness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study. BMC Med 2021; 19:163Xiong L, Li Q, Cao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256745 3. COVID-19: a confrmed case of reinfection in a nurse. BMJ Case Rep. 2021; 14Scarpati G, Piazza O, Pagliano P, Rizzo F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257135 4. Vulnerability of patients on immunosuppressive therapy to SARS-CoV-2 reinfection. BMJ Support Palliat Care 2021; Pathania YS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257064 5. Post-COVID worsening of a Parkinson's disease patient. Clin Case Rep 2021; 9:e04409Boika AV, Sialitski MM, Chyzhyk VA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257979 6. Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability. Cureus 2021; 13:e16171Burley NB, Dy PS, Kalantri S, Razzaq K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258131 7. Development of a Large Pneumatocele in a Patient Recovering from COVID-19 Pneumonitis. Eur J Case Rep Intern Med 2021; 8:002605Hampson F, Salih W, Helm J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268263 8. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam. Pract. 2021; van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268556 9. Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity. Front Med (Lausanne) 2021; 8:682087Zhou M, Xu J, Liao T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249973 10. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021; 12:698169Proal AD, VanElzakker MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248921 11. Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge. Indian J Otolaryngol Head Neck Surg 2021:1- 8Kapoor D, Verma N, Gupta N, Goyal A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249668 12. The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors. Int. J. Gen. Med. 2021; 14:3271-3280Salem AM, Al Khathlan N, Alharbi AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267545 13. Pulmonary Covid Fibrosis a New Pharmaceutic Approach. Int. J. Prev. Med. 2021; 12:35Menicagli R, Limodio M, Limodio M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249284 14. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report. J Med Case Rep 2021; 15:382Awada H, Nassereldine H, Hajj Ali A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271967 15. Recurrent COVID-19 infection in a health care worker: a case report. J Med Case Rep 2021; 15:363Garg J, Agarwal J, Das A, Sen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253225 16. Post-covid Syndrome: A Single-Center Questionnaire Study On 1007 Participants Recovered from COVID-19. J Med Virol 2021; Kayaaslan B, Eser F, Kalem AK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255355 17. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021:1410768211032850Aiyegbusi OL, Hughes SE, Turner G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265229 18. Health consequences of covid-19 disease in adults and children and their long-term rehabilitative treatment consequences. Pravention und Rehabilitation 2021; 33:66-76Steuernagel T, Wiesner C, Doering TJ. 19. Prevalence of exercise-induced oxygen desaturation after recovery from SARS-CoV-2 pneumonia and use of lung ultrasound to predict need for pulmonary rehabilitation. Pulmonology 2021; Carlucci A, Paneroni M, Carotenuto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247995 20. Clinical characteristics and outcomes of COVID-19 long-term nucleic acid positive patients. Technol. Health Care 2021; Zhu X, Zhu X, Wang M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250914
Cardiovascular disease (60 articles) 1. Comparison of ventricular repolarization parameters of Covid-19 patients diagnosed with chest CT and RT-PCR. Acta Cardiol. 2021:1-6Ibisoglu E, Boyraz B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254875 2. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report. Acta Neurol. Scand. 2021; de Mélo Silva ML, Jr., Lopes DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273119 3. Brugada pattern in an afebrile patient with acute COVID-19. BMJ Case Rep. 2021; 14Adedeji OM, Falk Z, Tracy CM, Batarseh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257116 4. COVID-19-associated myocarditis presenting as new-onset heart failure and atrial fbrillation. BMJ Case Rep. 2021; 14Gaine S, Devitt P, Coughlan JJ, Pearson I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253533 5. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 2021; 14Malik B, Kalantary A, Rikabi K, Kunadi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261635 6. Intracerebral bleeding after janus-kinase inhibitor baricitinib for COVID-19. Brain Hemorrhages 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250455 7. Cardiac Implications of Multisystem Infammatory Syndrome Associated with COVID-19 in Children under the age of Five Years. Cardiol. Young 2021:1- 15Rakha S, Sobh A, Hager AH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261560 8. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc. Toxicol. 2021:1-9Vitiello A, Ferrara F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255300 9. Cerebral Vasculitis in a COVID-19 Confrmed Postpartum Patient: A Case Report. Case Rep. Neurol. 2021; 13:324-328Chua AMU, Jamora RDG, Jose ACE, Anlacan VMM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248564 10. Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort Study. Circ Rep 2021; 3:375-380Yoshida N, Iwata S, Ogawa M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250278 11. Clinical patterns of endothelial damage and thrombotic events in two patients with COVID-19: A case report. Clin Case Rep 2021; 9:e04406Moghimi M, Khodadadi K, Sarvandi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257978 12. An Unusual Case of Acute Hemorrhagic Necrotizing Encephalomyelitis in a COVID-19 Patient. Cureus 2021; 13:e15542Baghal M, Ahmed M, Ibrahim M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268057 13. Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS- CoV-2 Patient. Cureus 2021; 13:e16149Ghafoor K, Ahmed A, Abbas M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262828 14. A Case Report on Extensive Arterial Thrombosis: A Rare Complication of COVID-19 Infection. Cureus 2021; 13:e15378Mandal S, Gami S, Khadka S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249531 15. Cardiovascular Risk Factors and the Severity of COVID-19 Disease. Cureus 2021; 13:e15486Motaib I, Zbiri S, Elamari S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262822 16. The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic. Curr. Oncol. Rep. 2021; 23:99Kwan JM, Henry ML, Christophers B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259950 17. Myocarditis after mRNA vaccination: Discussions about risks of the new COVID-19 vaccines for younger men. Deutsche Apotheker Zeitung 2021; 161Blasius H. 18. Recent trends in hypertension and diabetes therapy. Diabetologe 2021; Lindner TH. 19. Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series. Eur Heart J Case Rep 2021; 5:ytab239Garg A, Hakeem H, Chennu G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263128 20. Recurrent massive pulmonary embolism following catheter directed thrombolysis in a 21-year-old with COVID-19: a case report. Eur Heart J Case Rep 2021; 5:ytab140Hirschbaum JH, Bradley CP, Kingsford P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268475 21. COVID-19 mRNA Vaccine and Myocarditis. Eur J Case Rep Intern Med 2021; 8:002681Singh B, Kaur P, Cedeno L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268277 22. HFpEF and COVID-19: which comes frst, the chicken or the egg? REPLY. Eur J Heart Fail 2021; Anker MS, Tschöpe C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263996 23. Case Report: Acute Intracardiac Thrombosis in Children With Coronavirus Disease 2019 (COVID-19). Front Pediatr 2021; 9:656720Bigdelian H, Sedighi M, Sabri MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249807 24. Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center. Front Public Health 2021; 9:683683Arrivi A, Dominici M, Bier N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249847 25. Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis. Future Sci OA 2021; 7:Fso713Yassin A, Ghzawi A, Al-Mistarehi AH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254031 26. The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcifcation. Geroscience 2021:1-15Cereda A, Toselli M, Palmisano A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260010 27. Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis. Intern Emerg Med 2021:1-11Maddaloni E, D'Onofrio L, Siena A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273056 28. Exploring the Rescue Strategy for Cardiac Arrest in Makeshift (FangCang) Hospital Workers during the Pneumonia Outbreak Associated with COVID-19. Iran J. Public Health 2020; 49:76-81Feng K, Mei B, Chen Z, Fu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268208 29. Left ventricular thrombus with normal systolic function secondary to the novel prothrombotic association of acute on chronic calcifc pancreatitis and COVID-19. J Cardiol Cases 2021; Jariwala PV, Jadhav KP, Aurangabadkar H, Dommata RR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257751 30. COVID-19 diagnosis and testing in pediatric heart transplant recipients. J. Heart Lung Transplant. 2021; Bock MJ, Kuhn MA, Chinnock RE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253455 31. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine. J Korean Med Sci 2021; 36:e197Huh K, Na Y, Kim YE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254476 32. Cerebral venous thrombosis in a patient with Down syndrome and coronavirus disease 2019: a case report. J Med Case Rep 2021; 15:364Robayo- Amortegui H, Valenzuela-Faccini N, Quecano-Rosas C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253238 33. The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19. J Thromb Haemost 2021; Li A, Kuderer NM, Hsu CY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260813 34. Venous and arterial thromboembolic disease in COVID-19. J. Thromb. Thrombolysis 2021:1-3Ten Berg J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255267 35. Impact of the COVID-19 pandemic on drug treatment of patients with peripheral arterial disease: an observational cross-sectional study. J Vasc Bras 2021; 20:e20210021Braghieri HA, Correia MA, de Carvalho JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249118 36. Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal. Lancet Reg Health West Pac 2021; 12:100155Spaccarotella C, Sorrentino S, Indolf C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250516 37. Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study. Neurocrit. Care 2021; Sierra-Hidalgo F, Aragón Revilla E, Arranz García P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268645 38. A Unique Case of Branch Retinal Artery Occlusion Associated with a Relatively Mild Coronavirus Disease 2019. Ocul Immunol Infamm 2021:1-4Uzun A, Keles Sahin A, Bektas O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252339 39. Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2021; 8:ofab284Yetmar ZA, Chesdachai S, Kashour T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258316 40. COVID-19 and cardiovascular system-a comprehensive review. Rev Cardiovasc Med 2021; 22:343-351AlShahrani I, Hosmani J, Shankar VG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258902 41. Chronic disease management in heart failure: focus on telemedicine and remote monitoring. Rev Cardiovasc Med 2021; 22:403-413Alvarez P, Sianis A, Brown J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258907 42. Cardiac manifestations of COVID-19. Rev Cardiovasc Med 2021; 22:365- 371Bielecka-Dabrowa A, Cichocka-Radwan A, Lewek J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258904 43. COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations. Rev Cardiovasc Med 2021; 22:263- 265Stoner L, Faghy M, Conners R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34258892 44. Impact of SARS-CoV-2 pandemic on ST-elevation myocardial infarction admissions and outcomes in a Portuguese primary percutaneous coronary intervention center: Preliminary Data. Rev Port Cardiol (Engl Ed) 2021; 40:465- 471Azul Freitas A, Baptista R, Gonçalves V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274091 45. Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic. Telemed J E Health 2021; Sevilis T, McDonald M, Avila A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265222 46. Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study. Thromb Res 2021; 205:84-91Metra B, Summer R, Brooks SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274560 47. Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage. Toxicol Rep 2021; 8:1394- 1398Chalkias A, Pantazopoulos I, Papagiannakis N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258235
Diagnosis (7 articles)
1. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021; 20:102899Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274540 2. Synopsis on Pharmotechnological Approaches in Diagnostic to Management Strategies in Fighting Against COVID-19. Curr. Pharm. Des. 2021; Azhar A, Hassan N, Singh M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269664 3. Left ventricular mural thrombi with multisystem thrombosis in patients with COVID-19 and myocardial injury: a case series. Eur Heart J Case Rep 2021; 5:ytab239Garg A, Hakeem H, Chennu G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263128 4. A machine learning PROGRAM to identify COVID-19 and other diseases from hematology data. Future Sci OA 2021; 7:Fso733Gladding PA, Ayar Z, Smith K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254032 5. Challenges of Differential Diagnosis, Symptoms of Coronavirus Disease 2019 (COVID-19) or Cannabinoid Hyperemesis Syndrome (CHS)? A Rare Case Report. Iran J. Public Health 2020; 49:109-111Pirnia B, Pirnia K, Malekanmehr P, Zahiroddin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268213 6. COVID-19 diagnosis and testing in pediatric heart transplant recipients. J. Heart Lung Transplant. 2021; Bock MJ, Kuhn MA, Chinnock RE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253455 7. All That Coughs Is Not COVID-19: A Delayed Diagnosis of Disseminated Coccidioidomycosis Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open Forum Infect Dis 2021; 8:ofab246Chen JC, Wong D, Rabi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258312
DM-MS-Obesity (24 articles)
1. REPLY TO: What is the effect of obesity on the natriuretic peptide pathway? AACE Clin Case Rep 2021; Rao AN, Al-Ward RY, Gaba R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250225 2. Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis. Brief. Bioinform. 2021; Rahman MR, Islam T, Shahjaman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260684 3. COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults. Curr Obes Rep 2021:1-11Zeigler Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251647 4. Assessment and Management of Diabetic Patients During the COVID-19 Pandemic. Diabetes Metab. Syndr. Obes. 2021; 14:3131-3146Verma AK, Beg MMA, Bhatt D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262317 5. Higher admission activated partial thromboplastin time, neutrophil- lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K. Diabetes Res Clin Pract 2021; 178:108955Iqbal A, Greig M, Arshad MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273452 6. Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States. Diabetes Ther. 2021:1-17Boye KS, Tokar Erdemir E, Zimmerman N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275115 7. Outcome and death risk of diabetes patients with Covid-19 receiving pre- hospital and in-hospital metformin therapies. Diabetol. Metab. Syndr. 2021; 13:76Tamura RE, Said SM, de Freitas LM, Rubio IGS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256824 8. Recent trends in hypertension and diabetes therapy. Diabetologe 2021; Lindner TH. 9. Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression. Endocr. Metab. Immune Disord. Drug Targets 2021; Hariyanto TI, Lugito NPH, Yanto TA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250875 10. The Impact of COVID-19 Pandemic on Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: A Single-Centre Study in Central Pennsylvania. Endocrinol Diabetes Metab 2021; 4:e00235Bogale KT, Urban V, Schaefer E, Bangalore Krishna K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268453 11. The excess insulin requirement in severe COVID-19 compared to non-COVID- 19 viral pneumonitis is related to the severity of respiratory failure and pre- existing diabetes. Endocrinol Diabetes Metab 2021; 4:e00228Lockhart SM, Griffths H, Petrisor B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268452 12. Effect of the COVID-19 quarantine on metabolic control in children and adolescents with type 1 diabetes. Endocrinol Diabetes Nutr 2021; Turan H, Güneş Kaya D, Tarçın G, Evliyaoğlu SO. http://www.ncbi.nlm.nih.gov/pubmed/? term=34274306 13. Type 2 Diabetes Coagulopathy Proteins May Confict With Biomarkers Refective of COVID-19 Severity. Front. Endocrinol. (Lausanne) 2021; 12:658304Moin ASM, Al-Qaissi A, Sathyapalan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248840 14. Is obesity a risk factor in cancer patients with COVID-19? Future Oncol 2021; Park R, Wulff-Burchfeld E, Sun W, Kasi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254528 15. A protein interactions map of multiple organ systems associated with COVID- 19 disease. Genomics Inform 2021; 19:e14Bharne D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261299 16. Acute Fulminant Mucormycosis Triggered by Covid 19 Infection in a Young Patient. Indian J Otolaryngol Head Neck Surg 2021:1-5Eswaran S, Balan SK, Saravanam PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258246 17. Glycemic control among children and adolescents with type 1 diabetes during COVID-19 pandemic in Egypt: a pilot study. Int. J. Diabetes Dev. Ctries. 2021:1- 7Elhenawy YI, Eltonbary KY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257483 18. Mucormycosis and COVID-19: An Epidemic within a Pandemic in India. Mycoses 2021; Selarka L, Sharma S, Saini D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255907 19. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances. Obes Rev 2021; Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269511 20. Visceral Adiposity and Severe COVID-19 Disease: Application of an Artifcial Intelligence Algorithm to Improve Clinical Risk Prediction. Open Forum Infect Dis 2021; 8:ofab275Goehler A, Hsu TH, Seiglie JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258315 21. COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring. Prim. Care Diabetes 2021; Salabelle C, Ly Sall K, Eroukhmanoff J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257050 22. The Association Between Body Mass Index, Emotional Eating and Perceived Stress during COVID-19 Partial Quarantine in Healthy Adults. Public Health Nutr. 2021:1-23Barcın-Güzeldere HK, Devrim-Lanpir A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261563 23. COVID-19 infection and cardiometabolic complications: short- and long-term treatment and management considerations. Rev Cardiovasc Med 2021; 22:263- 265Stoner L, Faghy M, Conners R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34258892 24. Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis. Ther Adv Infect Dis 2021; 8:20499361211027390Windham S, Wilson MP, Fling C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249357
Education and training and science (61 articles)
1. Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned. Acad Pathol 2021; 8:23742895211020487Patel R, Hoppman NL, Gosse CM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263023 2. Impact of the COVID-19 pandemic on surgical trainee education and well- being spring 2020-winter 2020: A path forward. Am. J. Surg. 2021; Ellison EC, Nagler A, Stain SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272062 3. Is remote near-peer anatomy teaching an effective teaching strategy? Lessons learned from the transition to online learning during the Covid-19 pandemic. Anat Sci Educ 2021; Thom ML, Kimble BA, Qua K, Wish-Baratz S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268899 4. Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19. Ann. Allergy. Asthma. Immunol. 2021; Gabrielli S, Protudjer JL, Gooding G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260902 5. Sandwiches, 6 Feet Apart: Refections on Community (and Medical School) During COVID-19. Ann. Fam. Med. 2021; 19:368-370Fessler MM, Bishop RA, Jabour SM, Vasudevan A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264845 6. Impact of the COVID-19 pandemic on Caribbean Medical Students: A cross- sectional study. Ann Med Surg (Lond) 2021; 67:102515Thind AS, Singh H, Yerramsetty DL, Pandeya DR. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257958 7. Can being a 'frontline doctor' in the COVID-19 pandemic be a positive experience? Asian J Psychiatr 2021; 63:102769Mohindra R, Goyal M, Suri V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274630 8. Willingness to Donate Remnant Human Biospecimens in the Context of the COVID-19 Pandemic. Biopreserv. Biobank. 2021; Gao L, Li D, Liu X, Ren H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271844 9. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect. Dis. 2021; 21:677LaVergne SM, Stromberg S, Baxter BA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256735 10. Health authorities' health risk communication with the public during pandemics: a rapid scoping review. BMC Public Health 2021; 21:1401Berg SH, O'Hara JK, Shortt MT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266403 11. Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review. BMJ Open 2021; 11:e051224Misra V, Saf F, Brewerton KA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261692 12. Surgical training during the COVID-19 pandemic: preparing for future uncertainty. Br. J. Oral Maxillofac. Surg. 2020; Ellis R, Scrimgeour DSG, Brennan PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256956 13. Gender Disparities in Cardiology-Related COVID-19 Publications. Cardiol Ther 2021; Vasti EC, Ouyang D, Ngo S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268712 14. The Value of Medical Registries and Observational Studies Early in Pandemics: The COVID-19 Experience. Clin Infect Dis 2021; Albhaisi S, Wenzel RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270715 15. You Only Find What You Look for: Anchor Bias During the COVID-19 Pandemic. Cureus 2021; 13:e15416Abu-Rumaileh MA, Alsharif NM, Abdulelah M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249563 16. Content and Functionality of United States Medical School Websites. Cureus 2021; 13:e15534Pollock JR, Moore ML, Smith JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268052 17. Generation Z undergraduate students' resilience during the COVID-19 pandemic: a qualitative study. Curr. Psychol. 2021:1-15Ang WHD, Shorey S, Lopez V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253948 18. Occupational Commitment of Chinese Kindergarten Teachers During the COVID-19 Pandemic: Predictions of Anti-Epidemic Action, Income Reduction, and Career Confdence. Early Child Educ J 2021:1-15Wei Y, Wang L, Tan L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248326 19. "Working from home is one major disaster": An analysis of student feedback at a South African university during the Covid-19 lockdown. Educ Inf Technol (Dordr) 2021:1-23Fouche I, Andrews G. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248388 20. Design, implementation and initial fndings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease. Eur. J. Epidemiol. 2021:1-6Licher S, Terzikhan N, Splinter MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34275020 21. Transitioning Nursing Students' Education from Traditional Classroom to Online Education during the COVID-19 Pandemic: A Case Study Applied to the Meleis Trial. Florence Nightingale J Nurs 2021; 29:124-127Jallad ST, Işık B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263230 22. The Yin and the Yang of Transformative Research During the COVID-19 Pandemic-A Perspective. Front Pediatr 2021; 9:650302Sampath V, Ramchandran R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249804 23. Extra-Curricular Activities and Well-Being: Results From a Survey of Undergraduate University Students During COVID-19 Lockdown Restrictions. Front. Psychol. 2021; 12:647402Finnerty R, Marshall SA, Imbault C, Trainor LJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262502 24. Assessment of Knowledge and Practices Toward COVID-19 Prevention Among Healthcare Workers in Tigray, North Ethiopia. Front Public Health 2021; 9:614321Gebremeskel TG, Kiros K, Gesesew HA, Ward PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249827 25. Editorial: Coronavirus Research Landscape: Resources, Utilities, and Analytic Studies. Front Res Metr Anal 2021; 6:712672Chen C, Chavalarias D, Smalheiser NR, Wolfram D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250436 26. A call to action: Antiracist patient engagement in adolescent and young adult oncology research and advocacy. Future Oncol 2021; Cheung CK, Tucker-Seeley R, Davies S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263658 27. The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training. GE Port J Gastroenterol 2021; 92:1-6Pisani A, Cremers I, Ellul P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254042 28. COVID-19 and the Authority of Science. HEC Forum 2021:1-28Trotter G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251565 29. Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh. Heliyon 2021; 7:e07388Hossain MJ, Ahmmed F, Rahman SMA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258456 30. Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings. Infect Dis Health 2021; Sotomayor-Castillo C, Nahidi S, Li C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266812 31. Impact of school reopening on pandemic spread: A case study using an agent-based model for COVID-19. Infect Dis Model 2021; 6:839-847Tatapudi H, Das TK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258483 32. Value-Added Roles of Medical Students During the COVID-19 Pandemic: Assessment of Medical Students' Perceptions and Willingness in Sri Lanka. Int. J. Gen. Med. 2021; 14:3187-3196Wickramasinghe ND, Jayarathne SW, Pilapitiya SD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262332 33. Remote learning and online teaching in Fiji during COVID-19: The challenges and opportunities: Correspondence. Int J Surg 2021:106019Chand AA, Lal PP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252594 34. Remote learning and online teaching in Fiji during COVID-19: The challenges and opportunities. Int J Surg 2021:106019Chand AA, Lal PP, Chand KK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252594 35. Community Health Education for Health Crisis Management: The Case of COVID-19 in Cameroon. Int. Q. Community Health Educ. 2021:272684x211031106Mbah M, Bang H, Ndi H, Ndzo JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264140 36. COVID-19: Learning from experience. Internist 2021; 62:695-696Salzberger B, Schellong S. 37. #COVID#BACKTOSCHOOL: Qualitative study based on the voice of Portuguese adolescents. J. Community Psychol. 2021; Branquinho C, Santos AC, Ramiro L, Gaspar de Matos M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252981 38. Learning with lockdown: Utility of whatsApp status-based multiple-choice question discussion on COVID-19 among medical students and teaching faculty. J Educ Health Promot 2021; 10:168Doddaiah SK, Kulkarni P, Mohandas A, Murthy MRN. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250102 39. Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute. J Educ Health Promot 2021; 10:183Singh V, Supehia S, Gupta PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250117 40. In-person vs. home schooling during the COVID-19 pandemic: Differences in sleep, circadian timing, and mood in early adolescence. J. Pineal Res. 2021:e12757Stone JE, Phillips AJK, Chachos E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273194 41. Instilling resiliency in surgical education: The benefts of longitudinal medical student learning. J. Surg. Res. 2021; 267:512-515Abel MK, Collins C, Lancaster EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256193 42. Mentorship: a millennia-old remedy for learner success amidst the COVID-19 pandemic. J. Surg. Res. 2021; 267:593-597Santiesteban L, McKenney M, Elkbuli A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265603 43. Preservice teachers' perceptions of learning environments before and after pandemic-related course disruption. Learn Environ Res 2021:1-15Long CS, Sinclair BB, Fraser BJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248400 44. The landscape of COVID-19 trials in Australia. Med. J. Aust. 2021; 215:58- 61.e51Seidler AL, Aberoumand M, Williams JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275134 45. Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic. Ophthalmic Epidemiol. 2021:1-7Cartes C, Segovia C, Salinas-Toro D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251964 46. Urgent need to strengthen school health in Asia and the Pacifc Islands. Pediatr. Int. 2021; Kobayashi J, Takeuchi R, Toyama Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258829 47. Impact of the COVID-19 pandemic on surgical skills training in pediatric surgery residents. Pediatr. Surg. Int. 2021:1-6Lerendegui L, Boudou R, Percul C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272598 48. Health Beliefs and Preventive Behaviors Among Adults During the Early COVID-19 Pandemic in the United States: a Latent Class Analysis. Prev Sci 2021:1-10Smail E, Schneider KE, DeLong SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275054 49. Implications for social work teaching and learning in Universiti Sains Malaysia, Penang, due to the COVID-19 pandemic: A refection. Qual Soc Work 2021; 20:553-560Azman A, Singh PSJ, Isahaque A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253996 50. "Thanks for hearing me out": Voices of social work students during COVID-19. Qual Soc Work 2021; 20:63-66Cole SJ, Mitra SS, Robinson JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253955 51. Experiences of the Covid-19 pandemic: From the perspective of an MSW student. Qual Soc Work 2021; 20:604-609Hugo T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253999 52. A sanctuary: Mourning the loss of the classroom during COVID. Qual Soc Work 2021; 20:162-167Mitchell Dove L. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253962 53. An evaluation of the experiences of academics and practice educators who supported radiography students working on the temporary HCPC register during the COVID-19 pandemic. Radiography (Lond) 2021; Strudwick RM, Cushen-Brewster N, Doolan C, Driscoll-Evans P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274227 54. Covid-19 Knowledge and Perceptions Among Dental Specialists: A Cross- Sectional Online Questionnaire Survey. Risk Manag. Healthc. Policy 2021; 14:2851-2861Aldhuwayhi S, Mallineni SK, Sakhamuri S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262372 55. COVID-19 and aging: Identifying measures of severity. SAGE Open Med 2021; 9:20503121211027462Neves MT, de Matos LV, Vasques AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249362 56. Flipped classroom: How higher education institutions (HEIs) of Bangladesh could move forward during COVID-19 pandemic. Soc Sci Humanit Open 2021; 4:100187Khan MSH, Abdou BO. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250462 57. A living mapping review for COVID-19 funded research projects: nine-month update. Wellcome Open Res 2020; 5:209Norton A, Bucher A, Antonio E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33117894 58. Make nursing practice visible through nursing science in times of COVID-19. Wien. Med. Wochenschr. 2021; Hödl M, Bauer S, Eglseer D et al. 59. The impact of the coronavirus pandemic on European Neurosurgery Trainees. World Neurosurg 2021; Tzerefos C, Meling TR, Lafuente J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252632
Elderly (15 articles)
1. Neurological Manifestations in COVID-19: An Unrecognized Crisis in Our Elderly? Adv Geriatr Med Res 2021; 3Krupp K, Madhivanan P, Killgore WDS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268500 2. COVID-19 Associated Suicidal Ideation in Older Adults: Two Case Reports With a Review of the Literature. Am J Geriatr Psychiatry 2021; Asthana NK, Mehaffey E, Sewell DD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266752 3. Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic. BMC Res. Notes 2021; 14:271Weeks LE, Nesto S, Hiebert B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261523 4. Trends in emergency department use by older people during the COVID-19 pandemic. Eur. Geriatr. Med. 2021:1-9Howley F, Lavan A, Connolly E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273092 5. Comorbidities predict 30-day hospital mortality of older adults with COVID-19. Geriatr. Nurs. 2021; 42:1024-1028Pott Junior H, Cominetti MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256151 6. Frailty as a mortality predictor in older adults with COVID-19: A systematic review and meta-analysis of cohort studies. Geriatr. Nurs. 2021; 42:983- 992Saragih ID, Advani S, Saragih IS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256158 7. Therapeutic prevention of COVID-19 in elderly: a case-control study. Geroscience 2021:1-11Blanc F, Waechter C, Vogel T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273049 8. Effects of social prescribing pilot project for the elderly in rural area of South Korea during COVID-19 pandemic. Health Sci Rep 2021; 4:e320Kim JE, Lee YL, Chung MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250272 9. Ageism in the COVID-19 pandemic: age-based discrimination in triage decisions and beyond. Hist Philos Life Sci 2021; 43:91Rueda J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258692 10. Surviving older patients show preserved cellular and humoral immunological memory several months after SARS-CoV-2 infection. J Gerontol A Biol Sci Med Sci 2021; García-Torre A, Bueno-García E, López-Martínez R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252180 11. Association between Early Antibiotic Therapy and In-Hospital Mortality among Older Patients with SARS-CoV-2 Pneumonia. J Gerontol A Biol Sci Med Sci 2021; Putot A, Bouiller K, Laborde C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272847 12. Background rates of hospital transfer and death in Australian aged care facilities: estimates to assist interpretation of rates after COVID-19 vaccination. Med. J. Aust. 2021; Clothier HJ, Mesfn YM, Strange S, Buttery JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268767 13. Treating elderly geriatric patients right - some special aspects regarding sequential acute medical treatment and rehabilitation, rehabilitation and the new IPReG and long-Covid- rehabilitation. MMW-Fortschritte der Medizin 2021; 163:48-50Zeile T. 14. COVID 19 meets changing traditional care systems for the elderly and a budding social work practice. Refections for geriatric care in Ghana. Qual Soc Work 2021; 20:501-506Deku CS, Forkuor JB, Agyemang E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253991 15. Actual Frailty Conditions and Lifestyle Changes in Community-Dwelling Older Adults Affected by Coronavirus Disease 2019 Countermeasures in Japan: A Cross-Sectional Study. SAGE Open Nurs 2021; 7:23779608211025117Shinohara T, Saida K, Tanaka S, Murayama A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263028 Epidemiology (63 articles)
1. Medical Challenges in hosting 2020 Tokyo Olympic and Paralympic Games to let us see brilliant blue sky over the clouds. Anaesth Crit Care Pain Med 2021:100930Morimura N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252598 2. A multi-stage SEIR(D) model of the COVID-19 epidemic in Korea. Ann. Med. 2021; 53:1159-1169Shin HY. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269629 3. Transmission trend of the COVID-19 pandemic predicted by dendritic neural regression. Appl Soft Comput 2021; 111:107683Dong M, Tang C, Ji J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248448 4. Covid-19 and the next outbreak: decreasing frailty by using mild stress? Biogerontology 2021:1-5Le Bourg E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273015 5. Epidemiological characteristics and initial spatiotemporal visualisation of COVID-19 in a major city in the Middle East. BMC Public Health 2021; 21:1373MohammadEbrahimi S, Mohammadi A, Bergquist R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247616 6. Mere rhetoric? Using solidarity as a moral guide for deliberations on border closures, border reopenings and travel restrictions in the age of COVID-19. BMJ Glob Health 2021; 6Silva DS, Jackson C, Smith MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272273 7. National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates. BMJ Open 2021; 11:e049703Coltart CEM, Wells D, Sutherland E, Fowler A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257096 8. Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review. BMJ Open 2021; 11:e050519Jenniskens K, Bootsma MCJ, Damen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253676 9. Reducing COVID-19 quarantine with SARS-CoV-2 testing: a simulation study. BMJ Open 2021; 11:e050473Peng B, Zhou W, Pettit RW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272225 10. Protecting olympic participants from COVID-19: the trialled and tested process. Br. J. Sports Med. 2021; Pigozzi F, Wolfarth B, Cintron Rodriguez A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272272 11. A study on factors affecting privacy risk tolerance to prevent the spread of COVID-19 in South Korea. Bus. Horiz. 2021; Kim M, Jung Y, Kim J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248157 12. The devil in the details: Herd immunity and pandemic response. Cell Host Microbe 2021; 29:1048-1051Schaeffer B, Taylor B, Bushman M, Hanage WP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265244 13. Modelling and forecasting of growth rate of new COVID-19 cases in top nine affected countries: Considering conditional variance and asymmetric effect. Chaos Solitons Fractals 2021; 151:111227Ekinci A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253942 14. Clustering of Countries for COVID-19 Cases based on Disease Prevalence, Health Systems and Environmental Indicators. Chaos Solitons Fractals 2021:111240Rizvi SA, Umair M, Cheema MA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253943 15. Impact of COVID-19 outbreak on Italian healthcare workers versus general population: results from an online survey. Clin. Psychol. Psychother. 2021; Mansueto G, Lopes FL, Grassi L, Cosci F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255890 16. Bayesian inference of heterogeneous epidemic models: Application to COVID- 19 spread accounting for long-term care facilities. Comput Methods Appl Mech Eng 2021; 385:114020Chen P, Wu K, Ghattas O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248229 17. Impact of Nonpharmacological Public Health Interventions on Epidemiological Parameters of COVID-19 Pandemic in India. Cureus 2021; 13:e15393Kharya P, Koparkar AR, Dixit AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249543 18. Epidemic, pandemic or endemic: When and how will we overcome the corona crisis? Deutsche Apotheker Zeitung 2021; 161Grill E. 19. Lockdown effect on COVID-19 incidence and death: Iran experience. Disaster Med Public Health Prep 2021:1-10Delavari S, Jamali Z, Bayati M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247685 20. The impact of the COVID-19 pandemic on refugees and asylum seekers in Greece: A retrospective analysis of national surveillance data from 2020. EClinicalMedicine 2021; 37:100958Kondilis E, Papamichail D, McCann S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258570 21. Lifting COVID-19 mitigation measures in Spain (May-June 2020). Enferm. Infecc. Microbiol. Clin. 2021; Monge S, Zamalloa PL, Moros MJS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274154 22. COVID-19 and emerging infectious diseases: The society is still unprepared for the next pandemic. Environ. Res. 2021; 202:111676Frutos R, Gavotte L, Serra- Cobo J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252435 23. Transmission risks of respiratory infectious diseases in various confned spaces: A meta-analysis for future pandemics. Environ. Res. 2021:111679Moon J, Ryu BH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265349 24. Passive Sampling of SARS-CoV-2 for Wastewater Surveillance. Environ. Sci. Technol. 2021; Schang C, Crosbie ND, Nolan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264643 25. A Study of the Correlation between the Dates of the First Covid Case and the First Covid Death of 25 Selected Countries to Know the Virulence of the Covid- 19 in Different Tropical Conditions. Ethics Med Public Health 2021:100707Jamsheela O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254043 26. Trends in emergency department use by older people during the COVID-19 pandemic. Eur. Geriatr. Med. 2021:1-9Howley F, Lavan A, Connolly E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273092 27. Rapid spread of the SARS-CoV-2 Delta variant in some French regions, June 2021. Euro Surveill 2021; 26Alizon S, Haim-Boukobza S, Foulongne V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269174 28. Estimating the Prevalence of Asymptomatic COVID-19 Cases and Their Contribution in Transmission - Using Henan Province, China, as an Example. Front Med (Lausanne) 2021; 8:591372Li C, Zhu Y, Qi C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249953 29. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19. Front Public Health 2021; 9:628098Esposito S, Neglia C, Affanni P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249830 30. No detection of SARS-CoV-2 in animals exposed to infected keepers: results of a COVID-19 surveillance program. Future Sci OA 2021; 7:Fso711Cerino P, Buonerba C, Brambilla G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254029 31. The profle of patients hospitalized with COVID-19 under the Quarantine Act in a designated hospital near an international airport in Japan. Glob Health Med 2021; 3:180-183Hase R, Kubota Y, Niiyama Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250295 32. School openings and the COVID-19 outbreak in Italy. A provincial-level analysis using the synthetic control method. Health Policy 2021; Alfano V, Ercolano S, Cicatiello L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247845 33. Pattern of COVID-19 infection and death across countries: A pilot study. Heliyon 2021:e07504Asem N, Ramadan A, Hassany M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254048 34. Impact of school reopening on pandemic spread: A case study using an agent-based model for COVID-19. Infect Dis Model 2021; 6:839-847Tatapudi H, Das TK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258483 35. High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for heard immunity! Int J Infect Dis 2021; Núñez-Zapata SF, Benites- Peralta B, Mayta-Tristan P, Rodríguez-Morales AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260956 36. Reduction in COVID-19 prevalence in health care workers in a university hospital in southern Brazil after the start of vaccination. Int J Infect Dis 2021; Toniassoa SCC, Fernandesa FS, Jovelevithsb D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271203 37. Validity of the Use of Wrist and Forehead Temperatures in Screening the General Population for COVID-19: A Prospective Real-World Study. Iran J. Public Health 2020; 49:57-66Chen G, Xie J, Dai G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268206 38. Exponentially Increasing Trend of Infected Patients with COVID-19 in Iran: A Comparison of Neural Network and ARIMA Forecasting Models. Iran J. Public Health 2020; 49:92-100Moftakhar L, Seif M, Safe MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268211 39. Refections on the Cluster Epidemic of COVID-19; Lessons Learned from Wuhan's Experience: A Brief Review. Iran J. Public Health 2020; 49:12-17Zhou Q, Huang S, Xiao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268201 40. A novel hybrid fuzzy time series model for prediction of COVID-19 infected cases and deaths in India. ISA Trans. 2021; Kumar N, Kumar H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253340 41. The forecast of COVID-19 spread risk at the county level. J Big Data 2021; 8:99Hssayeni MD, Chala A, Dev R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249603 42. #COVID#BACKTOSCHOOL: Qualitative study based on the voice of Portuguese adolescents. J. Community Psychol. 2021; Branquinho C, Santos AC, Ramiro L, Gaspar de Matos M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252981 43. Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study. J. Epidemiol. Community Health 2021; Serván-Mori E, Seiglie JA, Gómez-Dantés O, Wirtz VJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266980 44. Lessons Learnt and Pathways forward for National Civil Registration and Vital Statistics Systems after the COVID-19 Pandemic. J Epidemiol Glob Health 2021; Kelly M, Mathenge G, Rao C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270182 45. COVID-19 spread in a classroom equipped with partition - A CFD approach. J. Hazard. Mater. 2021; 420:126587Mirzaie M, Lakzian E, Khan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273880 46. Viral infections amidst COVID-19 in Africa: Implications and recommendations. J Med Virol 2021; Uwishema O, Adanur I, Babatunde AO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260094 47. Contact Tracing Apps: Lessons Learned on Privacy, Autonomy, and the Need for Detailed and Thoughtful Implementation. JMIR Med Inform 2021; 9:e27449Hogan K, Macedo B, Macha V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254937 48. An epidemic model for COVID-19 transmission in Argentina: Exploration of the alternating quarantine and massive testing strategies. Math. Biosci. 2021:108664Vassallo L, Perez IA, Alvarez-Zuzek LG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271015 49. COVID-19 Community Temporal Visualizer: a new methodology for the network-based analysis and visualization of COVID-19 data. Netw Model Anal Health Inform Bioinform 2021; 10:46Milano M, Zucco C, Cannataro M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249598 50. Mathematical modelling of the second wave of COVID-19 infections using deterministic and stochastic SIDR models. Nonlinear Dyn 2021:1-15Lobato FS, Libotte GB, Platt GM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248281 51. A stochastic SEIHR model for COVID-19 data fuctuations. Nonlinear Dyn 2021:1-13Niu R, Chan YC, Wong EWM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248280 52. Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis. Pathol. Oncol. Res. 2021; 27:1609774Bogos K, Kiss Z, Kerpel Fronius A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257618 53. Forecasting the COVID-19 transmission in Italy based on the minimum spanning tree of dynamic region network. PeerJ 2021; 9:e11603Dong M, Zhang X, Yang K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249495 54. Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective. Prehosp. Disaster Med. 2021:1-12Ranse J, Beckwith D, Khan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261546 55. Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones. Proc Natl Acad Sci U S A 2021; 118Rüdiger S, Konigorski S, Rakowski A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261775 56. Refections on a pandemic and surveillance: Disruption, distractions, and discoveries in the United Arab Emirates. Qual Soc Work 2021; 20:331-335Abu Sarhan TM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253976 57. Risk contagion of COVID-19 in Japanese frms: A network approach. Res Int Bus Finance 2021; 58:101491Kanno M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248246 58. Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates? Risk Manag. Healthc. Policy 2021; 14:2877-2885Cegan JC, Trump BD, Cibulsky SM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267565 59. Spread of COVID-19 in Zambia: An assessment of environmental and socioeconomic factors using a classifcation tree approach. Sci Afr 2021; 12:e00827Phiri D, Salekin S, Nyirenda VR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250321 60. Monitoring of SARS-CoV-2 RNA in wastewater as an epidemiological surveillance tool in Mendoza, Argentina. Sci Total Environ 2021; 796:148887Giraud-Billoud M, Cuervo P, Altamirano JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274669 61. The existence, spread, and strategies for environmental monitoring and control of SARS-CoV-2 in environmental media. Sci Total Environ 2021; 795:148949Liu Z, Skowron K, Grudlewska-Buda K, Wiktorczyk-Kapischke N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252782 62. Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases. SN Comput Sci 2021; 2:372Shoaib M, Salahudin H, Hammad M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258586 63. One year of COVID-19 in Italy: are containment policies enough to shape the pandemic pattern? Socioecon. Plann. Sci. 2021:101120Panarello D, Tassinari G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248212
Gastro-enterology (12 articles)
1. Enteroclysis in gastrointestinal tuberculosis: an overview. Adv Respir Med 2021; Muntean PE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269410 2. Acute Acalculous Cholecystitis Due to COVID-19, an Unusual Presentation. Cureus 2021; 13:e15431Abaleka FI, Nigussie B, Bedanie G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258107 3. Coronavirus Disease 2019 Pneumonia and Acute Pancreatitis in a Young Girl. Cureus 2021; 13:e15374Ehsan P, Haseeb M, Khan Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249527 4. Liver dysfunction in COVID-19: a useful prognostic marker of severe disease? Frontline Gastroenterol. 2021; 12:293-298Lok J, Gess M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249314 5. COVID-19: impetus to the adoption of capsule endoscopy as a primary diagnostic tool? Frontline Gastroenterol. 2021; 12:263-264McAlindon M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249309 6. COVID-19 in Gastroenterology Departments: The Impact of the First Wave. GE Port J Gastroenterol 2021; 4:1-7Leal T, Gonçalves M, Mocanu I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254041 7. Reply to: "COVID-19-associated liver injury (COVALI): role of hepatologists". J. Gastroenterol. 2021:1-2Li D, Ding X, Tian D, Xia L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251568 8. Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury. J Hepatol 2021; Saviano A, Baumert TF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274367 9. A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. J. Oncol. Pharm. Pract. 2021:10781552211031304Demir E, Sütcüoğlu O, Demir B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255596 10. Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience. Rom. J. Intern. Med. 2021; Voiosu A, Roman A, Pop R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253002 11. Impact of the COVID-19 pandemic on infammatory bowel disease: the role of emotional stress and social isolation. Stress Health 2021; Nass BY, Dibbets P, Markus CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273129 12. High rate of percutaneous gastrostomy placement in COVID-19 patients with low overall complications. Tech Innov Gastrointest Endosc 2021; Lipcsey M, Stein DJ, Yu RL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250514
Guidelines (5 articles)
1. The dynamics in applied COVID-19 pharmacotherapy and the infuence of national guidance in The Netherlands: a quantitative and qualitative study. Eur J Hosp Pharm 2021; Uitvlugt EB, Soeng DYF, van der Linden P, van de Garde EMW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272215 2. NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients. Indian J. Nephrol. 2021; 31:89-91Kute VB, Agarwal SK, Prakash J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267426 3. Examining the role of governmsent in shaping disability inclusiveness around COVID-19: a framework analysis of Australian guidelines. Int J Equity Health 2021; 20:166Colon-Cabrera D, Sharma S, Warren N, Sakellariou D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271933 4. Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis. J Thromb Haemost 2021; Jevtic SD, Malinowski AK, Othman M, Kadir RAA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260818 5. Validation of the French IVF guidelines during the COVID-19 pandemic. Reprod. Biomed. Online 2021; Poulain M, Fossard C, Benammar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274240
Imaging (31 articles)
1. A human-computer collaboration for COVID-19 differentiation: combining a radiomics model with deep learning and human auditing. Ann Palliat Med 2021; Xin X, Mo R, Shao M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263624 2. A new composite approach for COVID-19 detection in X-ray images using deep features. Appl Soft Comput 2021; 111:107669Ozcan T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248447 3. FractalCovNet architecture for COVID-19 Chest X-ray image Classifcation and CT-scan image Segmentation. Biocybern Biomed Eng 2021; 41:1025- 1038Munusamy H, Karthikeyan JM, Shriram G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257471 4. Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study. BMJ Open Respir Res 2021; 8Takeshita Y, Terada J, Fujita R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272254 5. Intraoperative Ultrasonographic Assessment of Vocal Cord motion under sedation, following paediatric thyroidectomy in the Era of COVID-19: A double- blinded preliminary study. Clin. Otolaryngol. 2021; Zavdy O, Schwarz M, Gilony D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255927 6. Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review. Curr Med Imaging 2021; Mondal MRH, Bharati S, Podder P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259149 7. Deep Learning-Based COVID-19 Pneumonia Classifcation Using Chest CT Images: Model Generalizability. Front Artif Intell 2021; 4:694875Nguyen D, Kay F, Tan J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268489 8. Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review. Glob Health Med 2021; 3:129-133Minamimoto R, Kiyomatsu T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250287 9. SpecMEn-DL: spectral mask enhancement with deep learning models to predict COVID-19 from lung ultrasound videos. Health Inf Sci Syst 2021; 9:28Sadik F, Dastider AG, Fattah SA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257953 10. Dissociation between the clinical course and chest imaging in severe COVID- 19 pneumonia: A series of fve cases. Heart Lung 2021; 50:818-824Basille D, Auquier MA, Andréjak C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271253 11. Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a refection of the innate immune status. Int J Clin Pract 2021:e14624Ozcelik F, Tanoglu A, Guven BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251730 12. National and regional trends in MRI utilization in the face of the ongoing COVID-19 pandemic. Isr J Health Policy Res 2021; 10:40Luxenburg O, Saban M, Myers V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266476 13. Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring. J. Alzheimers Dis. 2021; Samkaria A, Punjabi K, Sharma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250939 14. Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report. J Med Case Rep 2021; 15:377Egoryan G, Hyser E, Mushtaq AH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256831 15. Evolution of (18)F-FDG-PET/CT fndings in patients following COVID-19 pneumonia: An Initial Investigation. J Nucl Med 2021; Thornton A, Fraioli F, Wan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272318 16. Neuroimaging Findings in Patients with COVID-19: A Systematic Review and Meta-Analysis. Korean J Radiol 2021; Kim PH, Kim M, Suh CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269530 17. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model. mBio 2021:e0097421Dhakal S, Ruiz- Bedoya CA, Zhou R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253053 18. Radiography-based triage for COVID-19 in the Emergency Department in a Spanish cohort of patients. Med Clin (Barc) 2021; Sempere-González A, Llaneras-Artigues J, Pinal-Fernández I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256936 19. Deep learning-based meta-classifer approach for COVID-19 classifcation using CT scan and chest X-ray images. Multimed Syst 2021:1-15Ravi V, Narasimhan H, Chakraborty C, Pham TD. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248292 20. Improved manta ray foraging optimization for multi-level thresholding using COVID-19 CT images. Neural Comput Appl 2021:1-21Houssein EH, Emam MM, Ali AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248291 21. An optimized KELM approach for the diagnosis of COVID-19 from 2D-SSA reconstructed CXR Images. Optik (Stuttg) 2021; 244:167572Mohanty F, Dora C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248209 22. CME Sonography 98/Answers: Chest Ultrasound. Praxis 2021; 110:508- 509Bürge T, Tuma J. 23. Ultrasound in times of corona. Praxis 2021; 110:419Schwarzenbach HR, Tuma J. 24. Prevalence of exercise-induced oxygen desaturation after recovery from SARS-CoV-2 pneumonia and use of lung ultrasound to predict need for pulmonary rehabilitation. Pulmonology 2021; Carlucci A, Paneroni M, Carotenuto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247995 25. Cross-sectional analysis of follow-up chest MRI and chest CT scans in patients previously affected by COVID-19. Radiol Med 2021:1-9Pecoraro M, Cipollari S, Marchitelli L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251585 26. COVID-19 pneumonia: relationship between initial chest X-rays and laboratory fndings. Radiologia (Roma) 2021; Nava-Muñoz Á, Gómez-Peña S, Fuentes-Ferrer ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253334 27. HOG + CNN Net: Diagnosing COVID-19 and Pneumonia by Deep Neural Network from Chest X-Ray Images. SN Comput Sci 2021; 2:371Rahman MM, Nooruddin S, Hasan KMA, Dey NK. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254055 28. Thoracic imaging outcomes in COVID-19 survivors. World J Radiol 2021; 13:149-156Alqahtani JS, Alghamdi SM, Aldhahir AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249236 29. COVID-19 imaging: Diagnostic approaches, challenges, and evolving advances. World J Radiol 2021; 13:171-191Pezzutti DL, Wadhwa V, Makary MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249238 30. Imaging in the COVID-19 era: Lessons learned during a pandemic. World J Radiol 2021; 13:192-222Sideris GA, Nikolakea M, Karanikola AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249239 31. Imaging spectrum of abdominal manifestations of COVID-19. World J Radiol 2021; 13:157-170Vaidya T, Nanivadekar A, Patel R. http://www.ncbi.nlm.nih.gov/pubmed/?term=3424923
Immune response (38 articles)
1. Dye-Loaded Polymersome-Based Lateral Flow Assay: Rational Design of a COVID-19 Testing Platform by Repurposing SARS-CoV-2 Antibody Cocktail and Antigens Obtained from Positive Human Samples. ACS Sens 2021; Ghorbanizamani F, Tok K, Moulahoum H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270230 2. [Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2]. Acta Med Port 2021; Moreira- Pinto J, Gregório S, Camarinha J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256902 3. Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report. Ann. Rheum. Dis. 2021; Golding B, Lee Y, Golding H, Khurana S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272252 4. Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'. Ann. Rheum. Dis. 2021; Westhoff TH, Seibert FS, Anft M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272253 5. Titres and neutralising capacity of SARS-CoV-2-specifc antibodies in human milk: a systematic review. Arch. Dis. Child. Fetal Neonatal Ed. 2021; Low JM, Low YW, Zhong Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257103 6. Incidence and predictors of COVID-19 and fares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France. Arthritis Res. Ther. 2021; 23:188Felten R, Scherlinger M, Guffroy A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256812 7. Dynamic changes of functional ftness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study. BMC Med 2021; 19:163Xiong L, Li Q, Cao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256745 8. COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. Br. J. Haematol. 2021; Passamonti F, Romano A, Salvini M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272724 9. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021; 45:123Hembram P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257504 10. Cardiac Implications of Multisystem Infammatory Syndrome Associated with COVID-19 in Children under the age of Five Years. Cardiol. Young 2021:1- 15Rakha S, Sobh A, Hager AH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261560 11. Longitudinal analysis shows durable and broad immune memory after SARS- CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med 2021:100354Cohen KW, Linderman SL, Moodie Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250512 12. Longitudinal analysis shows durable and broad immune memory after SARS- CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med 2021; 2:100354Cohen KW, Linderman SL, Moodie Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250512 13. SARS-CoV-2-specifc humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation. Clin Transl Immunology 2021; 10:e1306Sandberg JT, Varnaitė R, Christ W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257967 14. The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization. Eur J Case Rep Intern Med 2021; 8:002617Sazgary L, Meienberg A, Berger CT, Mayr M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268264 15. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem infammatory syndrome in children (MIS-C). Exp. Biol. Med. (Maywood) 2021:15353702211028560Kuypers FA, Rostad CA, Anderson EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255566 16. Case Report: Adult Post-COVID-19 Multisystem Infammatory Syndrome and Thrombotic Microangiopathy. Front. Immunol. 2021; 12:680567Boudhabhay I, Rabant M, Roumenina LT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248962 17. Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Effcacy of Remdesivir. Front. Immunol. 2021; 12:680188Chan YH, Young BE, Fong SW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262564 18. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome. Front. Immunol. 2021; 12:621440Illouz T, Biragyn A, Iulita MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248930 19. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front. Immunol. 2021; 12:700782Patterson BK, Guevara-Coto J, Yogendra R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262570 20. In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms. Front. Microbiol. 2021; 12:698944Lassaunière R, Fonager J, Rasmussen M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248922 21. How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients. Front. Physiol. 2021; 12:628288Laveneziana P, Straus C, Meiners S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267671 22. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19. Front Public Health 2021; 9:628098Esposito S, Neglia C, Affanni P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249830 23. COVID-19 vaccine mRNA-1273 elicits a protective immune profle in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity 2021; DiPiazza AT, Leist SR, Abiona OM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270939 24. Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt. Infuenza Other Respir Viruses 2021; El Rifay AS, Mahmoud SH, Marouf MA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34264010 25. Analysis of SARS-CoV-2 RT-qPCR Ct values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region. Int J Infect Dis 2021; Markewitz R, Torge A, Wandinger KP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273511 26. SARS-CoV-2 infection in the immunodefcient host: necessary and dispensable immune pathways. J Allergy Clin Immunol Pract 2021; Giardino G, Romano R, Coppola E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273582 27. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study. J. Clin. Immunol. 2021:1-12García-Abellán J, Padilla S, Fernández-González M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273064 28. Surviving older patients show preserved cellular and humoral immunological memory several months after SARS-CoV-2 infection. J Gerontol A Biol Sci Med Sci 2021; García-Torre A, Bueno-García E, López-Martínez R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252180 29. Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. J Immunother Cancer 2021; 9Switzer B, Haanen J, Lorigan PC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272309 30. SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion. J Infect Dis 2021; Ferreira I, Kemp S, Datir R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260717 31. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight 2021; Lopez E, Haycroft ER, Adair A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251356 32. Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease. Kidney Int Rep 2021; Carr EJ, Kronbichler A, Graham-Brown M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250319 33. Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. Open Forum Infect Dis 2021; 8:ofab299Velasco M, Galán MI, Casas ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258322 34. Immunity and infammatory biomarkers in COVID-19: A systematic review. Rev Med Virol 2021; 31:e2199Iwamura APD, Tavares da Silva MR, Hümmelgen AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260778 35. A systematic meta-analysis of immune signatures in patients with COVID-19. Rev Med Virol 2021; 31:e2195Liu K, Yang T, Peng XF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260780 36. Short-term outcomes in children recovered from multisystem infammatory syndrome associated with SARS-CoV-2 infection. Rheumatol. Int. 2021:1- 6Patnaik S, Jain MK, Ahmed S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259880 37. Comment on: Emerging Evidence on Multisystem Infammatory Syndrome in Children Associated with SARS-CoV-2 Infection. SN Compr Clin Med 2021:1- 2Mantina NM, Madhivanan P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250445 38. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences. Virulence 2021; 12:1771- 1794Alshammary AF, Al-Sulaiman AM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34251989
Management miscellaneous diseases (58 articles)
1. ECONOMIC IMPACT OF COVID-19 ON BRAZILIAN ORTHOPEDISTS. Acta Ortop Bras 2021; 29:61-66Stirma GA, Belangero PS, Pochini AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248402 2. Impact of COVID-19 pandemic on non-COVID patient's management in urology: a public hospital experience in Mumbai. Afr J Urol 2021; 27:96Jibhakate NA, Patwardhan SK, Sawant AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248350 3. Patterns of Emergency Department visits for acute and chronic diseases during the two pandemic waves in Italy. Am J Emerg Med 2021; 50:22-26Golinelli D, Campinoti F, Sanmarchi F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271231 4. Kids are back in town: the return of high demand for paediatric emergency care. Arch. Dis. Child. 2021; Jenner R, Walker A, Isba R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266875 5. Surveillance for Pressure Injuries upon admission to Inpatient Rehabilitation HOSPITALS during the COVID-19 Pandemic. Arch. Phys. Med. Rehabil. 2021; Kendall JA, Haberl JK, Hartsgrove C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252395 6. Strategies to Offer Uninterrupted Neurosurgical Care at a Tertiary Center in Makka amid COVID-19 Pandemic. Asian. J. Neurosurg. 2021; 16:271-275Azab MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268150 7. Getting Neurosurgery Services Back on Its Feet: "Learning to Live" with COVID-19. Asian. J. Neurosurg. 2021; 16:340-348Goyal N, Gupta K, Chaturvedi J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268162 8. The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database. Biosci Trends 2021; Sato K, Mano T, Niimi Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261836 9. Role of respiratory intermediate care units during the SARS-CoV-2 pandemic. BMC Pulm. Med. 2021; 21:228Matute-Villacís M, Moisés J, Embid C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256747 10. Delayed diagnosis of ingested button battery leading to tracheoesophageal fstula in a child infected with SARS-CoV-2. BMJ Case Rep. 2021; 14Goussard P, Janson J, Nel E, Schubert P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253535 11. The orthopaedic waiting list crisis : two sides of the story. Bone Jt Open 2021; 2:530-534Hampton M, Riley E, Garneti N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261360 12. The personal limitations checklist: human factors insights from air accidents to reduce intraoperative harm. Br. J. Oral Maxillofac. Surg. 2020; Hardie JA, Brennan PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274172 13. Characteristics of burn injury during COVID-19 pandemic in Tokyo: A descriptive study. Burns Open 2021; Yamamoto R, Sato Y, Matsumura K, Sasaki J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254050 14. COVID-19 Pandemic Impact and Response in Canadian Pediatric Chronic Pain Care: A National Survey of Medical Directors and Pain Professionals. Can J Pain 2021; 5:139-150Killackey T, Noel M, Birnie KA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263096 15. Pain Management Revisited. Clin. J. Oncol. Nurs. 2021; 25:361-362Carr E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269344 16. Homecare Encounters: An Organizational Response to Innovative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation During COVID- 19. Clin. J. Oncol. Nurs. 2021; 25:457-464Liu J, Allen DH, Lassiter M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269347 17. The impact of COVID-19 on obesity services across Europe: A physician survey. Clin Obes 2021:e12474Nather K, Bolger F, DiModica L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254445 18. Intraoperative Ultrasonographic Assessment of Vocal Cord motion under sedation, following pediatric thyroidectomy in the Era of COVID-19, a double- blinded preliminary study. Clin. Otolaryngol. 2021; Zavdy O, Schwarz M, Gilony D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255927 19. COVID-19 Impact on Medical Practice in Sub-Saharan Africa; The Need to Guard Against Medical Negligence: A Case Report in a Health Care Facility in Kumasi, Ghana. Clin Pathol 2021; 14:2632010x211025308Ossei PPS, Ayibor WG, Taylor J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263164 20. Impacts of the COVID-19 epidemic on the department of stomatology in a tertiary hospital: A case study in the General Hospital of the Central Theater Command, Wuhan, China. Community Dent. Oral Epidemiol. 2021; Dong Q, Kuria A, Weng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270106 21. Sociodemographic changes in emergency department visits due to alcohol during COVID-19. Drug Alcohol Depend. 2021; 226:108877Myran DT, Cantor N, Pugliese M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256266 22. SARS-CoV-2 infection and paediatric endocrine disorders: Risks and management considerations. Endocrinol Diabetes Metab 2021; 4:e00262Miller R, Ashraf AP, Gourgari E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268455 23. Rethinking the management of immune checkpoint inhibitor-related adrenal insuffciency in cancer patients during the COVID-19 pandemic. Endocrinol Diabetes Metab 2021; 4:e00246Yuen KCJ, Mortensen MJ, Azadi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268454 24. How Do Breast Cancer Patients Present Following COVID-19 Early Peak in a Breast Cancer Center in Turkey? Eur J Breast Health 2021; 17:253-257Dauti Işıklar A, Deniz C, Soyder A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263153 25. Impact of the COVID-19 pandemic on the management of chronic non- infectious respiratory diseases. Expert Rev. Respir. Med. 2021; Tiotiu A, Chong- Neto H, Bikov A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253132 26. How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center. Front. Oncol. 2021; 11:669786Pasello G, Menis J, Pilotto S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262861 27. COVID-19 and its impact on the control of Aedes (Stegomyia) aegypti mosquito and epidemiological surveillance of arbovirus infections. Gac Med Mex 2021; 157:187-193Castañeda-Gómez J, González-Acosta C, Jaime-Rodríguez JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270541 28. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. Hematol. Oncol. 2021; Cuneo A, Rigolin GM, Coscia M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258787 29. Trends in urological emergencies in the Era of COVID-19. Int Braz J Urol 2021; 47:997-1005Frumer M, Aharony SM, Shoshany O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260177 30. Acute and Late Toxicities of Patients Infected with SARS-CoV-2 and Treated for Cancer with Radiation Therapy During the COVID-19 Pandemic. Int. J. Radiat. Biol. 2021:1-13Beddok A, Chevrier M, Calugaru V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269644 31. The impact of COVID-19 on emergency surgical presentations in a university teaching hospital. Ir. J. Med. Sci. 2021:1-7Kamil AM, Davey MG, Marzouk F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254230 32. Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-center cohort study. J Eur Acad Dermatol Venereol 2021; Koch E, Villanueva F, Marchetti MA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260770 33. Level of Knowledge, Understanding, and Impact of the COVID-19 Pandemic on Continuing Fixed Orthodontic Treatment in Adults: A Questionnaire Study. J. Indian Orthod. Soc. 2021; 55:184-189Ram RR, Ranganayakulu I, Viswanadh KA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248253 34. The aftermath of COVID-19 pandemic on the diagnosis of TB at a tertiary care hospital in India. J Infect Public Health 2021; 14:1095-1098Hazra D, Chawla K, Shenoy VP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274858 35. Challenges with the proposed approach in enhancing the accessibility of antimalarial activities during COVID 19 pandemic. J Infect Public Health 2021; 14:1089-1094Kant R, Yadav P, Singh M, Meena MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252846 36. Resorting to alternate anesthesia techniques during Covid-19 crisis. J. Maxillofac. Oral Surg. 2021:1-2Shadamarshan RA, Agrawal N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257482 37. Viral Infections amidst COVID-19 in Africa: Implications and Recommendations. J Med Virol 2021; Uwishema O, Adanur I, Babatunde AO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260094 38. Impact of COVID-19 on Aesthetic Plastic Surgery Practice in the United Kingdom. J. Plast. Reconstr. Aesthet. Surg. 2021; Joji N, Nugent N, Vadodaria S, Sankar TK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257034 39. Room for Improvement: The Trephination Procedure for Pediatric Patients with Pilonidal Disease. J. Surg. Res. 2021; 267:605-611Metzger GA, Apfeld JC, Nishimura L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271267 40. Increased risk of severe malaria in travellers during the COVID-19 pandemic. J Travel Med 2021; de Laval F, Maugey N, de Bonet d'Oléon A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254146 41. Emergency endovascular repair of aortoiliac aneurysms in COVID-19 times. J Vasc Bras 2021; 20:e20200173Soares RA, Cury MVM, da Silva LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267788 42. What is the impact of COVID-19 on tissue viability services and pressure ulceration? J. Wound Care 2021; 30:522-531Vowden K, Hill L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256597 43. COVID-19 in chronic myeloid leukemia patients in Latin America. Leuk. Lymphoma 2021:1-7Pagnano KB, Peralta EH, Navarro JR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254886 44. Endophthalmitis rate in immediately sequential vs delayed sequential bilateral cataract surgery within the IRIS® Registry data. Ophthalmology 2021; Lacy M, Kung TH, Owen JP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265315 45. Infuence of COVID-19 Restrictions on Patients' Self-reported Oral Health Care Needs. Oral Health Prev Dent 2021; 19:339-343Sekundo C, Langowski E, Frese C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259426 46. Leukaemia and lockdown: The delayed infection model of childhood acute lymphoblastic leukaemia and the COVID-19 pandemic. Pediatr Blood Cancer 2021:e29194Lillie K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251092 47. COVID-19 in the Intensive Care Unit: Medical, Nursing, and Physical Therapy Challenges. Praxis 2021; 110:512-516Jakob SM, Michel K, Kindler A. 48. [Outcomes following the triage of patients for urological cancer and non- cancer surgery during Covid-19 pandemic peak]. Prog Urol 2021; Durand M, Bentellis I, Barthe F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256992 49. [Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion]. Rev Clin Esp 2021; García Palacios JD, Puente Ruiz N, Napal Lecumberri JJ, Hernández Hernández JL. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248175 50. [The waiting list in times of pandemic. A refection about its indicators.]. Rev. Esp. Salud Publica 2021; 95:e1-e3Núñez Díaz S, Espinilla Yagüe C, Mahtani Mahtani V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269335 51. Stick or twist: Everolimus for seizures in tuberous sclerosis complex during the COVID-19 pandemic. Seizure 2021; 91:271-272Moloney PB, Delanty N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252878 52. Impact of COVID-19 and lockdown regarding blood transfusion. Transfusion 2021; Delabranche X, Kientz D, Tacquard C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255374 53. Is it safe to perform abdominal transplantation from SARS-CoV-2 polymerase chain reaction positive donors? Transpl Infect Dis 2021; Frattaroli P, Anjan S, Coro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258844 54. Blunt and penetrating chest trauma with concomitant COVID-19 infections: Two case reports. Trauma Case Rep 2021; 34:100507VanDruff RR, Lee JK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250219 55. Epidemic of plague amidst COVID-19 in Madagascar: efforts, challenges, and recommendations. Trop Med Health 2021; 49:56Aborode AT, Dos Santos Costa AC, Mohan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256858 56. Viral infections in urology. Urologe 2021; Magistro G, Pilatz A, Schneede P et al. 57. The negative effects of COVID-19 and national lockdown on emergency surgery morbidity due to delayed access. World J Emerg Surg 2021; 16:37Ciarleglio FA, Rigoni M, Mereu L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256781 58. [COVID-19 pandemic-related burden and SARS-CoV-2 prevalence in care facilities]. Z Gerontol Geriatr 2021:1-8Perkhofer L, Grünke P, Gashi-Ymeri E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259902
Management (52 articles)
1. The Management of Pulmonary Fibrosis in COVID-19. Acta Med Indones 2021; 53:233-241Rumende CM, Susanto EC, Sitorus TP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251354 2. Aktuelle Ernahrungsmedizin 2021; 46:144. 3. French Multicentre Observational Study on SARS-CoV-2 infections Intensive care initial management: the FRENCH CORONA Study. Anaesth Crit Care Pain Med 2021:100931Roger C, Collange O, Mezzarobba M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256165 4. Management of a COVID-19-infected critically ill patient treated by extracorporeal membrane oxygenation: a case report. Ann Palliat Med 2021; Fu Q, Li D, He W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263609 5. Practice of adjunctive treatments in critically ill COVID-19 patients-rational for the multicenter observational PRoAcT-COVID study in The Netherlands. Ann Transl Med 2021; 9:813Valk CMA, Swart P, Boers LS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268426 6. Nurses' pandemic lives: A mixed-methods study of experiences during COVID-19. Appl. Nurs. Res. 2021; 60:151437Gray K, Dorney P, Hoffman L, Crawford A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247785 7. Thromboprophylaxis strategies for COVID-19 patients. Arch Med Res 2021; Porres-Aguilar M, Pérez-Nieto OR, Zamarrón-López É I, Ñamendys-Silva SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274156 8. Air leak with COVID-19 - A meta-summary. Asian Cardiovasc. Thorac. Ann. 2021:2184923211031134Nasa P, Juneja D, Jain R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247490 9. Maintaining face-to-face contact during the COVID-19 pandemic: a longitudinal qualitative investigation in UK primary care. BJGP Open 2021; Turner A, Scott A, Horwood J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257067 10. Role of respiratory intermediate care units during the SARS-CoV-2 pandemic. BMC Pulm. Med. 2021; 21:228Matute-Villacís M, Moisés J, Embid C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256747 11. Health service experiences and preferences of frail home care clients and their family and friend caregivers during the COVID-19 pandemic. BMC Res. Notes 2021; 14:271Weeks LE, Nesto S, Hiebert B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261523 12. Converting a British-era hospital into a state-of-the-art COVID-19 care centre. BMJ Mil Health 2021; Dawra S, Patnaik S, Tevatia MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253641 13. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc. Toxicol. 2021:1-9Vitiello A, Ferrara F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255300 14. Longitudinal changes in compliance, oxygenation and ventilatory ratio in COVID-19 versus non-COVID-19 pulmonary acute respiratory distress syndrome. Crit Care 2021; 25:248Beloncle F, Studer A, Seegers V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266454 15. Impact of Nonpharmacological Public Health Interventions on Epidemiological Parameters of COVID-19 Pandemic in India. Cureus 2021; 13:e15393Kharya P, Koparkar AR, Dixit AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249543 16. Lessons Learned From the COVID-19 Response in a Major New York City Hot Zone. Curr. Probl. Diagn. Radiol. 2021; Yee J, Erdfarb A, Goldberg-Stein S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274190 17. Outcome and death risk of diabetes patients with Covid-19 receiving pre- hospital and in-hospital metformin therapies. Diabetol. Metab. Syndr. 2021; 13:76Tamura RE, Said SM, de Freitas LM, Rubio IGS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256824 18. Protection and Response of a Tertiary Hospital in Shenzhen, China to the COVID-19 Outbreak-the Practice of the Comprehensive Response Mode. Disaster Med Public Health Prep 2021:1-17Hu B, Yang L, Wei C, Luo M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250888 19. Variations in Presentation and Management of COVID-19 Inpatients by Race and Ethnicity in a Large Texas Metroplex. Disaster Med Public Health Prep 2021:1-23Liu A, Patel A, Pierce A, Fowler R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247684 20. Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the frst phase of the pandemic: Derivation of a risk model for emergency departments. Emergencias 2021; 33:273-281García- Martínez A, López-Barbeito B, Coll-Vinent B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251140 21. Challenges faced by people with epilepsy on ketogenic diet therapy and their caregivers during the COVID-19 pandemic in Brazil. Epilepsy Behav. 2021; 122:108193Alencastro Veiga Domingues Carneiro R, Dos Santos Lunardi M, Matheus Uberna Giacomini F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256342 22. Impact of non-pharmaceutical interventions against COVID-19 in Europe in 2020: a quasi-experimental non-equivalent group and time series design study. Euro Surveill 2021; 26Hunter PR, Colón-González FJ, Brainard J, Rushton S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269173 23. Maintenance of Muscle Mass and Cardiorespiratory Fitness to Cancer Patients During COVID-19 Era and After SARS-CoV-2 Vaccine. Front. Physiol. 2021; 12:655955Conceição MS, Derchain S, Vechin FC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248658 24. COVID-19 Preparedness and Response: Validation of a Rapid Assessment Tool to Evaluate Priorities of Health Workers at the Grassroots Level. Front Public Health 2021; 9:562600Tran BX, Hoang CL, Nguyen NTT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268282 25. Standardization of Procedures to Contain Cost and Reduce Variability of Care After the Pandemic. Front Surg 2021; 8:695341Raveglia F, Orlandi R, Rimessi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250010 26. Relevance of vitamin D(3) in COVID-19 infection. Gene Rep 2021; 24:101270Ul Afshan F, Nissar B, Chowdri NA, Ganai BA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250314 27. Changes in general practitioners' attitudes toward COVID-19 vaccination after frst interim results: a longitudinal approach in France. Hum Vaccin Immunother 2021:1-5Verger P, Scronias D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254880 28. The Effcacy of Tracheotomy for Covid-19 Pneumonia: Impacts on Survival and Prognostic Factors. Indian J Otolaryngol Head Neck Surg 2021:1-6Tuna B, Birdane L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249667 29. Infection control professionals' and infectious diseases physicians' knowledge, preparedness, and experiences of managing COVID-19 in Australian healthcare settings. Infect Dis Health 2021; Sotomayor-Castillo C, Nahidi S, Li C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266812 30. COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Defciencies as Determinants of Risk and Severity of Disease: A Narrative Review. Infect Dis Ther 2021:1-11Salgo MP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251655 31. Impact of Non-pharmaceutical Interventions on the Control of COVID-19 in Iran: A Mathematical Modeling Study. Int J Health Policy Manag 2021; Nakhaeizadeh M, Eybpoosh S, Jahani Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273920 32. The effectiveness of Colchicine as an anti-infammatory drug in the treatment of coronavirus disease 2019: Meta-analysis. Int. J. Immunopathol. Pharmacol. 2021; 35:20587384211031763Golpour M, Mousavi T, Alimohammadi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250834 33. Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case. Int J Infect Dis 2021; Connor BA, Couto-Rodriguez M, Barrows JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271202 34. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19. Int J Infect Dis 2021; Yamaguchi T, Shinagawa T, Kobata H, Nakagawa H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273512 35. The impact of COVID-19 on nursing workload and planning of nursing staff on the Intensive Care: A prospective descriptive multicenter study. Int. J. Nurs. Stud. 2021; 121:104005Hoogendoorn ME, Brinkman S, Bosman RJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273806 36. Inhaled budesonide in the treatment of COVID-19. Internist 2021; Kluge S, Nitschmann S, Scherer M. 37. Views on Discharge Criteria and Stratifed Management of Admission for COVID-19: A Case Report. Iran J. Public Health 2020; 49:101-108Jiang L, Lin SH, Lin JJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268212 38. An Increase in Respiratory Protection Device Injuries Associated with the COVID-19 Pandemic. J Am Acad Dermatol 2021; McGwin G, Jr., McGwin M, Griffn RL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274413 39. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. J. Endocrinol. Invest. 2021:1-13Oristrell J, Oliva JC, Casado E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273098 40. Association between Early Antibiotic Therapy and In-Hospital Mortality among Older Patients with SARS-CoV-2 Pneumonia. J Gerontol A Biol Sci Med Sci 2021; Putot A, Bouiller K, Laborde C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272847 41. Effective use of an advanced isolation unit during the COVID-19 pandemic: A retrospective cohort study. J Microbiol Immunol Infect 2021; Park Y, Kwak SH, Chung K, Park MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261612 42. "The offce of disaster management" Nurse managers' experiences during COVID-19: A qualitative interview study using thematic analysis. J. Nurs. Manag. 2021; Jackson J, Nowell L. http://www.ncbi.nlm.nih.gov/pubmed/? term=34270140 43. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021:1410768211032850Aiyegbusi OL, Hughes SE, Turner G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265229 44. Heparin -Messias or Verschlimmbesserung? J Thromb Haemost 2021; Swan D, Carrier M, Lisman T, Thachil J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272818 45. Vitamin D in infectious complications in critically ill patients with or without COVID-19. Metabol Open 2021:100106Vassiliou AG, Jahaj E, Orfanos SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250458 46. SSRIs: Applications in infammatory lung disease and implications for COVID- 19. Neuropsychopharmacol Rep 2021; Meikle CKS, Creeden JF, McCullumsmith C, Worth RG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254465 47. Workplace challenges and nurses recovered from COVID-19. Nurs. Ethics 2021:9697330211020439Mohammadi F, Radfar M, Hemmati Maslak Pak M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254555 48. Innovative Strategies to Facilitate Safe Assessment and Intervention for Intimate Partner Violence During a Pandemic and Beyond. Nurs. Womens Health 2021; Guarino JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270999 49. Lactoferrin: The Natural Protector of the Eye against Coronavirus-19. Ocul Immunol Infamm 2021:1-2Alpogan O, Karakucuk S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255583 50. Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2021; 8:ofab284Yetmar ZA, Chesdachai S, Kashour T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258316 51. Outcomes of Continuous Positive Airway Pressure in the Management of Patients with Coronavirus (COVID-19) Pneumonia who are not Suitable for Invasive Ventilation. Open Respir. Med. J. 2021; 15:23-27Aung H, Avraam E, Ashraf M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249179 52. SARS-CoV-2: What changes in the consultation. Pharm. Ztg. 2020; 165:26- 36Ude M, Ude C. 53. COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization? Praxis 2021; 110:517-524Lehmann B, Baumgartner C, Brill AK et al. 54. COVID 19 meets changing traditional care systems for the elderly and a budding social work practice. Refections for geriatric care in Ghana. Qual Soc Work 2021; 20:501-506Deku CS, Forkuor JB, Agyemang E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253991 55. Death, dying and bereavement care during COVID-19: Creativity in hospital social work practice. Qual Soc Work 2021; 20:131-137Fox M, McIlveen J, Murphy E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253960 56. Interactive virtual medication counselling in outpatient pharmacy: An accessible and safe patient counselling method during the COVID-19 pandemic. Res Social Adm Pharm 2021; Yong WY, Chang CT, Chew CC, Khoo TE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272201 57. Integrating Risk Assessment and Decision-Making Methods in Analyzing the Dynamics of COVID-19 Epidemics in Davao City, Mindanao Island, Philippines. Risk Anal. 2021; Logrosa G, Mata MA, Lachica ZP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269475 58. COVID-19 in a rural health system in New York - case series and an approach to management. Rural Remote Health 2021; 21:6464Kedar E, Scott R, Soule DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253026 59. Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil. Thromb Res 2021; 205:81-83Machado KLC, Rosa STD, Dobner S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265606 60. Identifying areas of potential critical healthcare shortages: A case study of spatial accessibility to ICU beds during the COVID-19 pandemic in Florida. Transp Policy (Oxf) 2021; 110:478-486Kim K, Ghorbanzadeh M, Horner MW, Ozguven EE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257481 61. A randomized open-label trial to evaluate the effcacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:451Sharma A, Sharma C, Raina S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266452 62. Contribution of phytotherapy to the management of COVID-19: Thinking instead of empty phrases. Zeitschrift fur Phytotherapie 2021; 42:117-118.
Mental – public health (167 articles)
1. Psychotherapy for Healthcare Provider During COVID-19 Pandemic: An Evidence Based Clinical Review. Acta Med Indones 2021; 53:225-232Shatri H, Putranto R, Faisal E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251353 2. [Internet Addiction During the Pandemic COVID-19: A New Paradigm?]. Acta Med Port 2021; 34:402Nascimento S, Silva M, Oliveira J, Reis J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253283 3. [Reply to: Early Detection of COVID-19 in Portugal: Use of Clinical Records]. Acta Med Port 2021; 34:404Valim AP, Franciscatto ME, Gomes E, Santos EM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253285 4. Dental Students' Discomfort and Anxiety During the First and the Second Lockdown Due to COVID-19 Pandemic at the School of Dental Medicine, University of Zagreb. Acta Stomatol. Croat. 2021; 55:186-197Adam M, Urbančič- Rak T, Crnić T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248152 5. COVID-19 Associated Suicidal Ideation in Older Adults: Two Case Reports With a Review of the Literature. Am J Geriatr Psychiatry 2021; Asthana NK, Mehaffey E, Sewell DD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266752 6. Altered Mental Status: An Important but Overlooked Presenting Symptom of COVID-19 in Older Adults. Am J Geriatr Psychiatry 2021; Oommen A, Thomas J, Parmar P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257003 7. The impact of mental health on COVID 19 disease progression: Case report. Ann Med Surg (Lond) 2021; 68:102543Bouabdallaoui A, Taouihar S, El Aidouni G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249355 8. "It is the only constant in what feels like a completely upside down and scary world": Living with an eating disorder during COVID-19 and the importance of perceived control for recovery and relapse. Appetite 2021; 167:105596Branley- Bell D, Talbot CV. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252493 9. Field observations and survey evidence to assess predictors of mask wearing across different outdoor activities in an Argentine city during the COVID-19 pandemic. Appl Psychol Health Well Being 2021; Freidin E, Acera Martini L, Senci CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254447 10. Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism. Appl Psychol Health Well Being 2021; Gao Y, Ao H, Hu X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265167 11. The effect of type D personality on anxiety, depression and fear of COVID-19 disease in healthcare workers. Arch. Environ. Occup. Health 2021:1-8Tuman TC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264179 12. Elevated risk for obsessive-compulsive symptoms in women pregnant during the COVID-19 pandemic. Arch Womens Ment Health 2021; Mahaffey BL, Levinson A, Preis H, Lobel M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269873 13. Association between COVID-19 and catatonia manifestation in two adolescents in Central Asia: Incidental fndings or cause for alarm? Asian J Psychiatr 2021; 63:102761Kopishinskaia S, Cumming P, Karpukhina S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271538 14. The need for integrated primary and behavioral healthcare care in the post- pandemic era. Asian J Psychiatr 2021; 63:102772Ulupinar D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274632 15. Impact of social media use (SMU) on mental health during COVID-19 pandemic. Asian J Psychiatr 2021; 63:102767Verma K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274631 16. COVID-19 and loneliness: A rapid systematic review. Aust. N. Z. J. Psychiatry 2021:48674211031489Pai N, Vella SL. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256632 17. COVID-19 as a context in suicide: early insights from Victoria, Australia. Aust. N. Z. J. Public Health 2021; Dwyer J, Dwyer J, Hiscock R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251732 18. Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures. Biosci Trends 2021; Sawakami T, Karako K, Song P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261848 19. Risk perception and adherence to preventive behaviours related to the COVID- 19 pandemic: a community-based study applying the health belief model. BJPsych Open 2021; 7:e133Kamran A, Isazadehfar K, Heydari H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253277 20. Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward. BJPsych Open 2021; 7:e131Williams R, Tweed J, Rebolledo L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256887 21. Fatores associados ao óbito em casos confrmados de COVID-19 no estado do Rio de Janeiro. BMC Infect. Dis. 2021; 21:687Cini Oliveira M, de Araujo Eleuterio T, de Andrade Corrêa AB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271868 22. Fear and depression during the COVID-19 outbreak in Cameroon: a nation- wide observational study. BMC Psychiatry 2021; 21:356Siewe Fodjo JN, Ngarka L, Njamnshi WY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266400 23. How have people been coping during the COVID-19 pandemic? Patterns and predictors of coping strategies amongst 26,016 UK adults. BMC Psychol 2021; 9:107Fluharty M, Fancourt D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266498 24. Moderating effect of people-oriented public health services on depression among people under mandatory social isolation during the COVID-19 pandemic: a cross-sectional study in China. BMC Public Health 2021; 21:1374Cao B, Wang D, Wang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247618 25. The impact of the COVID-19 pandemic on stress, mental health and coping behavior in German University students - a longitudinal study before and after the onset of the pandemic. BMC Public Health 2021; 21:1385Voltmer E, Köslich- Strumann S, Walther A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256717 26. Informal collectives and access to healthcare during India's COVID-19 second wave crisis. BMJ Glob Health 2021; 6Faruqui N, Raman VR, Shiv J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257140 27. Mere rhetoric? Using solidarity as a moral guide for deliberations on border closures, border reopenings and travel restrictions in the age of COVID-19. BMJ Glob Health 2021; 6Silva DS, Jackson C, Smith MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272273 28. A pilot study of the depression, anxiety and stress in Greek military personnel during the frst year of the COVID-19 pandemic. BMJ Mil Health 2021; Kotoulas AS, Karamanavis D, Lambrou G, Karanikas P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266974 29. Development and validation of the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C): an internet-based cross-sectional study in the UK and USA. BMJ Open 2021; 11:e043758Kantor BN, Kantor J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261678 30. COVID-19: a novel risk factor for perioperative neurocognitive disorders. Br J Anaesth 2021; Wei P, Lyu W, Wan T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34266660 31. [Pandemic forced telework, a new psychosocial risk. Refections on the health issues and the necessary support.]. Bull. Acad. Natl. Med. 2021; Chamoux A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248143 32. A study on factors affecting privacy risk tolerance to prevent the spread of COVID-19 in South Korea. Bus. Horiz. 2021; Kim M, Jung Y, Kim J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248157 33. High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients. Cephalalgia 2021:3331024211027568Cerami C, Crespi C, Bottiroli S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256651 34. Mental health diffculties in students with suspected COVID-19 symptoms and students without suspected COVID-19 symptoms: A cross-sectional comparative study during the COVID-19 pandemic. Child Youth Serv Rev 2021; 128:106137Sultana MS, Khan AH, Hossain S, Hasan MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248237 35. What Lessons Did I Learn From My Experience With Cancer and COVID-19 During the Pandemic? Clin. J. Oncol. Nurs. 2021; 25:488Stiver W. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269340 36. Risk and protective factors for psychological distress during COVID-19 in Israel. Curr. Psychol. 2021:1-12Oryan Z, Avinir A, Levy S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248314 37. Mental health status and psychosocial issues during Nationwide COVID-19 quarantine in Iran in 2020: A cross-sectional study in Mazandaran Province. Curr. Psychol. 2021:1-17Reskati MH, Shafzad M, Aarabi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253946 38. Moderation of Technology Use in the Association Between Self-Isolation During COVID-19 Pandemic and Adolescents' Romantic Relationship Quality. Cyberpsychol Behav Soc Netw 2021; 24:493-498Wright MF, Wachs S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264769 39. Impfung im EU-Ausland Digitale Zertifkate möglich. Deutsche Apotheker Zeitung 2021; 161. 40. Coping with COVID 19: Health Risk Communication and Vulnerable Groups. Disaster Med Public Health Prep 2021:1-25Bailey A, Harris MA, Bogle D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247692 41. Your call is important to us: COVID-19 and trends in Public Health Unit call service utilization. Disaster Med Public Health Prep 2021:1-21Horn ZB, Uren AM, Young MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247688 42. The effects of the COVID-19 lockdown on adolescents with an eating disorder and identifying factors predicting disordered eating behaviour. Early Interv Psychiatry 2021; Akgül S, Akdemir D, Nalbant K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263541 43. The linkage "Body Mass Index-Insomnia Levels-Eating Disorder Flexibility" in Italian nurses during the Covid-19 outbreak: a psychoendocrinological employment disease. Endocr. Metab. Immune Disord. Drug Targets 2021; Vitale E, Galatola V, Mea R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269670 44. Lifting COVID-19 mitigation measures in Spain (May-June 2020). Enferm. Infecc. Microbiol. Clin. 2021; Monge S, Zamalloa PL, Moros MJS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274154 45. A closer look to the high burden of the psychiatric disorders among health care workers (HCWs) in Egypt during COVID-19 outbreak: A meta-analysis of 3137 HCWs. Epidemiol Health 2021:e2021045El-Qushayri AE, Dahy A, Reda A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265893 46. Considering temporality in causal relationship between seizure worsening and psychological stress in patients with epilepsy during the COVID-19 pandemic: A systematic review. Epilepsy Behav. 2021; 122:108184Kuroda N, Fujimoto A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252833 47. Differential psychological response to the COVID-19 pandemic in psychiatric inpatients compared to a non-clinical population from Germany. Eur. Arch. Psychiatry Clin. Neurosci. 2021; Rek SV, Freeman D, Reinhard MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268618 48. Mental health responses to COVID-19 around the world. Eur J Psychotraumatol 2021; 12:1929754Olff M, Primasari I, Qing Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262666 49. COVID-19 related diffculties and perceived coping among university and college students: the moderating role of media-related exposure and stress. Eur J Psychotraumatol 2021; 12:1929029Pat-Horenczyk R, Bergman YS, Schiff M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249243 50. COVID-19 unmasked: preschool children's negative thoughts and worries during the COVID-19 pandemic in Australia. Eur J Psychotraumatol 2021; 12:1924442Vasileva M, Alisic E, De Young A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249241 51. Sleep quality among undergraduate students of a medical college in Nepal during COVID-19 pandemic: an online survey. F1000Res 2021; 10:505Shrestha D, Adhikari SP, Rawal N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249344 52. The Association of Suicidal Ideation With Family Characteristics and Social Support of the First Batch of Students Returning to a College During the COVID-19 Epidemic Period: A Cross Sectional Study in China. Front Psychiatry 2021; 12:653245Chen Y, Zhu LJ, Fang ZM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262488 53. A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences. Front Psychiatry 2021; 12:650671De Berardis D, Gianfelice G, Fornaro M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248699 54. Leveraging Technology for the Wellbeing of Individuals With Autism Spectrum Disorder and Their Families During Covid-19. Front Psychiatry 2021; 12:566809Doenyas C, Shohieb SM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262486 55. One Year Into the Pandemic: A Systematic Review of Perinatal Mental Health Outcomes During COVID-19. Front Psychiatry 2021; 12:674194Iyengar U, Jaiprakash B, Haitsuka H, Kim S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248710 56. Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension. Front Psychiatry 2021; 12:668647Park DH, Fuge J, Meltendorf T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248706 57. Inverse Correlation Between Distress and Performance in the Medical Rescuers Against COVID-19 in Wuhan. Front Psychiatry 2021; 12:563533Xie F, Wang X, Zhao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248686 58. High Prevalence of Post-stroke Anxiety in Elderly Patients Following COVID- 19 Outbreak. Front Psychiatry 2021; 12:699869Yao M, Li H, Luo Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248720 59. The Prevalence and Correlative Factors of Depression Among Chinese Teachers During the COVID-19 Outbreak. Front Psychiatry 2021; 12:644276Zhou J, Yuan X, Huang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267681 60. Explanatory Model of Perceived Stress in the General Population: A Cross- Sectional Study in Peru During the COVID-19 Context. Front. Psychol. 2021; 12:673945Boluarte-Carbajal A, Navarro-Flores A, Villarreal-Zegarra D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248770 61. Social and Cognitive Interactions Through an Interactive School Service for RTT Patients at the COVID-19 Time. Front. Psychol. 2021; 12:676238Dovigo L, Caprì T, Iannizzotto G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248774 62. Gender Differences in Psychological Impact of the Confnement During the COVID-19 Outbreak in Spain: A Longitudinal Study. Front. Psychol. 2021; 12:682860Fenollar-Cortés J, Jiménez Ó, Ruiz-García A, Resurrección DM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248784 63. Dealing With the Pandemic of COVID-19 in Portugal: On the Important Role of Positivity, Experiential Avoidance, and Coping Strategies. Front. Psychol. 2021; 12:647984Ferreira MJ, Sofa R, Carreno DF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248745 64. Engagement in Music-Related Activities During the COVID-19 Pandemic as a Mirror of Individual Differences in Musical Reward and Coping Strategies. Front. Psychol. 2021; 12:673772Ferreri L, Singer N, McPhee M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262511 65. What Should I Trust? Individual Differences in Attitudes to Conficting Information and Misinformation on COVID-19. Front. Psychol. 2021; 12:588478Filkuková P, Ayton P, Rand K, Langguth J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248728 66. Extra-Curricular Activities and Well-Being: Results From a Survey of Undergraduate University Students During COVID-19 Lockdown Restrictions. Front. Psychol. 2021; 12:647402Finnerty R, Marshall SA, Imbault C, Trainor LJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262502 67. Perceptions of the Post First-Lockdown Era in the Current Covid-19 Pandemic: Quantitative and Qualitative Survey of the French Population. Front. Psychol. 2021; 12:668961Fouques D, Castro D, Mouret M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262509 68. How Should Athletes Coping With COVID-19: Focus on Severity and Psychological Support. Front. Psychol. 2021; 12:559125Han Q, Li X, Wang Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248725 69. A Crowd-Sourced Database of Coronamusic: Documenting Online Making and Sharing of Music During the COVID-19 Pandemic. Front. Psychol. 2021; 12:684083Hansen NC, Treider JMG, Swarbrick D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248787 70. Fatalism in the Early Days of the COVID-19 Pandemic: Implications for Mitigation and Mental Health. Front. Psychol. 2021; 12:560092Hayes J, Clerk L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262498 71. What Explains Natives and Sojourners Preventive Health Behavior in a Pandemic: Role of Media and Scientifc Self-Effcacy. Front. Psychol. 2021; 12:664399Keren F, Siddiquei AN, Anwar MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267704 72. The Mental Health Impacts of COVID-19 on Pediatric Patients Following Recovery. Front. Psychol. 2021; 12:628707Liu D, Liu W, Rodriguez M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267693 73. An Innovative Approach for Online Neuroanatomy and Neurorrehabilitation Teaching Based on 3D Virtual Anatomical Models Using Leap Motion Controller During COVID-19 Pandemic. Front. Psychol. 2021; 12:590196Obrero- Gaitán E, Nieto-Escamez FA, Zagalaz-Anula N, Cortés-Pérez I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262499 74. Mindfully Reframing the Psychological Impact of the COVID-19 Outbreak Through a Social Media Community for Students: A Pragmatic Study. Front. Psychol. 2021; 12:566778Pagnini F, Bonalda E, Montrasi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248726 75. Teleworking in Times of COVID-19: Effects on the Acquisition of Personal Resources. Front. Psychol. 2021; 12:685275Pulido-Martos M, Cortés-Denia D, Lopez-Zafra E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248789 76. A Game of Covid: Strategic Thoughts About a Ludifed Pandemic. Front. Psychol. 2021; 12:607309Raab MH, Döbler NA, Carbon CC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267692 77. Protect ya Grandma! The Effects of Students' Epistemic Beliefs and Prosocial Values on COVID-19 Vaccination Intentions. Front. Psychol. 2021; 12:683987Rosman T, Adler K, Barbian L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248786 78. State Anhedonia in Young Healthy Adults: Psychometric Properties of the German Dimensional Anhedonia Rating Scale (DARS) and Effects of the COVID-19 Pandemic. Front. Psychol. 2021; 12:682824Wellan SA, Daniels A, Walter H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248783 79. The Impact of General Self-Effcacy on Psychological Resilience During the COVID-19 Pandemic: The Mediating Role of Posttraumatic Growth and the Moderating Role of Deliberate Rumination. Front. Psychol. 2021; 12:684354Zeng W, Wu X, Xu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248788 80. Latent Profles and Infuencing Factors of Posttraumatic Stress Symptoms Among Adults During the COVID-19 Pandemic. Front Public Health 2021; 9:620521Duan W, Guan Q, Jin Q. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249828 81. Psychological and Demographic Determinants of Substance Use and Mental Health During the COVID-19 Pandemic. Front Public Health 2021; 9:680028Mougharbel F, Sampasa-Kanyinga H, Heidinger B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249844 82. Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review. Front Public Health 2021; 9:606666Tegegne GT, Kefale B, Engidaw MT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249826 83. Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic. Front Public Health 2021; 9:672344Travis SA, Best AA, Bochniak KS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249839 84. Impact of COVID-19 on the Mental Health and Distress of Community-Dwelling Older Adults. Geriatr. Nurs. 2021; 42:998-1005Scott JM, Yun SW, Qualls SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256160 85. Behavioral changes adopted to constrain COVID-19 in Japan: What are the implications for seasonal infuenza prevention and control? Glob Health Med 2021; 3:125-128Sawakami T, Karako K, Song P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250286 86. Psychological response to the COVID-19 pandemic in Canada: main stressors and assets. Glob Health Promot 2021:17579759211023671Généreux M, Roy M, David MD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269131 87. Lives saved during economic downturns: Evidence from Australia. Health Econ. 2021; Atalay K, Edwards R, Schurer S, Ubilava D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268828 88. The effectiveness of mobility control, shortening of restaurants' opening hours, and working from home on control of COVID-19 spread in Japan. Health Place 2021; 70:102622Chiba A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34274896 89. The importance of investing in a public health system: evidence from COVID- 19 mortality. Indian Econ Rev 2021:1-22Balakrishnan P, Namboodhiry SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248183 90. A Public Safety Compliance Model of Safety Behaviors in the Age of the COVID-19 Pandemic. Inquiry 2021; 58:469580211031382Al-Bsheish M, Jarrar M, Scarbrough A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261334 91. Evaluation of dyspnea severity and sleep quality in patients with novel coronavirus. Int J Clin Pract 2021:e14631Gungor S, Tosun B, Unal N, Dusak I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260144 92. Needs, gaps and opportunities for standard and e-mental health care among at-risk populations in the Asia Pacifc in the context of COVID-19: a rapid scoping review. Int J Equity Health 2021; 20:161Murphy JK, Khan A, Sun Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253198 93. Increments of gender-based violence amid COVID-19 in Bangladesh: A threat to global public health and women's health. Int. J. Health Plann. Manage. 2021; Islam MR, Hossain MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254362 94. The Impact of COVID-19 Traumatic Stressors on Mental Health: Is COVID-19 a New Trauma Type. Int J Ment Health Addict 2021:1-20Kira IA, Shuwiekh HAM, Ashby JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248442 95. Phobic COVID-19 Disorder Scale: Development, Dimensionality, and Item- Structure Test. Int J Ment Health Addict 2021:1-13Nasir M, Adil M, Kumar M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254004 96. Global prevalence of mental health problems among healthcare workers during the Covid-19 pandemic: A systematic review and meta-analysis. Int. J. Nurs. Stud. 2021; 121:104002Saragih ID, Tonapa SI, Saragih IS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271460 97. Covid-19 fear, happiness and stress in adults: the mediating role of psychological resilience and coping with stress. Int. J. Psychiatry Clin. Pract. 2021:1-9Peker A, Cengiz S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253128 98. Perceived stress in different countries at the beginning of the coronavirus pandemic. Int. J. Psychiatry Med. 2021:912174211033710Gamonal-Limcaoco S, Montero-Mateos E, Lozano-López MT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34266339 99. The effect of COVID-19 lockdowns on sleep time perception: Comparing actigraphy and sleep diary measures. Int. J. Psychophysiol. 2021; 167:86-93He L, Zhao W, Gao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252481 100. Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID- 19 Pandemic in Italy. Int J Womens Health 2021; 13:653-662Colli C, Penengo C, Garzitto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262355 101. Perceived and sources of occupational stress in intensive care nurses during the COVID-19 pandemic. Intensive Crit Care Nurs 2021:103107Şanlıtürk D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247941 102. COVID-19 with a Public Health Perspective: Measures Taken in Turkey and Public Compliance with the Measures. Iran J. Public Health 2020; 49:67-75Doğan M, Bayraktar M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268207 103. The Impact of the COVID-19 Pandemic on the Number of Adolescents/Young Adults Seeking Eating Disorder-Related Care. J. Adolesc. Health 2021; Lin JA, Hartman-Munick SM, Kells MR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34266715 104. Impact of the COVID-19 pandemic on adults with current and prior depression: initial fndings from the longitudinal Texas RAD study. J. Affect. Disord. 2021; 294:103-108Czysz AH, Nandy K, Hughes JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274785 105. Psychometric properties of the Italian version of the Pandemic-Related Pregnancy Stress Scale (PREPS) and its correlation with anxiety and depression. J. Affect. Disord. 2021; 294:48-53Penengo C, Colli C, Garzitto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271249 106. Social Isolation and Anxiety Disorder During the COVID-19 Pandemic and Lockdown in China. J. Affect. Disord. 2021; 294:10-16Wu S, Yao M, Deng C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256180 107. Brain Stress Mapping in COVID-19 Survivors Using MR Spectroscopy: New Avenue of Mental Health Status Monitoring. J. Alzheimers Dis. 2021; Samkaria A, Punjabi K, Sharma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250939 108. Resolving delayed sleep-wake phase disorder with a pandemic: two case reports. J. Clin. Sleep Med. 2021; Epstein LJ, Cai A, Klerman EB, Czeisler CA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254935 109. The mediating role of psychological distress on the link between socio- ecological factors and quality of life of Filipino adults during COVID-19 crisis. J. Community Psychol. 2021; Aruta J, Callueng C, Antazo BG, Ballada CJA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260751 110. Anxiety symptoms and alcohol abuse during the COVID-19 pandemic: A cross-sectional study with Brazilian dental undergraduate students. J. Dent. Educ. 2021; Fernandez MDS, Vieira IS, Silva N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268733 111. Notifable diseases interoperable framework toward improving Iran public health surveillance system: Lessons learned from COVID-19 pandemic. J Educ Health Promot 2021; 10:179Shanbehzadeh M, Kazemi-Arpanahi H, Valipour AA, Zahedi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250113 112. Bereavement from COVID-19, Gender, and Reports of Depression among Older Adults in Europe. J. Gerontol. B Psychol. Sci. Soc. Sci. 2021; Wang H, Verdery AM, Margolis R, Smith-Greenaway E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252179 113. Financial distress and suicidal behaviour during COVID-19: Family identifcation attenuates the negative relationship between COVID-related fnancial distress and mental Ill-health. J Health Psychol 2021:13591053211014597Stevenson C, Wakefeld JRH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259082 114. Identifying Patterns of Turnover Intention Among Alabama Frontline Nurses in Hospital Settings During the COVID-19 Pandemic. J Multidiscip Healthc 2021; 14:1783-1794Cole A, Ali H, Ahmed A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267525 115. Curbing Nurses' Burnout during COVID-19: the roles of Servant Leadership and Psychological Safety. J. Nurs. Manag. 2021; Ma Y, Faraz NA, Ahmed F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259372 116. Does time change the anxiety and depression scores for pregnant women on Covid-19 pandemic? J. Obstet. Gynaecol. Res. 2021; Geren A, Birge Ö, Bakır MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254394 117. Neural Responses to Social Reward Predict Depressive Symptoms in Adolescent Girls During the COVID-19 Pandemic. J. Pediatr. Psychol. 2021; Sequeira SL, Silk JS, Hutchinson E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34270756 118. Social distancing measures differentially affected rats in North America and Tokyo. J Pest Sci (2004) 2021:1-8Kiyokawa Y, Tanikawa T, Ootaki M, Parsons MH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248453 119. Facing the "new normal": How adjusting to the easing of COVID-19 lockdown restrictions exposes mental health inequalities. J. Psychiatr. Res. 2021; 141:276-286Fineberg NA, Pellegrini L, Wellsted D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271458 120. Do Black Lives Matter in the American Public's Mitigation Responses to the COVID-19 Pandemic? An Analysis of Mask Wearing and Racial/Ethnic Disparities in Deaths from COVID-19. J Racial Ethn Health Disparities 2021; Franz B, Milner A, Braddock I. http://www.ncbi.nlm.nih.gov/pubmed/? term=34269992 121. Further evidence for motivated helplessness in the context of the COVID-19 outbreak: the case of Argentina before and during the pandemic. J. Soc. Psychol. 2021:1-14Lifshin U, Mikulincer M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259124 122. What Predicts the Mood of Athletes Involved in Preparations for Tokyo 2020/2021 Olympic Games During the Covid - 19 Pandemic? The Role of Sense of Coherence, Hope for Success and Coping Strategies. J. Sports Sci. Med. 2021; 20:421-430Szczypińska M, Samełko A, Guszkowska M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267581 123. Stress among nurses from countries variously affected by the COVID-19 pandemic - results collected in Poland and Iran. Med. Pr. 2021; Piotrowski A, Nikkhah-Farkhani Z, Makarowski R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254588 124. Did social isolation due to COVID-19 interfere with the quality of sleep and excessive daytime sleepiness in individuals with grade III obesity about to enter a surgical prehabilitation program? An observational study. Metabol Open 2021; 11:100104de Medeiros G, Artismo RS, Coelho P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258573 125. Dynamic analysis of emergency inter-organizational communication network under public health emergency: a case study of COVID-19 in Hubei Province of China. Nat Hazards (Dordr) 2021:1-24Lu Y, Liu T, Wang T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248278 126. The Impact of Quarantine on Sleep Quality and Psychological Distress During the COVID-19 Pandemic. Nat Sci Sleep 2021; 13:1037-1048AlRasheed MM, Alkadir AM, Bin Shuqiran KI et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262375 127. Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients. Neurooncol Pract 2021; 8:485-496Gardner MM, Aslanzadeh FJ, Zarrella GV et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267923 128. Innovative Strategies to Facilitate Safe Assessment and Intervention for Intimate Partner Violence During a Pandemic and Beyond. Nurs. Womens Health 2021; Guarino JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270999 129. A National Public Health Workforce to Control COVID-19 and Address Health Disparities in the United States. Open Forum Infect Dis 2021; 8:ofab304Kilmarx PH, Long T, Reid MJA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258323 130. Reckoning with Our Trustworthiness, Leveraging Community Engagement. Popul Health Manag 2021; Gray DM, 2nd, Nolan TS, Bignall ONR, 2nd et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271849 131. Health Beliefs and Preventive Behaviors Among Adults During the Early COVID-19 Pandemic in the United States: a Latent Class Analysis. Prev Sci 2021:1-10Smail E, Schneider KE, DeLong SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275054 132. Telehealth Use for Mental Health Conditions Among Enrollees in Commercial Insurance. Psychiatr. Serv. 2021:appips202000778Yu J, Casalino L, Pincus HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253038 133. The impact of the COVID-19 pandemic on suicide ideation and suicide attempts in a sample of psychiatric inpatients. Psychiatry Res 2021; 303:114072Berardelli I, Sarubbi S, Rogante E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256349 134. Longitudinal changes in the mental health of UK young male and female adults during the COVID-19 pandemic. Psychiatry Res 2021; 303:114074Stroud I, Gutman LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271372 135. Parents' Perceived Impact of the Societal Lockdown of COVID-19 on Family Well-Being and on the Emotional and Behavioral State of Walloon Belgian Children Aged 4 to 13 Years: An Exploratory Study. Psychol. Belg. 2021; 61:186- 199Stassart C, Wagener A, Etienne AM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249370 136. Sleep quality and mental health status of healthcare professionals during the outbreak of coronavirus disease 2019 (COVID-19). Psychol Health Med 2021:1- 8Jiang YF, Chen JQ, Wang YG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263682 137. The Impact of the COVID-19 Epidemic on Mental Health Among Residents of Assela Town. Psychol. Res. Behav. Manag. 2021; 14:957-970Disasa B, Teshome E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262366 138. Psychological Distress Among Ethiopian Pregnant Women During COVID-19: Negative Correlation with Self-Effcacy. Psychol. Res. Behav. Manag. 2021; 14:1001-1010Dule A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267564 139. Interpretive voices: coproducing creative enquiry in the time of COVID-19. Public Health 2021; 196:201-203Younie L, Elliott F, Buckland R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273606 140. Food insuffciency and mental health service utilization in the U.S. during the COVID-19 pandemic. Public Health Nutr. 2021:1-15Nagata JM, Ganson KT, Cattle CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261566 141. Experiences of the coronavirus disease-19 (COVID-19) pandemic from the perspectives of young people: Rapid qualitative study. Public Health Pract (Oxf) 2021; 2:100162Fisher H, Lambert H, Hickman M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254057 142. A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto. Public Health Rep. 2021:333549211032974Harris MTH, Young S, Barocas J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34269625 143. Exposing health inequities: Surreal snapshots from the Grand Canyon to global COVID-19 pandemic. Qual Soc Work 2021; 20:90-96Balestrery JE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253957 144. The dialogue between what we are living and what we are teaching and learning during Covid-19 pandemic: Refections of two social work educators from Italy and Spain. Qual Soc Work 2021; 20:273-283Cabiati E, Gómez-Ciriano EJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253972 145. Demoralization in the wake of the COVID-19 pandemic: Whereto the future for young Australians? Qual Soc Work 2021; 20:487-493Fronek P, Briggs L. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253989 146. The COVID-19 pandemic, emergency aid and social work in Brazil. Qual Soc Work 2021; 20:356-365Garcia MLT, Pandolf AF, Leal FX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253979 147. The impacts of the Covid-19 pandemic on surrogacy in India: The role of social work. Qual Soc Work 2021; 20:472-478Goswami L, Larmar SA, Boddy J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253988 148. COVID-19: Where are the Nigerian social workers? Qual Soc Work 2021; 20:343- 349Isangha SO, Choi WMA, Chiu MYL. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253977 149. Safeguarding health equality for the disadvantaged during the COVID-19 pandemic: Lessons learned for the social work profession. Qual Soc Work 2021; 20:463-469Kwan CK, Ling HW, Cheung JC, Chui EW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253987 150. Safe uncertainty: Refecting on the pandemic responses of two Asian cities. Qual Soc Work 2021; 20:305-311Sim T. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253975 151. Black women and COVID-19: The need for targeted mental health research and practice. Qual Soc Work 2021; 20:247-255Walton QL, Campbell RD, Blakey JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253970 152. Tales of precarity: A refexive essay on experiencing the COVID pandemic as a social work educator on a precarious contract. Qual Soc Work 2021; 20:579- 586Whelan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253997 153. The limitations of polling data in understanding public support for COVID-19 lockdown policies. R Soc Open Sci 2021; 8:210678Foad CMG, Whitmarsh L, Hanel PHP, Haddock G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258021 154. Knowledge, Attitude, and Perceived Risks Towards COVID-19 Pandemic and the Impact of Risk Communication Messages on Healthcare Workers in Saudi Arabia. Risk Manag. Healthc. Policy 2021; 14:2811-2824Mushi A, Yassin Y, Khan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262368 155. Care for the Carers: An Evaluation of Job Satisfaction of Community Healthcare Workers in Charge of Infectious Disease Prevention and Control in Vietnam. Risk Manag. Healthc. Policy 2021; 14:2831-2839Thai TT, Le TAT, Truong LTT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262370 156. US trends in mask wearing during the COVID-19 pandemic depend on rurality. Rural Remote Health 2021; 21:6596Pro G, Schumacher K, Hubach R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252284 157. Weathering the storm: A qualitative study of social prescribing in urban and rural Scotland during the COVID-19 pandemic. SAGE Open Med 2021; 9:20503121211029187Fixsen A, Barrett S, Shimonovich M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262766 158. How the Norwegian population was affected by non-pharmaceutical interventions during the frst six weeks of the COVID-19 lockdown. Scand J Public Health 2021:14034948211027817Mæland S, Bjørknes R, Lehmann S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250865 159. The COVID-19 Pandemic Introduces Diagnostic and Treatment Planning Complexity for Individuals at Clinical High Risk for Psychosis. Schizophr. Bull. 2021; Mittal VA, Walker EF, Strauss GP. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259874 160. Perception towards E-learning and COVID-19 on the mental health status of university students in Malaysia. Sci. Prog. 2021; 104:368504211029812Moy FM, Ng YH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260295 161. How the COVID-19 Pandemic Affects Sexual Behavior of Hetero-, Homo-, and Bisexual Males in Germany. Sex Med 2021; 9:100380Mumm JN, Vilsmaier T, Schuetz JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273787 162. Suffcient sleep attenuates COVID-19 pandemic-related executive dysfunction in late adolescents and young adults. Sleep Med. 2021; 85:21-24Ji X, Saylor J, Earle FS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271179 163. Validation of the Japanese version of Stress and Anxiety to Viral Epidemics-9 (SAVE-9) and relationship among stress, insomnia, anxiety, and depression in healthcare workers exposed to coronavirus disease 2019. Sleep Med. 2021; 84:397-402Okajima I, Chung S, Suh S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265636 164. The psychological distress and mental health disorders from COVID-19 stigmatization in Ghana. Soc Sci Humanit Open 2021; 4:100186Adom D, Mensah JA, Osei M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250461 165. One year of COVID-19 in Italy: are containment policies enough to shape the pandemic pattern? Socioecon. Plann. Sci. 2021:101120Panarello D, Tassinari G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248212 166. [Development of a psychiatric care facility into a Covid unit]. Soins Psychiatr. 2021; 42:43-47Kimmel É, Satori N, Ménage G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266550 167. Impact of the COVID-19 pandemic on infammatory bowel disease: the role of emotional stress and social isolation. Stress Health 2021; Nass BY, Dibbets P, Markus CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273129
Meta-analyses - systematic reviews (21 articles)
1. Neurological Manifestations in COVID-19 Patients: A Meta-Analysis. ACS Chem Neurosci 2021; D V, Sharma A, Kumar A, Flora SJS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260855 2. Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression. Adv. Med. Sci. 2021; 66:304- 314Zinellu A, Sotgia S, Fois AG, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256241 3. Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression. Endocr. Metab. Immune Disord. Drug Targets 2021; Hariyanto TI, Lugito NPH, Yanto TA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250875 4. Transmission risks of respiratory infectious diseases in various confned spaces: A meta-analysis for future pandemics. Environ. Res. 2021:111679Moon J, Ryu BH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265349 5. B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Cardiovasc Med 2021; 8:690790Zinellu A, Sotgia S, Carru C, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250044 6. COVID-19 and Infuenza Co-infection: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:681469Dadashi M, Khaleghnejad S, Abedi Elkhichi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249971 7. Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:670744Wu X, Xu Y, Jin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249969 8. Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2. Front. Microbiol. 2021; 12:676314Castonguay N, Zhang W, Langlois MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267735 9. Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis. Future Sci OA 2021; 7:Fso713Yassin A, Ghzawi A, Al-Mistarehi AH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254031 10. Frailty as a mortality predictor in older adults with COVID-19: A systematic review and meta-analysis of cohort studies. Geriatr. Nurs. 2021; 42:983- 992Saragih ID, Advani S, Saragih IS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256158 11. Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients:A Systematic Review and Meta-Analysis. Int J Infect Dis 2021; Alkofde H, Almohaizeie A, Almuhaini S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273515 12. Global prevalence of mental health problems among healthcare workers during the Covid-19 pandemic: A systematic review and meta-analysis. Int. J. Nurs. Stud. 2021; 121:104002Saragih ID, Tonapa SI, Saragih IS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271460 13. Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis. Intern Emerg Med 2021:1-11Maddaloni E, D'Onofrio L, Siena A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273056 14. Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining. J. Clin. Epidemiol. 2021; Honarmand K, Penn J, Agarwal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274489 15. Bereavement from COVID-19, Gender, and Reports of Depression among Older Adults in Europe. J. Gerontol. B Psychol. Sci. Soc. Sci. 2021; Wang H, Verdery AM, Margolis R, Smith-Greenaway E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252179 16. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. Microvasc. Res. 2021:104224Andrianto, Al-Farabi MJ, Nugraha RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273359 17. Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2021; 8:ofab284Yetmar ZA, Chesdachai S, Kashour T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258316 18. Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis. Phytother. Res. 2021; Jiang F, Xu N, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256418 19. The impact of Parkinson's disease on manifestations and outcomes of Covid- 19 patients: A systematic review and meta-analysis. Rev Med Virol 2021:e2278El-Qushayri AE, Ghozy S, Reda A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260773 20. A systematic meta-analysis of immune signatures in patients with COVID-19. Rev Med Virol 2021; 31:e2195Liu K, Yang T, Peng XF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260780 21. Effcacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis. Travel Med Infect Dis 2021; 43:102135Chivese T, Musa OAH, Hindy G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265436
Mortality (46 articles)
1. Serum CK-MB, COVID-19 severity and mortality: An updated systematic review and meta-analysis with meta-regression. Adv. Med. Sci. 2021; 66:304- 314Zinellu A, Sotgia S, Fois AG, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256241 2. Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study. Ann Intensive Care 2021; 11:111Marais C, Claude C, Semaan N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259942 3. Clinical features and survival analysis of 97 coronavirus disease 2019 (COVID- 19) patients. Ann Palliat Med 2021; Li A, Chen F, Gao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263633 4. Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study. BMC Med. Res. Methodol. 2021; 21:146Marateb HR, von Cube M, Sami R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261439 5. Fatal Case of COVID-19 Pneumonia Associated with Acute Myelopathy. Case Rep. Neurol. 2021; 13:398-404Hassoun HK, Radeef MR, Aljid Z, Allebban Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248577 6. Biomarkers Predictive of Extubation and Survival of COVID-19 Patients. Cureus 2021; 13:e15462Topp G, Bouyea M, Cochran-Caggiano N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258124 7. Higher admission activated partial thromboplastin time, neutrophil- lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K. Diabetes Res Clin Pract 2021; 178:108955Iqbal A, Greig M, Arshad MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273452 8. Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States. Diabetes Ther. 2021:1-17Boye KS, Tokar Erdemir E, Zimmerman N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275115 9. The association between disability and risk of exposure to peer cyber victimisation is moderated by gender: Cross-sectional survey. Disabil Health J 2021:101170Emerson E, Aitken Z, King T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253505 10. Lockdown effect on COVID-19 incidence and death: Iran experience. Disaster Med Public Health Prep 2021:1-10Delavari S, Jamali Z, Bayati M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247685 11. Mortality in patients treated for COVID-19 in the emergency department of a tertiary care hospital during the frst phase of the pandemic: Derivation of a risk model for emergency departments. Emergencias 2021; 33:273-281García- Martínez A, López-Barbeito B, Coll-Vinent B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251140 12. Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly. Emergencias 2021; 33:282-291López-Izquierdo R, Ruiz Albi T, Bermejo-Martín JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251141 13. Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center. Emergencias 2021; 33:265-272Martín-Rodríguez F, Sanz-García A, Alberdi Iglesias A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251139 14. A Study of the Correlation between the Dates of the First Covid Case and the First Covid Death of 25 Selected Countries to Know the Virulence of the Covid- 19 in Different Tropical Conditions. Ethics Med Public Health 2021:100707Jamsheela O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254043 15. Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning. Front Artif Intell 2021; 4:673527Jamshidi E, Asgary A, Tavakoli N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250465 16. B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Cardiovasc Med 2021; 8:690790Zinellu A, Sotgia S, Carru C, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250044 17. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome. Front. Immunol. 2021; 12:621440Illouz T, Biragyn A, Iulita MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248930 18. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients. Front. Immunol. 2021; 12:634416Luft T, Wendtner CM, Kosely F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248931 19. Comorbidities predict 30-day hospital mortality of older adults with COVID-19. Geriatr. Nurs. 2021; 42:1024-1028Pott Junior H, Cominetti MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256151 20. The "Great Lockdown": Inactive workers and mortality by Covid-19. Health Econ. 2021; Borri N, Drago F, Santantonio C, Sobbrio F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250694 21. Pattern of COVID-19 infection and death across countries: A pilot study. Heliyon 2021:e07504Asem N, Ramadan A, Hassany M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254048 22. Pattern and determinants of COVID-19 infection and mortality across countries: An ecological study. Heliyon 2021; 7:e07504Asem N, Ramadan A, Hassany M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254048 23. The importance of investing in a public health system: evidence from COVID- 19 mortality. Indian Econ Rev 2021:1-22Balakrishnan P, Namboodhiry SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248183 24. Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a refection of the innate immune status. Int J Clin Pract 2021:e14624Ozcelik F, Tanoglu A, Guven BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251730 25. CareFiji app to track people during COVID-19 pandemic: "Digital gap and challenges triggered in Fiji": Correspondence. Int J Surg 2021:106023Chand SS, Chand AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252596 26. Deaths of people with intellectual disabilities: Analysis of deaths in England from COVID-19 and other causes. J Appl Res Intellect Disabil 2021; Heslop P, Byrne V, Calkin R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272793 27. Mortality associated with early changes in ARDS severity in COVID-19 patients - Insights from the PRoVENT-COVID study. J Crit Care 2021; 65:237-245Schuijt MTU, Martin-Loeches I, Schultz MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271294 28. Age-standardized mortality rate and predictors of mortality among COVID-19 patients in Iran. J Educ Health Promot 2021; 10:169Moradzadeh R, Jamalian SM, Nazari J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250103 29. Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational study. J. Epidemiol. Community Health 2021; Serván-Mori E, Seiglie JA, Gómez-Dantés O, Wirtz VJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266980 30. Association between Early Antibiotic Therapy and In-Hospital Mortality among Older Patients with SARS-CoV-2 Pneumonia. J Gerontol A Biol Sci Med Sci 2021; Putot A, Bouiller K, Laborde C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272847 31. The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients. J. Intensive Care Med. 2021:8850666211032175Ritter LA, Britton N, Heil EL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247526 32. Maternal deaths due to COVID-19 disease: The cases in a single center pandemic hospital in the south east of Turkey. J. Obstet. Gynaecol. Res. 2021; Bağlı İ, Öcal E, Yavuz M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254718 33. Clinical utility of biochemical markers for the prediction of COVID-19-related mortality in kidney transplant recipients. Kidney Int Rep 2021; Caillard S, Chavarot N, Francois H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254049 34. Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal. Lancet Reg Health West Pac 2021; 12:100155Spaccarotella C, Sorrentino S, Indolf C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250516 35. Background rates of hospital transfer and death in Australian aged care facilities: estimates to assist interpretation of rates after COVID-19 vaccination. Med. J. Aust. 2021; Clothier HJ, Mesfn YM, Strange S, Buttery JP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268767 36. Comparison of the effects of etomidate, ketamine, sodium thiopental, and midazolam on the mortality of patients with COVID-19 requiring intubation. Med. J. Islam. Repub. Iran 2021; 35:49Edalatkhah A, Kazemi MR, Samadi Khorshidi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268237 37. Palliative medicine in times of COVID-19 pandemia. Nieren- und Hochdruckkrankheiten 2021; 50:216-219Pommer W, Hoffmann U. 38. Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran. Parkinsonism Relat. Disord. 2021; 89:90-92Salari M, Etemadifar M, Ashraf F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256334 39. Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis. Pathol. Oncol. Res. 2021; 27:1609774Bogos K, Kiss Z, Kerpel Fronius A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257618 40. COVID-19: Increased mortality among pregnant women. Pharm. Ztg. 2021; 166:52-53Dingermann T. 41. Longitudinal changes in the mental health of UK young male and female adults during the COVID-19 pandemic. Psychiatry Res 2021; 303:114074Stroud I, Gutman LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271372 42. Death, dying and bereavement care during COVID-19: Creativity in hospital social work practice. Qual Soc Work 2021; 20:131-137Fox M, McIlveen J, Murphy E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253960 43. Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates? Risk Manag. Healthc. Policy 2021; 14:2877-2885Cegan JC, Trump BD, Cibulsky SM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267565 44. The COVID-19 pandemic and cause of death. Sociol. Health Illn. 2021; Armstrong D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255866 45. Spatial-temporal generalized additive model for modeling COVID-19 mortality risk in Toronto, Canada. Spat Stat 2021:100526Feng C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249608 46. Deaths due to COVID-19 in a state of northeastern Brazil: spatiotemporal distribution, sociodemographic and clinical and operational characteristics. Trans. R. Soc. Trop. Med. Hyg. 2021; da Silva WM, Brito PDS, de Sousa G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252184
Online – IT – Apps (51 articles)
1. [Internet Addiction During the Pandemic COVID-19: A New Paradigm?]. Acta Med Port 2021; 34:402Nascimento S, Silva M, Oliveira J, Reis J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253283 2. Is remote near-peer anatomy teaching an effective teaching strategy? Lessons learned from the transition to online learning during the Covid-19 pandemic. Anat Sci Educ 2021; Thom ML, Kimble BA, Qua K, Wish-Baratz S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268899 3. Social media exposure during COVID-19 lockdowns could lead to emotional overeating via anxiety: The moderating role of neuroticism. Appl Psychol Health Well Being 2021; Gao Y, Ao H, Hu X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265167 4. Impact of social media use (SMU) on mental health during COVID-19 pandemic. Asian J Psychiatr 2021; 63:102767Verma K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274631 5. Acceptability and Feasibility of Virtual Behavior Analysis Supervision. Behav Anal Pract 2021:1-17Simmons CA, Ford KR, Salvatore GL, Moretti AE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257834 6. Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review. BMJ Open 2021; 11:e050519Jenniskens K, Bootsma MCJ, Damen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253676 7. Are the rights of people with disabilities included in international guidance on WASH during the COVID-19 pandemic? Content analysis using EquiFrame. BMJ Open 2021; 11:e046112Scherer N, Mactaggart I, Huggett C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257092 8. Telemedicine in primary healthcare for the quality of care in times of COVID- 19: a scoping review protocol. BMJ Open 2021; 11:e046227Silva C, Lopes RH, Júnior OGB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253666 9. Pulmonary Telerehabilitation and Effcacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study. Clin. Respir. J. 2021; Lei J, Yang L, Wen G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260823 10. Media use before, during and after COVID-19 lockdown according to parents in a clinically referred sample in child and adolescent psychiatry: Results of an online survey in Switzerland. Compr. Psychiatry 2021; 109:152260Werling AM, Walitza S, Grünblatt E, Drechsler R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265597 11. The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial. Contemp Clin Trials 2021:106509Bunning B, Hedlin H, Purington N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34274494 12. Content and Functionality of United States Medical School Websites. Cureus 2021; 13:e15534Pollock JR, Moore ML, Smith JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268052 13. Promise and Perils of Telehealth in the Current Era. Curr Cardiol Rep 2021; 23:115Mahtta D, Daher M, Lee MT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34269884 14. The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic. Curr. Oncol. Rep. 2021; 23:99Kwan JM, Henry ML, Christophers B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259950 15. Developing a digital health strategy for people who use drugs: Lessons from COVID-19. Digit Health 2021; 7:20552076211028404Perri M, Guta A, Gagnon M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262782 16. General Public Perception of Social Media, Impact of Covid-19 Pandemic, and Related Misconceptions. Disaster Med Public Health Prep 2021:1-22Ali R, Jawed S, Baig M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261567 17. NOTA: a novel online teaching and assessment scheme using Blockchain for emergency cases. Educ Inf Technol (Dordr) 2021:1-18Cheriguene A, Kabache T, Kerrache CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248386 18. Flow of online misinformation during the peak of the COVID-19 pandemic in Italy. EPJ Data Sci 2021; 10:34Caldarelli G, De Nicola R, Petrocchi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249599 19. COVID-19 related diffculties and perceived coping among university and college students: the moderating role of media-related exposure and stress. Eur J Psychotraumatol 2021; 12:1929029Pat-Horenczyk R, Bergman YS, Schiff M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249243 20. A COVID-19 Emergency Response for Remote Control of a Dialysis Machine with Mobile HRI. Front Robot AI 2021; 8:612855Wazir HK, Lourido C, Chacko SM, Kapila V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262944 21. A machine learning PROGRAM to identify COVID-19 and other diseases from hematology data. Future Sci OA 2021; 7:Fso733Gladding PA, Ayar Z, Smith K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254032 22. Social media affordances and information abundance: Enabling fake news sharing during the COVID-19 health crisis. Health Informatics J 2021; 27:14604582211021470Apuke OD, Omar B. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250868 23. Telemedicine as a component of forward triage in a pandemic. Healthc (Amst) 2021; 9:100567Gupta VS, Popp EC, Garcia EI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274883 24. Impact of online education on fear of academic delay and psychological distress among university students following one year of COVID-19 outbreak in Bangladesh. Heliyon 2021; 7:e07388Hossain MJ, Ahmmed F, Rahman SMA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258456 25. Needs, gaps and opportunities for standard and e-mental health care among at-risk populations in the Asia Pacifc in the context of COVID-19: a rapid scoping review. Int J Equity Health 2021; 20:161Murphy JK, Khan A, Sun Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253198 26. Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers. Int J Gynaecol Obstet 2021; Picardo E, Baù MG, Anatrone C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258764 27. High variability in model performance of Google relative search volume in spatially clustered COVID-19 areas of the United States. Int J Infect Dis 2021; Husnayain A, Chuang TW, Fuad A, Su EC. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273513 28. Remote learning and online teaching in Fiji during COVID-19: The challenges and opportunities: Correspondence. Int J Surg 2021:106019Chand AA, Lal PP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252594 29. Remote learning and online teaching in Fiji during COVID-19: The challenges and opportunities. Int J Surg 2021:106019Chand AA, Lal PP, Chand KK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252594 30. Health technology assessment applied to emergency preparedness: a new perspective. Int. J. Technol. Assess. Health Care 2021; 37:e77Miglietta A, de Waure C, Chronaki C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269171 31. Effectiveness of video modules in infection control trainings during COVID-19 pandemic: A quasi-experimental study in tertiary care institute. J Educ Health Promot 2021; 10:183Singh V, Supehia S, Gupta PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250117 32. Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology. J Genet Couns 2021; Dratch L, Paul RA, Baldwin A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265143 33. Investigating Public Discourses Around Gender and COVID-19: a Social Media Analysis of Twitter Data. J Healthc Inform Res 2021:1-21Al-Rawi A, Grepin K, Li X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258510 34. Remote Reporting During a Pandemic Using Digital Pathology Solution: Experience from a Tertiary Care Cancer Center. J. Pathol. Inform. 2021; 12:20Ramaswamy V, Tejaswini BN, Uthaiah SB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267985 35. YouTube as a source of information about COVID-19 for children: Content quality, reliability, and audience participation analysis. J. Pediatr. Nurs. 2021; Azak M, Şahin K, Korkmaz N, Yıldız S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247879 36. In-person vs. home schooling during the COVID-19 pandemic: Differences in sleep, circadian timing, and mood in early adolescence. J. Pineal Res. 2021:e12757Stone JE, Phillips AJK, Chachos E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273194 37. Analysis of COVID-19 Resulting Cough Using Formants and Automatic Speech Recognition System. J. Voice 2021; Zealouk O, Satori H, Hamidi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256982 38. Strategies for the Identifcation and Prevention of Survey Fraud: Data Analysis of a Web-Based Survey. JMIR Cancer 2021; 7:e30730Pratt-Chapman M, Moses J, Arem H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269685 39. Contact Tracing Apps: Lessons Learned on Privacy, Autonomy, and the Need for Detailed and Thoughtful Implementation. JMIR Med Inform 2021; 9:e27449Hogan K, Macedo B, Macha V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254937 40. eHealth solutions to fght against COVID-19: A scoping review of applications. Med. J. Islam. Repub. Iran 2021; 35:43Eslami P, Niakan Kalhori SR, Taheriyan M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268231 41. Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients. Neurooncol Pract 2021; 8:485-496Gardner MM, Aslanzadeh FJ, Zarrella GV et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267923 42. Associations between individual and environmental determinants and physical activity levels of an active population during the Spanish lockdown. Prev. Med. 2021:106719Gonzalo-Encabo P, Cereijo L, Remón Á LC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256066 43. COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring. Prim. Care Diabetes 2021; Salabelle C, Ly Sall K, Eroukhmanoff J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257050 44. Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones. Proc Natl Acad Sci U S A 2021; 118Rüdiger S, Konigorski S, Rakowski A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261775 45. Telehealth Use for Mental Health Conditions Among Enrollees in Commercial Insurance. Psychiatr. Serv. 2021:appips202000778Yu J, Casalino L, Pincus HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253038 46. #SupportLocal: how online food delivery services leveraged the COVID-19 pandemic to promote food and beverages on Instagram. Public Health Nutr. 2021:1-11Jia SS, Raeside R, Redfern J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247686 47. Chronic disease management in heart failure: focus on telemedicine and remote monitoring. Rev Cardiovasc Med 2021; 22:403-413Alvarez P, Sianis A, Brown J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258907 48. Perception towards E-learning and COVID-19 on the mental health status of university students in Malaysia. Sci. Prog. 2021; 104:368504211029812Moy FM, Ng YH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260295 49. Performance Evaluation of Soft Computing Approaches for Forecasting COVID-19 Pandemic Cases. SN Comput Sci 2021; 2:372Shoaib M, Salahudin H, Hammad M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258586 50. Telestroke: Maintaining Quality Acute Stroke Care During the COVID-19 Pandemic. Telemed J E Health 2021; Sevilis T, McDonald M, Avila A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265222 51. Pandemic Telemedicine Technology Response Plan and Technology Assessment Phase 2: Pandemic Action Plan Key Issues and Technology Solutions for Health Care Delivery Organizations in a Pandemic. Telemed J E Health 2021; VanderWerf M, Bernard J, Barta DT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265217
Other – Miscellaneous (79 articles)
1. Impact of COVID-19 on Radiology Faculty - An Exacerbation of Gender Differences in Unpaid Home Duties and Professional Productivity. Acad Radiol 2021; Plaunova A, Heller SL, Babb JS, Heffernan CC. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266739 2. Fluid Dynamics of Respiratory Infectious Diseases. Annu. Rev. Biomed. Eng. 2021; 23:547-577Bourouiba L. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255991 3. COVID-19 & culinary behaviours of Australian household food gatekeepers: A qualitative study. Appetite 2021:105598Ronto R, Nanayakkara J, Worsley A, Rathi N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271079 4. Equity without human rights: a false COVID-19 narrative? BMJ Glob Health 2021; 6Khosla R, Gruskin S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266850 5. Impact of severe SARS-CoV-2 infection on nutritional status and subjective functional loss in a prospective cohort of COVID-19 survivors. BMJ Open 2021; 11:e048948Quilliot D, Gérard M, Bonsack O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261689 6. COVID-19-related attitudes, risk perceptions, preventive behaviours and economic impact in sub-Saharan African countries: implementing a longitudinal phone-based survey protocol in rural Senegalese households. BMJ Open 2021; 11:e050090Seror V, Maradan G, Ba EH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272224 7. Social isolation and its psychosocial factors in mild lockdown for the COVID- 19 pandemic: a cross-sectional survey of the Japanese population. BMJ Open 2021; 11:e048380Sugaya N, Yamamoto T, Suzuki N, Uchiumi C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261687 8. ["From Crisis to Health in All Policies." Conference report from the Poverty and Health 2021 Congress]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021:1-6Amler M, Bollmann J, Waldhauer J, Janella M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251465 9. Who are the essential and frontline workers? Bus Econ 2021:1-11Blau FD, Koebe J, Meyerhofer PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253931 10. Investigating similarities and differences in individual reactions to the COVID- 19 pandemic and the climate crisis. Clim Change 2021; 167:1Geiger N, Gore A, Squire CV, Attari SZ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248235 11. The World Against Versatile SARS-Cov-2 Nanomachines; Mythological or Reality? Curr. Stem Cell Res. Ther. 2021; Tavakol S, Tavakol H, Alavijeh MS, Seifalian A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254928 12. Training bonuses doubled: Federal program aims to mitigate corona consequences. Deutsche Apotheker Zeitung 2021; 161. 13. Risk management required: Pension funds hold their ground in the corona pandemic. Deutsche Apotheker Zeitung 2021; 161Ulbrich H. 14. Food insecurity of people with disabilities who were Medicare Benefciaries during the COVID-19 pandemic. Disabil Health J 2021:101166Friedman C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272190 15. Local Perceptions of COVID-19 in Pakistan's Sindh Province: "Political Game", Supernatural Test, or Western Conspiracy? Disaster Med Public Health Prep 2021:1-19Ali I, Saddique S, Ali S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247693 16. COVID-19 and the Demand for Online Grocery Shopping: Empirical Evidence from the Netherlands. Economist (Leiden) 2021:1-14Baarsma B, Groenewegen J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253932 17. A post-pandemic sustainable scenario: What actions can be pursued to increase the raw materials availability? Environ. Res. 2021:111681Zanoletti A, Cornelio A, Bontempi E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273363 18. The contribution of bovines to human health against viral infections. Environ. Sci. Pollut. Res. Int. 2021:1-25Saied AA, Metwally AA, Mohamed HMA, Haridy MAM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272669 19. The impact of artifcial intelligence and digital style on industry and energy post-COVID-19 pandemic. Environ. Sci. Pollut. Res. Int. 2021; Sharif A, Ahmadi M, Ala A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269979 20. Contextualizing the COVID-19 pandemic's impact on food security in two small cities in Bangladesh. Environ. Urban. 2021; 33:239-254Ruszczyk HA, Rahman MF, Bracken LJ, Sudha S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253941 21. Challenges faced by people with epilepsy on ketogenic diet therapy and their caregivers during the COVID-19 pandemic in Brazil. Epilepsy Behav. 2021; 122:108193Alencastro Veiga Domingues Carneiro R, Dos Santos Lunardi M, Matheus Uberna Giacomini F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256342 22. How the COVID-19 pandemic can distort risk adjustment of health plan payment. Eur J Health Econ 2021; van Kleef RC, Reuser M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264411 23. Changes in patterns of take-away food ordering among youths before and after COVID-19 lockdown in China: the COVID-19 Impact on Lifestyle Change Survey (COINLICS). Eur. J. Nutr. 2021:1-11Luo M, Wang Q, Yang S, Jia P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254188 24. Food insecurity during the COVID-19 pandemic: evidence from a survey of low-income Americans. Food Secur 2021:1-19Fang D, Thomsen MR, Nayga RM, Jr., Yang W. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254010 25. Association Between Air Pollution and Acute Coronary Syndromes During Lockdown for COVID-19: Results From the Terni Hub Center. Front Public Health 2021; 9:683683Arrivi A, Dominici M, Bier N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249847 26. Social Class and Changes in Australian Women's Affect and Alcohol Consumption During COVID-19. Front Public Health 2021; 9:645376Lunnay B, Toson B, Wilson C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268284 27. Covid-19 Impact on the Music Sector in Belo Horizonte (Minas Gerais, Brazil). Front Sociol 2021; 6:643344Teixeira N, Mello Vianna G, Lima R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268350 28. The Impact of the Covid-19 Pandemic on Food Consumers' Awareness of Antimicrobial Resistance, OneHealth, and Animal Welfare Information on Food Labels. Front Vet Sci 2021; 8:678509Regan Á, Sweeney S, McKernan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268348 29. Health economy. Foreign Trade Day 2021: Corona crisis must not become a protectionism crisis. Gesundheitsokonomie und Qualitatsmanagement 2021; 26:132-133. 30. A Gulf in Lockdown: how an enforced ban on recreational vessels increased dolphin and fsh communication ranges. Glob. Chang. Biol. 2021; Pine MK, Wilson L, Jeffs AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254409 31. Care Ethics versus the CARES Act. Hastings Cent Rep 2021; 51:7-8Sontan O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255366 32. The Impact of Embarrassment to Product Purchase and Brand Infuence on the Perceived Benefts and Availability of Ayurveda Products in the COVID-19 Era: an Investigation by SEM Approach. Hosp. Top. 2021:1-8Mhatre K, Singh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251990 33. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19. Int J Infect Dis 2021; Yamaguchi T, Shinagawa T, Kobata H, Nakagawa H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273512 34. Comparing Food Security Before and During the COVID-19 Pandemic: Considerations When Choosing Measures. J. Acad. Nutr. Diet. 2021; Poblacion A, Ettinger de Cuba S, Cook JT. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247979 35. Stock price reaction to appointment of a chief health offcer during COVID-19. J Behav Exp Finance 2021; 31:100541Ichev R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249615 36. Food Safety and Employee Health Implications of COVID-19. J. Food Prot. 2021; Trmcic A, Demmings E, Kniel K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265068 37. Effect of COVID-19 on the Generation of Waste in Marrakech, Morocco. J Health Pollut 2021; 11:210606Ouigmane A, Boudouch O, Hasib A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267993 38. COVID-19 Leads to Dramatic Changes in the Food Retail Environment in New York City: May-July 2020. J Immigr Minor Health 2021:1-7Yi SS, Ali SH, Russo RG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258716 39. Letter to the Editor in Response to Zhou et al. J Infect Dis 2021; Troth S, Butterton J, DeAnda CS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251432 40. Lord Sumption and the values of life, liberty and security: before and since the COVID-19 outbreak. J. Med. Ethics 2021; Coggon J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253623 41. Age and Social Disparities in the Use of Telemedicine During the COVID-19 Pandemic in Japan: Cross-sectional Study. J Med Internet Res 2021; 23:e27982Miyawaki A, Tabuchi T, Ong MK, Tsugawa Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259641 42. Unamuno on suffering and Frankl's 'will to meaning': a philo-logotherapeutic advice to humankind here and beyond and the role of social relations towards mental ftness. J Public Health (Oxf) 2021; Pacaol NF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252976 43. Young African Americans' Communication with Family Members About COVID-19: Impact on Vaccination Intention and Implications for Health Communication Interventions. J Racial Ethn Health Disparities 2021:1-7Francis DB, Mason N, Occa A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272682 44. An Ethical Roadmap for Prioritizing Medical Resources Within Muslim Societies During the COVID-19 Pandemic. J Relig Health 2021:1-7Al-Balas QAE, Al-Delaimy WK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275033 45. Spiritual Health and the COVID-19 Pandemic: Impacts on Orthodox Christianity Devotion Practices, Rituals, and Religious Pilgrimages. J Relig Health 2021; Papazoglou AS, Moysidis DV, Tsagkaris C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263390 46. Islam and the COVID-19 Pandemic: Between Religious Practice and Health Protection. J Relig Health 2021; Piwko AM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268671 47. The Orthodox Church and the Mental Health Burden of a Pandemic: A Narrative Mini-Review. J Relig Health 2021; Schieffer DA, Jr., Genig J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263389 48. The onset of COVID-19, common identity, and intergroup prejudice. J. Soc. Psychol. 2021:1-17Toprakkiran S, Gordils J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34251994 49. Measuring business-level expectations and uncertainty: survey evidence and the COVID-19 pandemic. Jpn Econ Rev (Oxf) 2021:1-24Chen C, Senga T, Zhang H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248384 50. #workfromhome: how multi-level marketers enact and subvert federal language policy for proft. Lang Policy 2021:1-34Fluegel S, King K. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248446 51. Provision and utilisation of health and nutrition services during COVID-19 pandemic in urban Bangladesh. Matern. Child Nutr. 2021:e13218Nguyen PH, Sununtnasuk C, Pant A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264002 52. Declaration of COVID-19 as an occupational disease in healthcare workers: challenges and reality. Med Clin (Engl Ed) 2021; Gil-Blanco L, Martínez-Jarreta B. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250245 53. A mirror in fction: drawing parallelisms between Camus's La Peste and COVID-19. Med. Humanit. 2021; Pérez Romero C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253585 54. Clinical pharmacy goes Hollywood - Depiction of medication in movies. Med. Monatsschr. Pharm. 2020; 43:489-495Pudritz YM, Albien AL, Barth M et al. 55. [Change in dietary consciousness and its related factors among Japanese adults under the COVID-19 pandemic: Analysis using Dietary Consciousness Scale]. Nihon Koshu Eisei Zasshi 2021; Hayashi F, Takemi Y, Akaiwa Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261842 56. Ethical dilemmas faced by frontline support nurses fghting COVID-19. Nurs. Ethics 2021:9697330211015284Liu X, Xu Y, Chen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254552 57. Understanding the disproportionate effects of COVID-19 on nurses from ethnic minority backgrounds. Nurs. Stand. 2021; Qureshi I, Garcia R, Ali N, Randhawa G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250768 58. Clinical signifcance of prognostic nutrition index in hospitalized patients with COVID-19: Results from single-center experience with systematic review and meta-analysis. Nutr. Clin. Pract. 2021; Rashedi S, Keykhaei M, Pazoki M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270114 59. The Effect of the COVID-19 on Corrosive Ingestion in Thailand. Open Access Emerg. Med. 2021; 13:299-304Thongchuam C, Mahawongkajit P, Kanlerd A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267561 60. Customized bus passenger boarding and deboarding planning optimization model with the least number of contacts between passengers during COVID- 19. Physica A 2021; 582:126244Chen F, Peng H, Ding W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257475 61. COVID-19: High prevalence of malnutrition. Pneumologie 2021; 75:412Simon A. 62. Associations between individual and environmental determinants and physical activity levels of an active population during the Spanish lockdown. Prev. Med. 2021; 153:106719Gonzalo-Encabo P, Cereijo L, Remón Á LC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256066 63. From Shelters to Hotels: An Enduring Solution to Ending Homelessness for Thousands of Americans. Psychiatr. Serv. 2021:appips202100170Padgett DK, Herman D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253037 64. An exploration of the impact of SARS-CoV-2 (COVID-19) restrictions on marginalised groups in the UK. Public Health 2021; 197:6-10Eshareturi C, Wareham A, Rattray M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256281 65. The lie of pandemic pivot and essential work. Qual Soc Work 2021; 20:193- 199Crampton A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253964 66. Migrants in Chile: Social crisis and the pandemic (or sailing over troubled water…). Qual Soc Work 2021; 20:284-288Jara-Labarthé V, Cisneros Puebla CA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253973 67. Resisting the politics of the pandemic and racism to foster humanity. Qual Soc Work 2021; 20:225-232Lee E, Johnstone M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253968 68. Global collaboration and social practices to mitigate impacts of COVID-19 in the world: a lived experience of infecting. Qual Soc Work 2021; 20:366- 374Moshtagh M, Mirlashari J, Amiri R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253980 69. The revitalization of "Osekkai": How the COVID-19 pandemic has emphasized the importance of Japanese voluntary social work. Qual Soc Work 2021; 20:423-432Ohta R, Yata A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253984 70. Interactive virtual medication counselling in outpatient pharmacy: An accessible and safe patient counselling method during the COVID-19 pandemic. Res Social Adm Pharm 2021; Yong WY, Chang CT, Chew CC, Khoo TE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272201 71. Plastic waste footprint in the context of COVID-19: Reduction challenges and policy recommendations towards sustainable development goals. Sci Total Environ 2021; 796:148951Mallick SK, Pramanik M, Maity B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271381 72. Sandstorm and its effect on particulate matter PM 2.5, carbon monoxide, nitrogen dioxide, ozone pollutants and SARS-CoV-2 cases and deaths. Sci Total Environ 2021; 795:148764Meo SA, Almutairi FJ, Abukhalaf AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252765 73. Unveiling the changes in urban atmospheric CO(2) in the time of COVID-19 pandemic: A case study of Florence (Italy). Sci Total Environ 2021; 795:148877Venturi S, Randazzo A, Tassi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252774 74. Thoughts of social distancing experiences affect food intake and hypothetical binge eating: Implications for people in home quarantine during COVID-19. Soc. Sci. Med. 2021; 284:114218Yi-Chi Chang Y, Wu PL, Chiou WB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265658 75. 6 Feet Apart: Spaces and Cultures of Quarantine. Space Cult 2020; 23:216- 220Shields R, Schillmeier M, Lloyd J, Van Loon J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253950 76. Urogynecological survey in a group of Italian women treated for overactive bladder: Symptoms and quality of life analysis during the Covid-19 period. Taiwan. J. Obstet. Gynecol. 2021; 60:674-678Schiavi MC, Zullo MA, Luffarelli P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247805 77. Impact of biomass induced black carbon particles in cascading COVID-19. Urban Clim 2021; 38:100913Rathod A, Beig G. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258181 78. Paying the Price for a Broken Healthcare System: Rethinking Employment, Labor, and Work in a Post-Pandemic World. Work Occup 2020; 47:267-279Avgar AC, Eaton AE, Givan RK, Litwin AS. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253939 79. Impact of COVID-19 on the exercise habits of Pennsylvania residents and their families. Z Gesundh Wiss 2021:1-8Wallace LN. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258148
Pathology (8 articles)
1. Laboratory Medicine and Pathology Education During the COVID-19 Pandemic-Lessons Learned. Acad Pathol 2021; 8:23742895211020487Patel R, Hoppman NL, Gosse CM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263023 2. Probe-based confocal laser endomicroscopy in COVID-19. Adv Respir Med 2021; Vasilev IV, Mamenko IS, Makarova AV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269405 3. Rethinking the management of immune checkpoint inhibitor-related adrenal insuffciency in cancer patients during the COVID-19 pandemic. Endocrinol Diabetes Metab 2021; 4:e00246Yuen KCJ, Mortensen MJ, Azadi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268454 4. Distinctive Pseudopalisaded Histiocytic Hyperplasia Characterizes the Transition of Exudative to Proliferative Phase of Diffuse Alveolar Damage in Patients Dying of COVID-19. Hum. Pathol. 2021; Kritselis M, Yambayev I, Prilutskiy A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273395 5. A clinico-pathological description of COVID-19-induced chilblains (COVID toes) correlated with a published literature review. J. Cutan. Pathol. 2021; Kolivras A, Thompson C, Pastushenko I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272741 6. Historical Evolution and Filtering Characteristics of Masks and Respirators in Dentistry in the Context of COVID-19: A Literature Review. J Int Soc Prev Community Dent 2021; 11:248-255Ramírez A, Ochoa D, Llanque G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268186 7. Remote Reporting During a Pandemic Using Digital Pathology Solution: Experience from a Tertiary Care Cancer Center. J. Pathol. Inform. 2021; 12:20Ramaswamy V, Tejaswini BN, Uthaiah SB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267985 8. Demystifying COVID-19 lung pathology: A clinicopathological study of postmortem core needle biopsy. Lung India 2021; 38:343-349Bhandari S, Solanki R, Jindal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259173
Protection (28 articles)
1. Wearing masks to reduce the spread of respiratory viruses: a systematic evidence mapping. Ann Transl Med 2021; 9:811Li Y, Wei Z, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268424 2. Field observations and survey evidence to assess predictors of mask wearing across different outdoor activities in an Argentine city during the COVID-19 pandemic. Appl Psychol Health Well Being 2021; Freidin E, Acera Martini L, Senci CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254447 3. Paediatric headbox as aerosol and droplet barrier. Arch. Dis. Child. 2021; Sahih M, Schultz A, Wilson A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266877 4. Effcacy of frontline chemical biocides and disinfection approaches for inactivating SARS-CoV-2 variants of concern that cause coronavirus disease (COVID-19) with emergence of opportunities for green eco-solutions. Curr Opin Environ Sci Health 2021:100290Rowan NJ, Meade E, Garvey M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250323 5. An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient. Drug Deliv 2021; 28:1496-1500Mac Giolla Eain M, Joyce M, MacLoughlin R. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259091 6. Face masks as a source of nanoplastics and microplastics in the environment: Quantifcation, characterization, and potential for bioaccumulation. Environ Pollut 2021; 288:117748Ma J, Chen F, Xu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265560 7. Changes in handwashing and hygiene product usage patterns in Korea before and after the outbreak of COVID-19. Environ Sci Eur 2021; 33:79Choi K, Sim S, Choi J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249592 8. Time patterns of precautionary health behaviours during an easing phase of the COVID-19 pandemic in Europe. Eur J Ageing 2021:1-12Bíró A, Branyiczki R, Elek P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248455 9. The Signifcance of Duration of Exposure and Circulation of Fresh Air in SARS-CoV-2 Transmission Among Healthcare Workers. Front Med (Lausanne) 2021; 8:664297Vlacha V, Feketea G, Petropoulou A, Trancá SD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249965 10. Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View. Front Pediatr 2021; 9:676718Assathiany R, Salinier C, Béchet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249814 11. COVID-19 Incidence After Exposures in Shared Patient Rooms, Tertiary Care Center, Iowa, July 2020-May 2021. Infect Control Hosp Epidemiol 2021:1- 13Trannel A, Kobayashi T, Dains A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250882 12. Detection of SARS-CoV-2 RNA on contact surfaces within shared sanitation facilities. Int J Hyg Environ Health 2021; 236:113807Amoah ID, Pillay L, Deepnarian N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265632 13. Effects of Masks Worn to Protect Against COVID-19 on the Perception of Facial Attractiveness. Iperception 2021; 12:20416695211027920Kamatani M, Ito M, Miyazaki Y, Kawahara JI. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262683 14. Discussion on the Management Method of COVID-19 Infection Prevention in Medical Residents. Iran J. Public Health 2020; 49:87-91Zhou Y, Fang JJ, Wang SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268210 15. COVID-19 spread in a classroom equipped with partition - A CFD approach. J. Hazard. Mater. 2021; 420:126587Mirzaie M, Lakzian E, Khan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273880 16. Presentation of a participatory approach to develop preventive measures to reduce COVID-19 transmission in child care. J. Occup. Med. Toxicol. 2021; 16:26Diebig M, Gritzka S, Dragano N, Angerer P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261512 17. Do Black Lives Matter in the American Public's Mitigation Responses to the COVID-19 Pandemic? An Analysis of Mask Wearing and Racial/Ethnic Disparities in Deaths from COVID-19. J Racial Ethn Health Disparities 2021; Franz B, Milner A, Braddock I. http://www.ncbi.nlm.nih.gov/pubmed/? term=34269992 18. COVID-19: Acoustic Measures of Voice in Individuals Wearing Different Facemasks. J. Voice 2021; Joshi A, Procter T, Kulesz PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261582 19. Operating-Room Procedures Do Not Increase Risk of COVID-19 Infection. JSLS 2021; 25Manuia EP, Ostapenko A, Liechty ST, Kleiner DE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248337 20. Effect of sanitizer on obliteration of SARS -CoV2/COVID 19: A mini review. Mater Today Proc 2021; Andal V, Lakshmipathy R, Jose D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249617 21. Effects of surgical and cloth facemasks during a submaximal exercise test in healthy adults. Respir. Med. 2021; 186:106530Reychler G, Straeten CV, Schalkwijk A, Poncin W. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273733 22. US trends in mask wearing during the COVID-19 pandemic depend on rurality. Rural Remote Health 2021; 21:6596Pro G, Schumacher K, Hubach R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252284 23. Hand Hygiene Practices and the Risk of Human Coronavirus Infections in a UK Community Cohort. Wellcome Open Res 2020; 5:98Beale S, Johnson AM, Zambon M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250260
Pulmonary disease (29 articles)
1. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment. Acta Med Indones 2021; 53:141-142Rumende CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251340 2. The Management of Pulmonary Fibrosis in COVID-19. Acta Med Indones 2021; 53:233-241Rumende CM, Susanto EC, Sitorus TP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251354 3. Management of non-COVID respiratory illnesses during the COVID-19 pandemic - a pulmonologist's perspective. Adv Respir Med 2021; Shadrach BJ, Jain A, Goel R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269413 4. Probe-based confocal laser endomicroscopy in COVID-19. Adv Respir Med 2021; Vasilev IV, Mamenko IS, Makarova AV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269405 5. The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study. Am J Respir Crit Care Med 2021; Crichton ML, Shoemark A, Chalmers JD. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265234 6. High risk of patient self-inficted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study. Ann Intensive Care 2021; 11:109Weaver L, Das A, Saffaran S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255207 7. Asthma and COVID-19: a dangerous liaison? Asthma Res Pract 2021; 7:9Lombardi C, Gani F, Berti A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261543 8. Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis. BMC Pulm. Med. 2021; 21:233Shi N, Huang C, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256743 9. Pulmonary Telerehabilitation and Effcacy among Discharged COVID-19 Patients: Rational and Design of a Prospective Real-world Study. Clin. Respir. J. 2021; Lei J, Yang L, Wen G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260823 10. Acute bronchiolitis during the COVID-19 pandemic. Enferm. Infecc. Microbiol. Clin. 2021; Flores-Pérez P, Gerig N, Cabrera-López MI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256973 11. Development of a Large Pneumatocele in a Patient Recovering from COVID-19 Pneumonitis. Eur J Case Rep Intern Med 2021; 8:002605Hampson F, Salih W, Helm J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268263 12. Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases. Expert Rev. Respir. Med. 2021:1-14Tiotiu A, Chong Neto H, Bikov A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253132 13. Impact of the COVID-19 pandemic on the management of chronic non- infectious respiratory diseases. Expert Rev. Respir. Med. 2021; Tiotiu A, Chong- Neto H, Bikov A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253132 14. Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:670744Wu X, Xu Y, Jin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249969 15. Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity. Front Med (Lausanne) 2021; 8:682087Zhou M, Xu J, Liao T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249973 16. How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients. Front. Physiol. 2021; 12:628288Laveneziana P, Straus C, Meiners S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267671 17. Distinctive Pseudopalisaded Histiocytic Hyperplasia Characterizes the Transition of Exudative to Proliferative Phase of Diffuse Alveolar Damage in Patients Dying of COVID-19. Hum. Pathol. 2021; Kritselis M, Yambayev I, Prilutskiy A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273395 18. The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors. Int. J. Gen. Med. 2021; 14:3271-3280Salem AM, Al Khathlan N, Alharbi AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267545 19. Pulmonary Covid Fibrosis a New Pharmaceutic Approach. Int. J. Prev. Med. 2021; 12:35Menicagli R, Limodio M, Limodio M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249284 20. Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia. J Allergy Clin Immunol Pract 2021; Margolis RHF, Patel SJ, Sheehan WJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265448 21. Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report. J Med Case Rep 2021; 15:377Egoryan G, Hyser E, Mushtaq AH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256831 22. Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil. Pediatr Pulmonol 2021; Friedrich F, LC EG, Petry LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265188 23. Change in CF care during COVID-19 pandemic: Single-center experience in a middle-income setting. Pediatr Pulmonol 2021; Hatziagorou E, Toulia I, Avramidou V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265187 24. Impact of COVID-19 on pediatric pulmonology healthcare practice. Pediatr Pulmonol 2021; Nayir Buyuksahin H, Emiralioglu N, Ademhan Tural D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265185 25. Unaffected asthma control in children with mild asthma after COVID-19. Pediatr Pulmonol 2021; Tosca MA, Crocco M, Girosi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265183 26. Monitoring lung injury with particle fow rate in LPS- and COVID-19-induced ARDS. Physiol Rep 2021; 9:e14802Stenlo M, Silva IAN, Hyllén S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250766 27. COVID-19 and acute exacerbation of interstitial lung disease. Respir Investig 2021; Kondoh Y, Kataoka K, Ando M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272158 28. Secondary spontaneous pneumothorax: a time to re-evaluate management. Respirol Case Rep 2021; 9:e00749Cortes-Telles A, Ortíz-Farias DL, Perez- Hernandez F, Rodriguez-Morejon D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262774 29. A randomized open-label trial to evaluate the effcacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:451Sharma A, Sharma C, Raina S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266452
Renal disease (10 articles) 1. SARS-CoV-2 assessment in an outpatient dialysis facility of a single center in Brazil. Braz. J. Infect. Dis. 2021; 25:101595Gorayeb-Polacchini FS, Caldas HC, Bottazzo AC, Abbud-Filho M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273270 2. Two episodes of acute dyspnea that were induced by COVID-19 in a peritoneal dialysis patient. CEN Case Rep 2021; Toda N, Takeoka J, Tanigaki K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269997 3. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 2021; 229:108795Jamaly S, Tsokos MG, Bhargava R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252574 4. A Retrospective Multi-Center Experience of Renal Transplants from India During COVID-19 Pandemic. Clin. Transplant. 2021; Jha PK, Yadav DK, Siddini V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255903 5. Impact of dexamethasone use to prevent from severe COVID-19-induced acute kidney injury. Crit Care 2021; 25:249Orieux A, Khan P, Prevel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271956 6. A COVID-19 Emergency Response for Remote Control of a Dialysis Machine with Mobile HRI. Front Robot AI 2021; 8:612855Wazir HK, Lourido C, Chacko SM, Kapila V. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262944 7. COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Defciencies as Determinants of Risk and Severity of Disease: A Narrative Review. Infect Dis Ther 2021:1-11Salgo MP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251655 8. [Kidney damage in COVID-19]. Nephrol. Ther. 2021; Burtey S, Sallée M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266783 9. [SFNDT in the heart of the COVID-19 epidemy]. Nephrol. Ther. 2021; Hourmant M, Frimat L, Moulin B, Vrtovsnik F. http://www.ncbi.nlm.nih.gov/pubmed/? term=34266784 10. [Why this special COVID issue?]. Nephrol. Ther. 2021; Vigneau C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274253
Reviews (42 articles)
1. Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies. Acta Cardiol Sin 2021; 37:355-364Chen PW, Tsai ZY, Chao TH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257485 2. Intention to COVID-19 vaccination and associated factors among health care workers: A systematic review and meta-analysis of cross-sectional studies. Am. J. Infect. Control 2021; Luo C, Yang Y, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273461 3. Titres and neutralising capacity of SARS-CoV-2-specifc antibodies in human milk: a systematic review. Arch. Dis. Child. Fetal Neonatal Ed. 2021; Low JM, Low YW, Zhong Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257103 4. COVID-19 and loneliness: A rapid systematic review. Aust. N. Z. J. Psychiatry 2021:48674211031489Pai N, Vella SL. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256632 5. Covid-19 and the next outbreak: decreasing frailty by using mild stress? Biogerontology 2021:1-5Le Bourg E. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273015 6. Health authorities' health risk communication with the public during pandemics: a rapid scoping review. BMC Public Health 2021; 21:1401Berg SH, O'Hara JK, Shortt MT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266403 7. Effectiveness of contact tracing apps for SARS-CoV-2: a rapid systematic review. BMJ Open 2021; 11:e050519Jenniskens K, Bootsma MCJ, Damen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253676 8. An outline of SARS-CoV-2 pathogenesis and the complement cascade of immune system. Bull Natl Res Cent 2021; 45:123Hembram P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257504 9. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc. Toxicol. 2021:1-9Vitiello A, Ferrara F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255300 10. 'It's history in the making all around us': examining COVID-19 through the lenses of HIV and epidemic history. Cult Health Sex 2021:1-16Braksmajer A, London AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254890 11. Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians. Curr. Allergy Asthma Rep. 2021; 21:38Chee J, Loh WS, Liu Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259961 12. A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants? Curr Clin Microbiol Rep 2021:1-8Noor R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249605 13. COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefts and Risks. Curr Clin Microbiol Rep 2021:1-5Noor R, Tasnim N, Saha C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249604 14. Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review. Curr Med Imaging 2021; Mondal MRH, Bharati S, Podder P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259149 15. Effcacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021. Euro Surveill 2021; 26Harder T, Koch J, Vygen-Bonnet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269175 16. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam. Pract. 2021; van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268556 17. Review article on COVID-19 and Guillain-Barré syndrome. Front Biosci (Schol Ed) 2021; 13:97-104Patnaik UJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256532 18. Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials. Front. Pharmacol. 2021; 12:656246Takayama S, Namiki T, Odaguchi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248620 19. Knowledge, Attitude, and Practice of Healthcare Providers Toward Novel Coronavirus 19 During the First Months of the Pandemic: A Systematic Review. Front Public Health 2021; 9:606666Tegegne GT, Kefale B, Engidaw MT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249826 20. Relevance of vitamin D(3) in COVID-19 infection. Gene Rep 2021; 24:101270Ul Afshan F, Nissar B, Chowdri NA, Ganai BA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250314 21. Pattern and determinants of COVID-19 infection and mortality across countries: An ecological study. Heliyon 2021; 7:e07504Asem N, Ramadan A, Hassany M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254048 22. The effectiveness of Colchicine as an anti-infammatory drug in the treatment of coronavirus disease 2019: Meta-analysis. Int. J. Immunopathol. Pharmacol. 2021; 35:20587384211031763Golpour M, Mousavi T, Alimohammadi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250834 23. Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review. Int. J. Prev. Med. 2021; 12:38Rahimi Pordanjani S, Hasanpour A, Askarpour H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249287 24. Frontier Therapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review. Iran J. Public Health 2020; 49:18-29Sheikhshahrokh A, Ranjbar R, Saeidi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268202 25. An Introduction to SARS Coronavirus 2; Comparative Analysis with MERS and SARS Coronaviruses: A Brief Review. Iran J. Public Health 2020; 49:30- 37Taherizadeh M, Tabibzadeh A, Panahi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268203 26. "Five-Early" Model: The Magic Weapon against COVID-19. Iran J. Public Health 2020; 49:82-86Yi Q, Fang W, Lang C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268209 27. Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests. J. Clin. Monit. Comput. 2021; Pavoni V, Gianesello L, Pazzi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264472 28. Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury. J Hepatol 2021; Saviano A, Baumert TF. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274367 29. N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence. J Infamm Res 2021; 14:2993-3013Wong KK, Lee SWH, Kua KP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262324 30. Clinical effcacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. J Microbiol Immunol Infect 2021; Lai CC, Chao CM, Hsueh PR. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253490 31. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021:1410768211032850Aiyegbusi OL, Hughes SE, Turner G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265229 32. Venous and arterial thromboembolic disease in COVID-19. J. Thromb. Thrombolysis 2021:1-3Ten Berg J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255267 33. Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease. Kidney Int Rep 2021; Carr EJ, Kronbichler A, Graham-Brown M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250319 34. Effect of sanitizer on obliteration of SARS -CoV2/COVID 19: A mini review. Mater Today Proc 2021; Andal V, Lakshmipathy R, Jose D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249617 35. eHealth solutions to fght against COVID-19: A scoping review of applications. Med. J. Islam. Repub. Iran 2021; 35:43Eslami P, Niakan Kalhori SR, Taheriyan M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268231 36. Mucormycosis and COVID-19: An Epidemic within a Pandemic in India. Mycoses 2021; Selarka L, Sharma S, Saini D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255907 37. A Narrative Review of Current Understanding and Classifcation of Dry Eye Disease with New Insights on the Impact of Dry Eye during the COVID-19 Pandemic. Ophthalmol Ther 2021:1-13Barabino S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275088 38. Novel Respiratory Viruses in the Context of Mass-Gathering Events: A Systematic Review to Inform Event Planning from a Health Perspective. Prehosp. Disaster Med. 2021:1-12Ranse J, Beckwith D, Khan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261546 39. COVID-19 and cardiovascular system-a comprehensive review. Rev Cardiovasc Med 2021; 22:343-351AlShahrani I, Hosmani J, Shankar VG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258902 40. The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence. Rev Med Virol 2021; 31:e2192Cardwell K, Jordan K, Byrne P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260781 41. Population-based prevalence surveys during the Covid-19 pandemic: A systematic review. Rev Med Virol 2021; 31:e2200Franceschi VB, Santos AS, Glaeser AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260777 42. Immunity and infammatory biomarkers in COVID-19: A systematic review. Rev Med Virol 2021; 31:e2199Iwamura APD, Tavares da Silva MR, Hümmelgen AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260778
Risk factors (75 articles)
1. Incidence of COVID-19 in patients with rheumatic diseases. Aktuelle Rheumatologie 2021; 46:225-227Kessing R. 2. Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study. Ann Intensive Care 2021; 11:111Marais C, Claude C, Semaan N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259942 3. Incidence and predictors of COVID-19 and fares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France. Arthritis Res. Ther. 2021; 23:188Felten R, Scherlinger M, Guffroy A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256812 4. Asthma and COVID-19: a dangerous liaison? Asthma Res Pract 2021; 7:9Lombardi C, Gani F, Berti A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261543 5. Fatores associados ao óbito em casos confrmados de COVID-19 no estado do Rio de Janeiro. BMC Infect. Dis. 2021; 21:687Cini Oliveira M, de Araujo Eleuterio T, de Andrade Corrêa AB et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271868 6. Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study. BMC Med. Res. Methodol. 2021; 21:146Marateb HR, von Cube M, Sami R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261439 7. Longitudinal trajectories of pneumonia lesions and lymphocyte counts associated with disease severity among convalescent COVID-19 patients: a group-based multi-trajectory analysis. BMC Pulm. Med. 2021; 21:233Shi N, Huang C, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256743 8. Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study. BMJ Open Respir Res 2021; 8Takeshita Y, Terada J, Fujita R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272254 9. Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients? Cancer Radiother. 2021; Allali S, Beddok A, Kirova Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274225 10. Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol 2021; 229:108795Jamaly S, Tsokos MG, Bhargava R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34252574 11. Cardiovascular Risk Factors and the Severity of COVID-19 Disease. Cureus 2021; 13:e15486Motaib I, Zbiri S, Elamari S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262822 12. Biomarkers Predictive of Extubation and Survival of COVID-19 Patients. Cureus 2021; 13:e15462Topp G, Bouyea M, Cochran-Caggiano N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258124 13. The Role of Antiphospholipid Antibodies in COVID-19. Curr. Rheumatol. Rep. 2021; 23:72Stelzer M, Henes J, Saur S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34259944 14. Higher admission activated partial thromboplastin time, neutrophil- lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K. Diabetes Res Clin Pract 2021; 178:108955Iqbal A, Greig M, Arshad MF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273452 15. Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States. Diabetes Ther. 2021:1-17Boye KS, Tokar Erdemir E, Zimmerman N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275115 16. Outcome and death risk of diabetes patients with Covid-19 receiving pre- hospital and in-hospital metformin therapies. Diabetol. Metab. Syndr. 2021; 13:76Tamura RE, Said SM, de Freitas LM, Rubio IGS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256824 17. Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly. Emergencias 2021; 33:282-291López-Izquierdo R, Ruiz Albi T, Bermejo-Martín JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251141 18. Mortality risk model for patients with suspected COVID-19 based on information available from an emergency dispatch center. Emergencias 2021; 33:265-272Martín-Rodríguez F, Sanz-García A, Alberdi Iglesias A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251139 19. Effects of chronic exposure to ambient air pollutants, demographic, and socioeconomic factors on COVID-19 morbidity: The Israeli case study. Environ. Res. 2021:111673Levi A, Barnett-Itzhaki Z. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260961 20. Association of ABO and Rh blood groups with obstetric outcomes in SARS- CoV-2 infected pregnancies: A prospective study with a multivariate analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 264:41-48Sainz Bueno JA, Cerrillos González L, Abascal-Saiz A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271364 21. Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study. Front. Aging Neurosci. 2021; 13:698184Pisaturo M, Calò F, Russo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267649 22. Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning. Front Artif Intell 2021; 4:673527Jamshidi E, Asgary A, Tavakoli N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250465 23. B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Cardiovasc Med 2021; 8:690790Zinellu A, Sotgia S, Carru C, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250044 24. PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19. Front Cell Dev Biol 2021; 9:627914Grimaudo S, Amodio E, Pipitone RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249902 25. The Gut Microbiota of Critically Ill Patients With COVID-19. Front Cell Infect Microbiol 2021; 11:670424Gaibani P, D'Amico F, Bartoletti M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268136 26. Type 2 Diabetes Coagulopathy Proteins May Confict With Biomarkers Refective of COVID-19 Severity. Front. Endocrinol. (Lausanne) 2021; 12:658304Moin ASM, Al-Qaissi A, Sathyapalan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248840 27. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study. Front. Endocrinol. (Lausanne) 2021; 12:611526Yue J, Xu H, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248834 28. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients. Front. Immunol. 2021; 12:634416Luft T, Wendtner CM, Kosely F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248931 29. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Infammatory Cytokine Production in Macrophages. Front. Immunol. 2021; 12:683800Pantazi I, Al-Qahtani AA, Alhamlan FS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248968 30. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning. Front. Immunol. 2021; 12:700782Patterson BK, Guevara-Coto J, Yogendra R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34262570 31. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021; 12:698169Proal AD, VanElzakker MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248921 32. Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Infammatory Response in COVID-19 Patients: A Cross-Sectional Study. Front. Microbiol. 2021; 12:687513Soffritti I, D'Accolti M, Fabbri C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248910 33. Liver dysfunction in COVID-19: a useful prognostic marker of severe disease? Frontline Gastroenterol. 2021; 12:293-298Lok J, Gess M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249314 34. Is obesity a risk factor in cancer patients with COVID-19? Future Oncol 2021; Park R, Wulff-Burchfeld E, Sun W, Kasi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254528 35. Validation of red cell distribution width as a COVID-19 severity screening tool. Future Sci OA 2021; 7:Fso712Pouladzadeh M, Safdarian M, Choghakabodi PM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254030 36. Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis. Future Sci OA 2021; 7:Fso713Yassin A, Ghzawi A, Al-Mistarehi AH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254031 37. Blood system ABO antigens as risk factor for severity of SARS-CoV-2 infection. Gac Med Mex 2021; 157:174-180Torres-Alarcón CG, García-Ruíz A, Cañete-Ibáñez CR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270530 38. Comorbidities predict 30-day hospital mortality of older adults with COVID-19. Geriatr. Nurs. 2021; 42:1024-1028Pott Junior H, Cominetti MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256151 39. Frailty as a mortality predictor in older adults with COVID-19: A systematic review and meta-analysis of cohort studies. Geriatr. Nurs. 2021; 42:983- 992Saragih ID, Advani S, Saragih IS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256158 40. The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcifcation. Geroscience 2021:1-15Cereda A, Toselli M, Palmisano A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260010 41. Assessment of severity and mortality of COVID-19 with anti-A1 and B IgM isohemagglutinins, a refection of the innate immune status. Int J Clin Pract 2021:e14624Ozcelik F, Tanoglu A, Guven BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251730 42. "Five-Early" Model: The Magic Weapon against COVID-19. Iran J. Public Health 2020; 49:82-86Yi Q, Fang W, Lang C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268209 43. Association Between Pediatric Asthma and Positive Tests for SARS-CoV-2 in the District of Columbia. J Allergy Clin Immunol Pract 2021; Margolis RHF, Patel SJ, Sheehan WJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265448 44. Deaths of people with intellectual disabilities: Analysis of deaths in England from COVID-19 and other causes. J Appl Res Intellect Disabil 2021; Heslop P, Byrne V, Calkin R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272793 45. Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study. J. Clin. Lab. Anal. 2021:e23911Zhu Z, Yang Y, Fan L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260764 46. Mortality associated with early changes in ARDS severity in COVID-19 patients - Insights from the PRoVENT-COVID study. J Crit Care 2021; 65:237-245Schuijt MTU, Martin-Loeches I, Schultz MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271294 47. Gut microbiota, infammation, and molecular signatures of host response to infection. J Genet Genomics 2021; Gou W, Fu Y, Yue L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257044 48. Association between Early Antibiotic Therapy and In-Hospital Mortality among Older Patients with SARS-CoV-2 Pneumonia. J Gerontol A Biol Sci Med Sci 2021; Putot A, Bouiller K, Laborde C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34272847 49. Does ABO Blood Groups Affect Outcomes in Hospitalized COVID-19 Patients? J Hematol 2021; 10:98-105Kumar G, Nanchal R, Hererra M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267846 50. Blood cell morphology and COVID-19 clinical course, severity, and outcome. J. Hematop. 2021:1-8Pezeshki A, Vaezi A, Nematollahi P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249171 51. Cross-sectional assessment of SARS-CoV-2 viral load by symptom status in Massachusetts congregate living facilities. J Infect Dis 2021; Lennon NJ, Bhattacharyya RP, Mina MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34255846 52. Self-infection with speech aerosol may contribute to COVID-19 severity. J Intern Med 2021; Kushalnagar P, Chow CC, Bax A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268819 53. Mucormycosis or black fungus infection is a new scare in South Asian countries during COVID-19 pandemic: Associated risk factors and preventive measures. J Med Virol 2021; Rahman FI, Islam MR, Bhuiyan MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260073 54. Dexamethasone treatment may mitigate adverse effects of vitamin D defciency in hospitalised Covid-19 patients. J Med Virol 2021; Wenban C, Heer RS, Baktash V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273116 55. Prevention and management of infections after exposure to ionizing radiation. J. Radiol. Prot. 2021; Maher K, Bouligny IM, Yeager AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265748 56. The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19. J Thromb Haemost 2021; Li A, Kuderer NM, Hsu CY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260813 57. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). J. Thromb. Thrombolysis 2021:1-10García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272635 58. Clinical utility of biochemical markers for the prediction of COVID-19-related mortality in kidney transplant recipients. Kidney Int Rep 2021; Caillard S, Chavarot N, Francois H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254049 59. Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? Med. Hypotheses 2021; 153:110641Figueiro-Filho EA, Hobson SR, Farine D, Yudin MH. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256245 60. Comparison of the effects of etomidate, ketamine, sodium thiopental, and midazolam on the mortality of patients with COVID-19 requiring intubation. Med. J. Islam. Repub. Iran 2021; 35:49Edalatkhah A, Kazemi MR, Samadi Khorshidi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268237 61. Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. Microvasc. Res. 2021:104224Andrianto, Al-Farabi MJ, Nugraha RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273359 62. Visceral Adiposity and Severe COVID-19 Disease: Application of an Artifcial Intelligence Algorithm to Improve Clinical Risk Prediction. Open Forum Infect Dis 2021; 8:ofab275Goehler A, Hsu TH, Seiglie JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258315 63. Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran. Parkinsonism Relat. Disord. 2021; 89:90-92Salari M, Etemadifar M, Ashraf F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256334 64. Platelet-leukocyte interactions in the pathogenesis of viral infections. Platelets 2021:1-8Hottz ED, Quirino-Teixeira AC, Merij LB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260328 65. Exposing health inequities: Surreal snapshots from the Grand Canyon to global COVID-19 pandemic. Qual Soc Work 2021; 20:90-96Balestrery JE. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253957 66. C-Reactive protein and SOFA scale: A simple score as early predictor of critical care requirement in patients with COVID-19 pneumonia in Spain. Rev. Esp. Anestesiol. Reanim. 2021; Vaquero-Roncero LM, Sánchez-Barrado E, Escobar-Macias D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247837 67. Can Comorbidity Data Explain Cross-State and Cross-National Difference in COVID-19 Death Rates? Risk Manag. Healthc. Policy 2021; 14:2877-2885Cegan JC, Trump BD, Cibulsky SM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34267565 68. Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience. Rom. J. Intern. Med. 2021; Voiosu A, Roman A, Pop R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253002 69. COVID-19 and aging: Identifying measures of severity. SAGE Open Med 2021; 9:20503121211027462Neves MT, de Matos LV, Vasques AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249362 70. Spatial-temporal generalized additive model for modeling COVID-19 mortality risk in Toronto, Canada. Spat Stat 2021:100526Feng C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249608 71. Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis. Ther Adv Infect Dis 2021; 8:20499361211027390Windham S, Wilson MP, Fling C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249357 72. Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study. Thromb Res 2021; 205:84-91Metra B, Summer R, Brooks SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274560 73. Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage. Toxicol Rep 2021; 8:1394- 1398Chalkias A, Pantazopoulos I, Papagiannakis N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258235 74. Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico. Vector Borne Zoonotic Dis. 2021; García- Alvarado FJ, Muñoz-Hernández MA, Moran Guel E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255563 75. Admission Braden Scale Score as an Early Independent Predictor of In- Hospital Mortality Among Inpatients With COVID-19: A Retrospective Cohort Study. Worldviews Evid. Based Nurs. 2021; Lovicu E, Faraone A, Fortini A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275200
Safety (35 articles) 1. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases. Acad Radiol 2021; Faermann R, Nissan N, Halshtok-Neiman O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257025 2. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report. Acta Neurol. Scand. 2021; de Mélo Silva ML, Jr., Lopes DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273119 3. Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine. Allergy Rhinol (Providence) 2021; 12:21526567211026271Alfen C, Birch K, Shilian R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249404 4. Post-COVID-19 vaccine Guillain-Barré syndrome; frst reported case from Qatar. Ann Med Surg (Lond) 2021; 67:102540Razok A, Shams A, Almeer A, Zahid M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249353 5. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 2021; 14Malik B, Kalantary A, Rikabi K, Kunadi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261635 6. Intracerebral bleeding after janus-kinase inhibitor baricitinib for COVID-19. Brain Hemorrhages 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250455 7. COVID-19 Vaccination-Induced Rash: Does the Choice of Vaccine Matter? Cureus 2021; 13:e15490Zafar M, Ewnetu B, Ahmed S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268022 8. Effcacy of frontline chemical biocides and disinfection approaches for inactivating SARS-CoV-2 variants of concern that cause coronavirus disease (COVID-19) with emergence of opportunities for green eco-solutions. Curr Opin Environ Sci Health 2021:100290Rowan NJ, Meade E, Garvey M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250323 9. Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections). Curr. Rheumatol. Rep. 2021; 23:74Varley CD, Winthrop KL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269903 10. Myocarditis after mRNA vaccination: Discussions about risks of the new COVID-19 vaccines for younger men. Deutsche Apotheker Zeitung 2021; 161Blasius H. 11. The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization. Eur J Case Rep Intern Med 2021; 8:002617Sazgary L, Meienberg A, Berger CT, Mayr M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268264 12. Primary adrenal insuffciency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Eur J Intern Med 2021; Varona JF, García-Isidro M, Moeinvaziri M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256983 13. Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England. Euro Surveill 2021; 26Powell AA, Power L, Westrop S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269172 14. COVID-19 vaccination associated severe immune thrombocytopenia. Exp Hematol Oncol 2021; 10:42Shah SRA, Dolkar S, Mathew J, Vishnu P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266487 15. Thromboembolic events in younger women exposed to Pfzer-BioNTech or Moderna COVID-19 vaccines. Expert Opin. Drug Saf. 2021; Sessa M, Kragholm K, Hviid A, Andersen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264151 16. NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients. Indian J. Nephrol. 2021; 31:89-91Kute VB, Agarwal SK, Prakash J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267426 17. Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center. Infect Control Hosp Epidemiol 2021:1-8De Vita E, Sbrana F, Quattrone F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261574 18. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. Int. J. Hematol. 2021; Waqar SHB, Khan AA, Memon S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264514 19. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int. Rev. Immunol. 2021:1- 10Novak N, Tordesillas L, Cabanillas B. http://www.ncbi.nlm.nih.gov/pubmed/? term=34251972 20. N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence. J Infamm Res 2021; 14:2993-3013Wong KK, Lee SWH, Kua KP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262324 21. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine. J Korean Med Sci 2021; 36:e197Huh K, Na Y, Kim YE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254476 22. SAFETY OF COVID-19 VACCINES. J Med Virol 2021; Al Khames Aga QA, Alkhaffaf WH, Hatem TH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34270094 23. Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report. J Med Virol 2021; Conticini E, D'Alessandro M, Bergantini L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251683 24. Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients. J Med Virol 2021; Kalantari S, Fard SR, Maleki D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255369 25. Commentary: The spectrum of neurological manifestations related to COVID- 19 and vaccinations. J. Neuroimmunol. 2021; 358:577660Samudralwar RD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274719 26. A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. J. Oncol. Pharm. Pract. 2021:10781552211031304Demir E, Sütcüoğlu O, Demir B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255596 27. Coincidence of fever following COVID-19 vaccine and endemic tropical diseases: A challenge to clinicians during the global rollout of COVID-19 vaccination. J Travel Med 2021; Asawapaithulsert P, Pisutsan P, Matsee W. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272852 28. Acute facial paresis as a possible complication of vaccination against SARS- CoV-2. Laryngo- Rhino- Otologie 2021; 100:526-528Volk GF, Kuttenreich AM, Geitner M, Guntinas-Lichius O. 29. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol Sci 2021:1-3Nasuelli NA, De Marchi F, Cecchin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272622 30. Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Signifcantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients. New Microbes New Infect 2021:100915Cadegiani FA, Goren A, Wambier CG, McCoy J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249367 31. Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis. Open Forum Infect Dis 2021; 8:ofab176Gibson EG, Pender M, Angerbauer M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258310 32. AstraZeneca's COVID-19 vaccine: Vector vaccine with high protective effect. Pharm. Ztg. 2020; 165:46-48Dingermann T. 33. Convalescent plasma treatment for early post-kidney-transplant acquired COVID-19. Transpl Infect Dis 2021; Kluger MA, Czogalla J, Schmidt-Lauber C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251081 34. Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine 2021; Hines AM, Murphy N, Mullin C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247902 35. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-beneft analysis for people < 60 years in Australia. Vaccine 2021; MacIntyre CR, Veness B, Berger D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272095
Treatment options (69 articles)
1. Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report. Acta Med Indones 2021; 53:194-201Syam AF, Pitoyo CW, Suhendro S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251348 2. Recent advances in developing small-molecule inhibitors against SARS-CoV- 2. Acta Pharm Sin B 2021; Xiang R, Yu Z, Wang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249607 3. Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab- treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff et al. Ann. Rheum. Dis. 2021; Bonelli M, Aletaha D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272251 4. Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report. Ann. Rheum. Dis. 2021; Golding B, Lee Y, Golding H, Khurana S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272252 5. Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2. Antiviral Res 2021; 193:105137Touret F, Driouich JS, Cochin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265358 6. The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome. Autoimmun Rev 2021; 20:102907Berciano J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274541 7. Traditional medicines for COVID-19: Perspectives from clinical pharmacologists. Br. J. Clin. Pharmacol. 2021; Yimer G, Ekuadzi E, Fasinu P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272755 8. Intracerebral bleeding after janus-kinase inhibitor baricitinib for COVID-19. Brain Hemorrhages 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250455 9. Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir. Clin Case Rep 2021; 9:e04459Oda N, Miyoshi K, Morichika D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257986 10. Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19. Clin Infect Dis 2021; Wong CKH, Lau KTK, Au ICH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34265054 11. Effcient machine learning model for predicting drug-target interactions with case study for Covid-19. Comput. Biol. Chem. 2021; 93:107536El-Behery H, Attia AF, El-Feshawy N, Torkey H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271420 12. Unravelling the therapeutic potential of marine drugs as SARS-CoV-2 inhibitors: An insight from essential dynamics and free energy landscape. Comput. Biol. Med. 2021; 135:104525Rampogu S, Gajula RG, Lee G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252682 13. Impact of dexamethasone use to prevent from severe COVID-19-induced acute kidney injury. Crit Care 2021; 25:249Orieux A, Khan P, Prevel R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271956 14. A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants? Curr Clin Microbiol Rep 2021:1-8Noor R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249605 15. COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefts and Risks. Curr Clin Microbiol Rep 2021:1-5Noor R, Tasnim N, Saha C. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249604 16. Drug repurposing: an alternative strategy to treat COVID-19. Curr. Pharm. Biotechnol. 2021; Han P, Zheng H, Wen P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250872 17. Synopsis on Pharmotechnological Approaches in Diagnostic to Management Strategies in Fighting Against COVID-19. Curr. Pharm. Des. 2021; Azhar A, Hassan N, Singh M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269664 18. Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections). Curr. Rheumatol. Rep. 2021; 23:74Varley CD, Winthrop KL. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269903 19. Visualized analyses of investigations upon mesenchymal stem/stromal cell- based cytotherapy and underlying mechanisms for COVID-19 associated ARDS. Curr. Stem Cell Res. Ther. 2021; Aitong W, Leisheng Z, Hao Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254927 20. Research cooperation reports initial successes: Lüdenscheid pharmacy fnances development of a phytotherapeutic agent against COVID-19. Deutsche Apotheker Zeitung 2021; 161. 21. Effcacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 Pandemic. Ear Nose Throat J 2021:1455613211032534Tsuda T, Hanada Y, Wada K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247535 22. Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression. Endocr. Metab. Immune Disord. Drug Targets 2021; Hariyanto TI, Lugito NPH, Yanto TA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250875 23. The dynamics in applied COVID-19 pharmacotherapy and the infuence of national guidance in The Netherlands: a quantitative and qualitative study. Eur J Hosp Pharm 2021; Uitvlugt EB, Soeng DYF, van der Linden P, van de Garde EMW. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272215 24. Oropharyngeal Probiotic ENT-K12 Prevents Respiratory Tract Infections Among Frontline Medical Staff Fighting Against COVID-19: A Pilot Study. Front Bioeng Biotechnol 2021; 9:646184Wang Q, Lin X, Xiang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249878 25. Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Effcacy of Remdesivir. Front. Immunol. 2021; 12:680188Chan YH, Young BE, Fong SW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262564 26. Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications. Front. Immunol. 2021; 12:582556Derosa G, Maffoli P, D'Angelo A, Di Pierro F. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262553 27. Interleukin-1- Receptor Kinase 4 Inhibition: Achieving Immunomodulatory Synergy to Mitigate the Impact of COVID-19. Front. Immunol. 2021; 12:693085Gupta A, Chun HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248990 28. A Computational Approach Identifed Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm. Front. Immunol. 2021; 12:648250Rehan M, Ahmed F, Howladar SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248936 29. Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection. Front. Pharmacol. 2021; 12:575877Ayatollahi SA, Sharif-Rad J, Tsouh Fokou PV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267652 30. Serratiopeptidase, A Serine Protease Anti-Infammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19. Front. Pharmacol. 2021; 12:603997Sharma C, Jha NK, Meeran MFN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248612 31. The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19. Front. Pharmacol. 2021; 12:698905Wang S, Li Z, Wang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267664 32. Therapeutic prevention of COVID-19 in elderly: a case-control study. Geroscience 2021:1-11Blanc F, Waechter C, Vogel T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273049 33. Mesenchymal stem cells: ideal seeds for treating diseases. Hum. Cell 2021:1- 16Gao G, Fan C, Li W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272720 34. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial. Int Immunopharmacol 2021; 99:107969Alavi Darazam I, Shokouhi S, Mardani M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273635 35. Tocilizumab and Systemic Corticosteroids in the Management of COVID-19 Patients:A Systematic Review and Meta-Analysis. Int J Infect Dis 2021; Alkofde H, Almohaizeie A, Almuhaini S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273515 36. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med 2021:1- 20Arabi YM, Gordon AC, Derde LPG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34251506 37. High-dose dexamethasone treatment for COVID-19 severe acute respiratory distress syndrome: a retrospective study. Intern Emerg Med 2021:1-7Vecchié A, Batticciotto A, Tangianu F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34275096 38. Benralizumab: a potential tailored treatment for life-threatening DRESS in the COVID-19 era. J Allergy Clin Immunol Pract 2021; Mesli F, Dumont M, Soria A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273579 39. Tocilizumab in patients with COVID-19: which patient, time, and dose? J. Anesth. 2021; Hasanin A, Mostafa M. http://www.ncbi.nlm.nih.gov/pubmed/? term=34264384 40. Computational drug repurposing study of antiviral drugs against main protease, RNA polymerase, and spike proteins of SARS-CoV-2 using molecular docking method. J. Basic Clin. Physiol. Pharmacol. 2021; Jalalvand A, Khatouni SB, Najaf ZB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265888 41. Clinical effcacy of low-dose emetine for patients with COVID-19: a real-world study. J BioX Res 2021; 4:53-59Fan S, Zhen Q, Chen C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254034 42. Clinical Features and Outcome of Low and High Corticosteroids in Admitted COVID-19 Patients. J Epidemiol Glob Health 2021; AlBahrani S, Al-Tawfq JA, Jebakumar AZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270179 43. N-acetylcysteine for the treatment of COVID-19 among hospitalized patients. J Infect 2021; Avdeev SN, Gaynitdinova VV, Merzhoeva ZM, Berikkhanov ZG. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252497 44. The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients. J. Intensive Care Med. 2021:8850666211032175Ritter LA, Britton N, Heil EL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247526 45. Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients. J Med Virol 2021; Kalantari S, Fard SR, Maleki D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255369 46. Dexamethasone treatment may mitigate adverse effects of vitamin D defciency in hospitalised Covid-19 patients. J Med Virol 2021; Wenban C, Heer RS, Baktash V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273116 47. Clinical effcacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. J Microbiol Immunol Infect 2021; Lai CC, Chao CM, Hsueh PR. http://www.ncbi.nlm.nih.gov/pubmed/? term=34253490 48. Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study. J. Mol. Struct. 2021; 1245:131020Omar AZ, Mosa TM, El-Sadany SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248201 49. A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. J. Oncol. Pharm. Pract. 2021:10781552211031304Demir E, Sütcüoğlu O, Demir B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255596 50. Integrated vaccination and non-pharmaceutical interventions based strategies in Ontario, Canada, as a case study: a mathematical modelling study. J R Soc Interface 2021; 18:20210009Betti M, Bragazzi NL, Heffernan JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255985 51. Synthetic Attempts Towards Eminent Anti-Viral Candidates of SARS-CoV. Mini Rev. Med. Chem. 2021; Kundu S, Sarkar D. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254915 52. Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Signifcantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients. New Microbes New Infect 2021:100915Cadegiani FA, Goren A, Wambier CG, McCoy J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249367 53. Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Open Forum Infect Dis 2021; 8:ofab254Bariola JR, McCreary EK, Wadas RJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250192 54. The Effcacy of Bamlanivimab in Reducing Emergency Department Visits and Hospitalizations in a Real-world Setting. Open Forum Infect Dis 2021; 8:ofab305Corwin DS, Ender PT, Sahu N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34258324 55. Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients. Open Forum Infect Dis 2021; 8:ofab292Piccicacco N, Zeitler K, Montero J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258319 56. Impact of nonpharmacological COVID-19 interventions in hospitalizations for childhood pneumonia in Brazil. Pediatr Pulmonol 2021; Friedrich F, LC EG, Petry LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265188 57. A synthetic defective interfering SARS-CoV-2. PeerJ 2021; 9:e11686Yao S, Narayanan A, Majowicz SA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249513 58. Ultraviolet C Supported Novel Phototherapy Units at the Crossroads of the COVID-19 Pandemic. Photobiomodul Photomed Laser Surg 2021; 39:437-438Kutlu Ö. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264764 59. Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (COVID-19), current evidence with systematic review and meta-analysis. Phytother. Res. 2021; Jiang F, Xu N, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256418 60. Dexamethasone treatment for COVID-19 investigated. Pneumologie 2021; 75:415Wagner A. 61. Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: a timing challenge for clinicians. Pulm. Pharmacol. Ther. 2021:102055Ji HL, Wagener BM, Ness TJ, Zhao R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271164 62. Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment. Respir. Med. 2021; 186:106531Gupta S, Ahuja R, Sharma N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260977 63. Platelet lysate for COVID-19 pneumonia-a newer adjunctive therapeutic avenue. Stem Cell Investig 2021; 8:11Jeyaraman M, Muthu S, Khanna M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268440 64. Combination of mesenchymal stem cells and nicorandil: an emerging therapeutic challenge against COVID-19 infection-induced multiple organ dysfunction. Stem Cell. Res. Ther. 2021; 12:404Safari A, Lionetti V, Razeghian- Jahromi I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266486 65. Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial. Stem Cell. Res. Ther. 2021; 12:410Saleh M, Vaezi AA, Aliannejad R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271988 66. Sequential dosing of convalescent COVID-19 plasma with signifcant temporal clinical improvements in a persistently SARS-COV-2 positive patient. Transfus. Apher. Sci. 2021:103180Mirihagalle N, Parajuli P, Sundareshan V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247970 67. Effcacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis. Travel Med Infect Dis 2021; 43:102135Chivese T, Musa OAH, Hindy G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265436 68. Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report. Virol J 2021; 18:146Doran MA, Aytogan H, Ayıntap E. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256791 69. Review of the potential of mesenchymal stem cells for the treatment of infectious diseases. World J. Stem Cells 2021; 13:568-593Sharma A, Chakraborty A, Jaganathan BG. http://www.ncbi.nlm.nih.gov/pubmed/?term=3424922
Trials (26 articles)
1. French Multicentre Observational Study on SARS-CoV-2 infections Intensive care initial management: the FRENCH CORONA Study. Anaesth Crit Care Pain Med 2021:100931Roger C, Collange O, Mezzarobba M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256165 2. Practice of adjunctive treatments in critically ill COVID-19 patients-rational for the multicenter observational PRoAcT-COVID study in The Netherlands. Ann Transl Med 2021; 9:813Valk CMA, Swart P, Boers LS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268426 3. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect. Dis. 2021; 21:677LaVergne SM, Stromberg S, Baxter BA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256735 4. Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study. BMC Med. Res. Methodol. 2021; 21:146Marateb HR, von Cube M, Sami R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261439 5. Development and validation of the Oxford Pandemic Attitude Scale-COVID-19 (OPAS-C): an internet-based cross-sectional study in the UK and USA. BMJ Open 2021; 11:e043758Kantor BN, Kantor J. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261678 6. Design, implementation and initial fndings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease. Eur. J. Epidemiol. 2021:1-6Licher S, Terzikhan N, Splinter MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34275020 7. Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials. Front. Pharmacol. 2021; 12:656246Takayama S, Namiki T, Odaguchi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248620 8. Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis. Hum Vaccin Immunother 2021:1-7Kumar V, Aranha V, Rajgarhia R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264174 9. COVID-19 vaccine mRNA-1273 elicits a protective immune profle in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity 2021; DiPiazza AT, Leist SR, Abiona OM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270939 10. NOTTO COVID-19 Vaccine Guidelines for Transplant Recipients. Indian J. Nephrol. 2021; 31:89-91Kute VB, Agarwal SK, Prakash J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267426 11. Adverse events and humoral response after two-dose SARS-CoV-2 mRNA vaccination in the hospital personnel of a cardiopulmonary tertiary care center. Infect Control Hosp Epidemiol 2021:1-8De Vita E, Sbrana F, Quattrone F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34261574 12. Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial. Int Immunopharmacol 2021; 99:107969Alavi Darazam I, Shokouhi S, Mardani M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273635 13. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study. Int J Infect Dis 2021; Lalwani P, Salgado BB, Filho IVP et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273518 14. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med 2021:1- 20Arabi YM, Gordon AC, Derde LPG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34251506 15. Placebo-controlled trials with COVID-19 vaccines: participants frst. J. Clin. Epidemiol. 2021; Dal-Ré R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271109 16. Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining. J. Clin. Epidemiol. 2021; Honarmand K, Penn J, Agarwal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274489 17. Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective. J. Clin. Pharm. Ther. 2021; Li N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254358 18. Mortality associated with early changes in ARDS severity in COVID-19 patients - Insights from the PRoVENT-COVID study. J Crit Care 2021; 65:237-245Schuijt MTU, Martin-Loeches I, Schultz MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271294 19. Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. J. Endocrinol. Invest. 2021:1-13Oristrell J, Oliva JC, Casado E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273098 20. Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients. J Med Virol 2021; Kalantari S, Fard SR, Maleki D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255369 21. The landscape of COVID-19 trials in Australia. Med. J. Aust. 2021; 215:58- 61.e51Seidler AL, Aberoumand M, Williams JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275134 22. Early COVID-19 Therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in Outpatient Settings Signifcantly Improved COVID-19 outcomes compared to Known outcomes in untreated patients. New Microbes New Infect 2021:100915Cadegiani FA, Goren A, Wambier CG, McCoy J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249367 23. Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial. Stem Cell. Res. Ther. 2021; 12:410Saleh M, Vaezi AA, Aliannejad R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271988 24. A randomized open-label trial to evaluate the effcacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:451Sharma A, Sharma C, Raina S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266452 25. Admission Braden Scale Score as an Early Independent Predictor of In- Hospital Mortality Among Inpatients With COVID-19: A Retrospective Cohort Study. Worldviews Evid. Based Nurs. 2021; Lovicu E, Faraone A, Fortini A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34275200 26. German registry www.Covid19-Rheuma.de: Status report after 1 year of the pandemic. Z. Rheumatol. 2021; Hasseli R, Pfeil A, Hoyer BF et al.
Vaccines (91 articles)
1. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases. Acad Radiol 2021; Faermann R, Nissan N, Halshtok-Neiman O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34257025 2. Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies. Acta Cardiol Sin 2021; 37:355-364Chen PW, Tsai ZY, Chao TH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257485 3. [Immune Response to Single-Dose Moderna Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2]. Acta Med Port 2021; Moreira- Pinto J, Gregório S, Camarinha J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256902 4. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report. Acta Neurol. Scand. 2021; de Mélo Silva ML, Jr., Lopes DP. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273119 5. Two Cases of Well Controlled Chronic Spontaneous Urticaria Triggered by the Moderna COVID-19 Vaccine. Allergy Rhinol (Providence) 2021; 12:21526567211026271Alfen C, Birch K, Shilian R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249404 6. Unique Predictors of Intended Uptake of a COVID-19 Vaccine in Adults Living in a Rural College Town in the United States. Am. J. Health Promot. 2021:8901171211026132Lennon RP, Small ML, Smith RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269077 7. Intention to COVID-19 vaccination and associated factors among health care workers: A systematic review and meta-analysis of cross-sectional studies. Am. J. Infect. Control 2021; Luo C, Yang Y, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34273461 8. Post-COVID-19 vaccine Guillain-Barré syndrome; frst reported case from Qatar. Ann Med Surg (Lond) 2021; 67:102540Razok A, Shams A, Almeer A, Zahid M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249353 9. Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab- treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff et al. Ann. Rheum. Dis. 2021; Bonelli M, Aletaha D. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272251 10. Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report. Ann. Rheum. Dis. 2021; Golding B, Lee Y, Golding H, Khurana S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272252 11. Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'. Ann. Rheum. Dis. 2021; Westhoff TH, Seibert FS, Anft M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272253 12. [Human resource management and vaccination strategies in primary care in Europe during COVID-19 pandemic]. Aten. Primaria 2021; 53:102132Ares-Blanco S, Astier-Peña MP, Gómez-Bravo R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256236 13. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 2021; 14Malik B, Kalantary A, Rikabi K, Kunadi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34261635 14. Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine. BMJ Glob Health 2021; 6Sekalala S, Forman L, Hodgson T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253631 15. Intention to have the seasonal infuenza vaccination during the COVID-19 pandemic among eligible adults in the UK: a cross-sectional survey. BMJ Open 2021; 11:e049369Sherman SM, Sim J, Amlôt R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257095 16. Effcacy information infuences intention to take COVID-19 vaccine. Br. J. Health Psychol. 2021; Davis CJ, Golding M, McKay R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250684 17. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses. Cell 2021; Nathan A, Rossin EJ, Kaseke C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265281 18. Evaluating Vaccine Effcacy Against SARS-CoV-2 Infection. Clin Infect Dis 2021; Lin DY, Gu Y, Zeng D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260716 19. Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID- 19 vaccine hesitancy in the United States. Clin Infect Dis 2021; Tram KH, Saeed S, Bradley C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272559 20. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in health care workers: an observational study using surveillance data. Clin Microbiol Infect 2021; Paris C, Perrin S, Hamonic S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265462 21. The SARS-CoV-2 Vaccine Hesitancy Among the General Population: A Large Cross-Sectional Study From Kuwait. Cureus 2021; 13:e16261Burhamah W, AlKhayyat A, Oroszlányová M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268064 22. COVID-19 Vaccination-Induced Rash: Does the Choice of Vaccine Matter? Cureus 2021; 13:e15490Zafar M, Ewnetu B, Ahmed S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268022 23. A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants? Curr Clin Microbiol Rep 2021:1-8Noor R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249605 24. A half measure: Every COVID-19 single-dose vaccination offers only suboptimal protection. Deutsche Apotheker Zeitung 2021; 161. 25. Impfung im EU-Ausland Digitale Zertifkate möglich. Deutsche Apotheker Zeitung 2021; 161. 26. Myocarditis after mRNA vaccination: Discussions about risks of the new COVID-19 vaccines for younger men. Deutsche Apotheker Zeitung 2021; 161Blasius H. 27. Leave of absence for COVID-19 vaccination?: Labor law in times of corona. Deutsche Apotheker Zeitung 2021; 161Van Den Heuvel M. 28. Lack of vaccination and associated comorbidities predispose to the need for intensive care in individuals infected with the delta variant - A case cohort study from a tertiary care hospital in New Delhi, India. Diabetes Metab Syndr 2021; 15:102203Vaishya R, Sibal A, Sharma H, Singh SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=34265494 29. The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization. Eur J Case Rep Intern Med 2021; 8:002617Sazgary L, Meienberg A, Berger CT, Mayr M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268264 30. COVID-19 mRNA Vaccine and Myocarditis. Eur J Case Rep Intern Med 2021; 8:002681Singh B, Kaur P, Cedeno L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34268277 31. Primary adrenal insuffciency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT). Eur J Intern Med 2021; Varona JF, García-Isidro M, Moeinvaziri M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34256983 32. Effcacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021. Euro Surveill 2021; 26Harder T, Koch J, Vygen-Bonnet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269175 33. Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England. Euro Surveill 2021; 26Powell AA, Power L, Westrop S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269172 34. Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2. EuroMediterr J Environ Integr 2021; 6:61Jbeli R, Jelassi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250222 35. COVID-19 vaccination associated severe immune thrombocytopenia. Exp Hematol Oncol 2021; 10:42Shah SRA, Dolkar S, Mathew J, Vishnu P. http://www.ncbi.nlm.nih.gov/pubmed/?term=34266487 36. Thromboembolic events in younger women exposed to Pfzer-BioNTech or Moderna COVID-19 vaccines. Expert Opin. Drug Saf. 2021; Sessa M, Kragholm K, Hviid A, Andersen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264151 37. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines 2021:1-13Cooper S, van Rooyen H, Wiysonge CS. http://www.ncbi.nlm.nih.gov/pubmed/?term=34252336 38. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets. Front. Immunol. 2021; 12:694857Riddell S, Goldie S, McAuley AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248993 39. Socio-Demographics Correlate of COVID-19 Vaccine Hesitancy During the Second Wave of COVID-19 Pandemic: A Cross-Sectional Web-Based Survey in Saudi Arabia. Front Public Health 2021; 9:698106Al-Mohaithef M, Padhi BK, Ennaceur S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249851 40. Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants. Front Public Health 2021; 9:702960Stoehr JR, Hamidian Jahromi A, Thomason C. http://www.ncbi.nlm.nih.gov/pubmed/? term=34249853 41. Effcacy of Covid-19 vaccines: several modes of expression should be presented in scientifc publications. Fundam. Clin. Pharmacol. 2021; Montastruc JL, Biron P, Sommet A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250637 42. Safety, effcacy and acceptability of SARS-CoV-2 vaccines in patients with cancer. Future Virol. 2021; Chebel R, Labaki C, Farhat M, Kattan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34249141 43. COVID outbreak after the 1st dose of COVID vaccine among the nursing home residents: What happened? Geriatr. Nurs. 2021; 42:1105-1108Ye P, Fry L, Liu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274688 44. Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review. Glob Health Med 2021; 3:129-133Minamimoto R, Kiyomatsu T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250287 45. Determinants of COVID-19 vaccine acceptance in the Arab world: a cross- sectional study. Glob Health Res Policy 2021; 6:23Kaadan MI, Abdulkarim J, Chaar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253254 46. COVID-19 Vaccination: crucial roles and opportunities for the mental health professionals. Glob Ment Health (Camb) 2021; 8:e25Banerjee D, Mukhopadhyay S, Sahana Asmeen M, Javed A. http://www.ncbi.nlm.nih.gov/pubmed/? term=34258020 47. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. Hematol. Oncol. 2021; Cuneo A, Rigolin GM, Coscia M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258787 48. Assessing licensed nurses COVID-19 vaccine attitudes and intentions: a cross-sectional survey in the state of Hawaii. Hum Vaccin Immunother 2021:1- 8Fontenot HB, Mattheus D, Lim E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254888 49. Landscape and progress of global COVID-19 vaccine development. Hum Vaccin Immunother 2021:1-5Huang HY, Wang SH, Tang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254894 50. Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis. Hum Vaccin Immunother 2021:1-7Kumar V, Aranha V, Rajgarhia R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264174 51. COVID-19 Vaccination Willingness and Hesitancy in Patients With Infammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association. Infamm. Bowel Dis. 2021; Costantino A, Noviello D, Conforti FS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34259844 52. Prosociality and Social Responsibility Were Associated With Intention of COVID-19 Vaccination Among University Students in China. Int J Health Policy Manag 2021; Yu Y, Luo S, Mo PK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34273931 53. Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine. Int. J. Hematol. 2021; Waqar SHB, Khan AA, Memon S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264514 54. Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case. Int J Infect Dis 2021; Connor BA, Couto-Rodriguez M, Barrows JE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271202 55. Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int. Rev. Immunol. 2021:1- 10Novak N, Tordesillas L, Cabanillas B. http://www.ncbi.nlm.nih.gov/pubmed/? term=34251972 56. Frontier Therapeutics and Vaccine Strategies for SARS-CoV-2 (COVID-19): A Review. Iran J. Public Health 2020; 49:18-29Sheikhshahrokh A, Ranjbar R, Saeidi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268202 57. Young Adult Perspectives on COVID-19 Vaccinations. J. Adolesc. Health 2021; Adams SH, Schaub JP, Nagata JM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34274212 58. Placebo-controlled trials with COVID-19 vaccines: participants frst. J. Clin. Epidemiol. 2021; Dal-Ré R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271109 59. Review of COVID-19 Variants and COVID-19 Vaccine Effcacy: What the Clinician Should Know? J. Clin. Med. Res. 2021; 13:317-325Vasireddy D, Vanaparthy R, Mohan G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267839 60. Participation in ENSEMBLE phase III multicenter clinical trial of Ad26.CoV2.S, a COVID-19 vaccine: An investigational drug services perspective. J. Clin. Pharm. Ther. 2021; Li N. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254358 61. Attitudes and intentions towards COVID-19 vaccines and associated factors among Egyptian adults. J Infect Public Health 2021; Omar DI, Hani BM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34247946 62. Predicted and Observed Incidence of Thromboembolic Events among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine. J Korean Med Sci 2021; 36:e197Huh K, Na Y, Kim YE et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34254476 63. Emergency Department Utilization by In-hospital Healthcare Workers after COVID-19 Vaccination. J Korean Med Sci 2021; 36:e196Park MJ, Choi YJ, Choi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254475 64. COVID-19 vaccination and the right to take risks. J. Med. Ethics 2021; Huang PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253621 65. SAFETY OF COVID-19 VACCINES. J Med Virol 2021; Al Khames Aga QA, Alkhaffaf WH, Hatem TH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34270094 66. Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report. J Med Virol 2021; Conticini E, D'Alessandro M, Bergantini L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34251683 67. Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy. J Med Virol 2021; Elgendy MO, Abdelrahim MEA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255346 68. Commentary: The spectrum of neurological manifestations related to COVID- 19 and vaccinations. J. Neuroimmunol. 2021; 358:577660Samudralwar RD. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274719 69. COVID-19 Vaccination in Pregnancy: The Benefts Outweigh the Risks. J. Obstet. Gynaecol. Can. 2021; 43:814-816Chavan M, Qureshi H, Karnati S, Kollikonda S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253304 70. Integrated vaccination and non-pharmaceutical interventions based strategies in Ontario, Canada, as a case study: a mathematical modelling study. J R Soc Interface 2021; 18:20210009Betti M, Bragazzi NL, Heffernan JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255985 71. COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfzer-BioNTech and Moderna Vaccines Among Community Healthcare Workers. J Racial Ethn Health Disparities 2021; Famuyiro TB, Ogunwale A, des Bordes J, Raji M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264506 72. Coincidence of fever following COVID-19 vaccine and endemic tropical diseases: A challenge to clinicians during the global rollout of COVID-19 vaccination. J Travel Med 2021; Asawapaithulsert P, Pisutsan P, Matsee W. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272852 73. Systematic Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients with Chronic Kidney Disease. Kidney Int Rep 2021; Carr EJ, Kronbichler A, Graham-Brown M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34250319 74. Acute facial paresis as a possible complication of vaccination against SARS- CoV-2. Laryngo- Rhino- Otologie 2021; 100:526-528Volk GF, Kuttenreich AM, Geitner M, Guntinas-Lichius O. 75. Reprint of: The Dark Side of the Moon: Global challenges in the distribution of vaccines and implementation of vaccination plans against COVID-19. Maturitas 2021; 150:61-63Mesa-Vieira C, Botero-Rodríguez F, Padilla-Muñoz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274076 76. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Mol. Pharm. 2021; Chatzikleanthous D, O'Hagan DT, Adamo R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264684 77. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol Sci 2021:1-3Nasuelli NA, De Marchi F, Cecchin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272622 78. Is it possible to ensure COVID19 vaccine supply by using plants? Nucleus (Calcutta) 2021:1-5Bhar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248208 79. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances. Obes Rev 2021; Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269511 80. Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. Open Forum Infect Dis 2021; 8:ofab299Velasco M, Galán MI, Casas ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258322 81. SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit. Pediatr Blood Cancer 2021:e29240Nigro O, Sironi G, Bergamaschi L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34264546 82. AstraZeneca's COVID-19 vaccine: Vector vaccine with high protective effect. Pharm. Ztg. 2020; 165:46-48Dingermann T. 83. COVID-19 vaccines: Unanswered questions about effectiveness. Pharm. Ztg. 2020; 165:38-40Hohmann-Jeddi C. 84. COVID-19 pandemics Stage II - Energy and environmental impacts of vaccination. Renew Sustain Energy Rev 2021; 150:111400Klemeš JJ, Jiang P, Fan YV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248390 85. [Explanatory factors on the acceptance of SARS-CoV-2 vaccine from consumer's behaviour perspective.]. Rev. Esp. Salud Publica 2021; 95de Andrés Sánchez J, Arias-Oliva M, Pelegrín-Borondo J, Lima Rua O. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267176 86. Safety and Tolerability of SARS-CoV-2 Emergency-Use Authorized Vaccines Allogeneic Hematopoietic Stem Cell Transplant Recipients. Transplant Cell Ther 2021; Ali H, Ngo D, Aribi A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34274492 87. Signifcance of SARS-CoV-2 specifc antibody testing during COVID-19 vaccine allocation. Vaccine 2021; Fujimoto AB, Keskinocak P, Yildirim I. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274126 88. One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model. Vaccine 2021; Gooch KE, Smith TRF, Salguero FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253420 89. Henoch-Schönlein purpura presenting post COVID-19 vaccination. Vaccine 2021; Hines AM, Murphy N, Mullin C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34247902 90. Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-beneft analysis for people < 60 years in Australia. Vaccine 2021; MacIntyre CR, Veness B, Berger D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272095 91. Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021. Vaccine 2021; Mateo-Urdiales A, Del Manso M, Andrianou X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253419
Women – pregnancy (35 articles) 1. Changes in obstetric interventions and preterm birth during COVID-19: A nationwide study from Iceland. Acta Obstet Gynecol Scand 2021; Einarsdóttir K, Swift EM, Zoega H. http://www.ncbi.nlm.nih.gov/pubmed/?term=34255860 2. Titres and neutralising capacity of SARS-CoV-2-specifc antibodies in human milk: a systematic review. Arch. Dis. Child. Fetal Neonatal Ed. 2021; Low JM, Low YW, Zhong Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34257103 3. Elevated risk for obsessive-compulsive symptoms in women pregnant during the COVID-19 pandemic. Arch Womens Ment Health 2021; Mahaffey BL, Levinson A, Preis H, Lobel M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34269873 4. Clinical relevance of SARS-CoV-2 infection in late pregnancy. BMC Pregnancy Childbirth 2021; 21:505Ruggiero M, Somigliana E, Tassis B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253173 5. [Adaptation of Health Care Organization in a level III Maternity Hospital during the COVID-19 pandemic]. Bull. Acad. Natl. Med. 2021; Hascoët JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248144 6. Cerebral Vasculitis in a COVID-19 Confrmed Postpartum Patient: A Case Report. Case Rep. Neurol. 2021; 13:324-328Chua AMU, Jamora RDG, Jose ACE, Anlacan VMM. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248564 7. COVID-19 in a pregnant patient with beta-thalassemia major: A case report. Clin Case Rep 2021; 9:e04331Hailan YMA, Sayed G, Yassin MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=34267898 8. Women's Sexual Health During the Pandemic of COVID-19: Declines in Sexual Function and Sexual Pleasure. Curr Sex Health Rep 2021:1-13de Oliveira L, Carvalho J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34248426 9. Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and in vitro fertilization outcomes: A retrospective cohort study. EClinicalMedicine 2021; 38:101013Wang M, Yang Q, Ren X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250457 10. Association of ABO and Rh blood groups with obstetric outcomes in SARS- CoV-2 infected pregnancies: A prospective study with a multivariate analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 264:41-48Sainz Bueno JA, Cerrillos González L, Abascal-Saiz A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=34271364 11. Impact of innovative pelvic foor muscle training on quality-adjusted life years (QALYs) in women with stress urinary incontinence treated by duloxetine. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 264:25-30Svihra J, Hagovska M, Breza J, Jr. et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271362 12. Thromboembolic events in younger women exposed to Pfzer-BioNTech or Moderna COVID-19 vaccines. Expert Opin. Drug Saf. 2021; Sessa M, Kragholm K, Hviid A, Andersen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=34264151 13. One Year Into the Pandemic: A Systematic Review of Perinatal Mental Health Outcomes During COVID-19. Front Psychiatry 2021; 12:674194Iyengar U, Jaiprakash B, Haitsuka H, Kim S. http://www.ncbi.nlm.nih.gov/pubmed/? term=34248710 14. Breastfeeding and COVID-19. Gac Med Mex 2021; 157:194-200Galindo-Sevilla NDC, Contreras-Carreto NA, Rojas-Bernabé A, Mancilla-Ramírez J. http://www.ncbi.nlm.nih.gov/pubmed/?term=34270527 15. COVID-19 during pregnancy. Geburtshilfe Frauenheilkd. 2021; 81:588Lorenz J. 16. The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcifcation. Geroscience 2021:1-15Cereda A, Toselli M, Palmisano A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260010 17. COVID-19 infection in pregnancy: a single center experience with 75 cases. Ginekol. Pol. 2021; Damar Çakırca T, Torun A, Hamidanoğlu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263921 18. The impact of COVID-19 pandemic on reproductive intentions among the Polish population. Ginekol. Pol. 2021; Sienicka A, Pisula A, Pawlik KK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34263917 19. Did the SARS-CoV-2 effect pregnancy complications? Ginekol. Pol. 2021; Yucel Celik O, Çelen Ş, Engin Üstün Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=34263916 20. Oncophone20 study: Patients' perception of telemedicine in the COVID-19 pandemic during follow-up visits for gynecological and breast cancers. Int J Gynaecol Obstet 2021; Picardo E, Baù MG, Anatrone C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34258764 21. Clinical Features and Outcomes of COVID-19 Infection among Pregnant Women in South Africa. Int J MCH AIDS 2021; 10:1-9Basu JK, Chauke L, Magoro T. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262795 22. Prenatal Stress and Psychiatric Symptoms During Early Phases of the COVID- 19 Pandemic in Italy. Int J Womens Health 2021; 13:653-662Colli C, Penengo C, Garzitto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34262355 23. Obstetrics and Neonatal Outcomes in Pregnant Women with COVID-19: A Systematic Review. Iran J. Public Health 2020; 49:38-47Banaei M, Ghasemi V, Saei Ghare Naz M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34268204 24. Psychometric properties of the Italian version of the Pandemic-Related Pregnancy Stress Scale (PREPS) and its correlation with anxiety and depression. J. Affect. Disord. 2021; 294:48-53Penengo C, Colli C, Garzitto M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34271249 25. Evaluation of clinical outcomes of neonates born to mothers with coronavirus (COVID-19) in Shahid Beheshti Hospitals. J Educ Health Promot 2021; 10:173Hosseini MS, Hosseini A, Ghaffari E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34250107 26. Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19. J Med Virol 2021; Akdemir Y, Haciseyitoglu D, Celebi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34260081 27. COVID-19 Vaccination in Pregnancy: The Benefts Outweigh the Risks. J. Obstet. Gynaecol. Can. 2021; 43:814-816Chavan M, Qureshi H, Karnati S, Kollikonda S. http://www.ncbi.nlm.nih.gov/pubmed/?term=34253304 28. Maternal deaths due to COVID-19 disease: The cases in a single center pandemic hospital in the south east of Turkey. J. Obstet. Gynaecol. Res. 2021; Bağlı İ, Öcal E, Yavuz M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254718 29. Does time change the anxiety and depression scores for pregnant women on Covid-19 pandemic? J. Obstet. Gynaecol. Res. 2021; Geren A, Birge Ö, Bakır MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34254394 30. Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis. J Thromb Haemost 2021; Jevtic SD, Malinowski AK, Othman M, Kadir RAA. http://www.ncbi.nlm.nih.gov/pubmed/? term=34260818 31. Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? Med. Hypotheses 2021; 153:110641Figueiro-Filho EA, Hobson SR, Farine D, Yudin MH. http://www.ncbi.nlm.nih.gov/pubmed/? term=34256245 32. Delivery management of suspected or confrmed COVID-19 positive mothers. Pediatr. Neonatol. 2021; Lin C, Chu SM, Hsu JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34272199 33. COVID-19: Increased mortality among pregnant women. Pharm. Ztg. 2021; 166:52-53Dingermann T. 34. Validation of the French IVF guidelines during the COVID-19 pandemic. Reprod. Biomed. Online 2021; Poulain M, Fossard C, Benammar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=34274240 35. COVID-19: The pandemic has serious consequences for mother and child. Z. Geburtshilfe Neonatol. 2021; 225:198Lorenz J.
to subscribe click here
mailing address is: [email protected]
© P.J. Lansberg